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ABSTRACT 
MECHANISTIC STUDIES OF THE ELONGATION CYCLE OF PROTEIN 
SYNTHESIS 
 
Wei Liu 
Barry S. Cooperman 
 
During translation elongation, amino acid residues are repetitively added to the 
growing nascent peptide chain, directed by the mRNA sequence and facilitated by two 
elongation factors, EF-Tu and EF-G. In this thesis, translation elongation is 
investigated from two new perspectives to further explore the underlying 
mechanisms.  
In the first approach, a functional EF-Tu derivative labeled with a fluorescence 
quencher was prepared and used for the development of two fluorescent assays to 
study EF-Tu:L11 and EF-Tu:tRNA FRET signals. Application of these two assays 
revealed the tRNA discrimination on the ribosomal A-site, the effects of 
error-inducing antibiotics on tRNA selection, and tRNA release from EF-Tu on the 
ribosome regulated by EF-Tu:tRNA affinity. In combination with other assays 
measuring pre-translocation complex formation, ensemble and single molecule FRET 
studies of the EF-Tu:L11:tRNA triangle indicated that EF-Tu:L11 separation occurs 
concurrently with inorganic phosphate release and tRNA accommodation, but prior to 
EF-Tu separation from tRNA and dissociation from the ribosome. The latter process 
 viii
proceeds through two possible pathways, rapid but reversible dissociation followed by 
a conformational change off the ribosome versus slow conformational change on the 
ribosome followed by rapid dissociation.  
Translation elongation was also studied using mRNAs specifically modified with 
fluorescent isomorphic nucleoside mimetics. These modified mRNAs maintain 
considerable functionalities in the formation of initiation, pre-translocation and 
post-translocation complexes, although with different efficiencies, and show 
fluorescence changes in different patterns upon ribosomal complex conversion. 
Pre-steady state measurements of these fluorescence changes demonstrate the 
responses of modified mRNAs to codon:anticodon interaction occurring after ternary 
complex initial binding to the ribosome but before tRNA accommodation into the 
A-site, and mRNA movements on the ribosome during translocation. 
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CHAPTER 1  
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2
1.1 Gene expression and the central dogma  
For the propagation of all three kingdoms of life, except for some viruses, heredity 
information is exclusively stored in genes made up of deoxyribonucleic acids (DNAs). 
During propagation, the double-helical structure of DNA allows gene replication by 
nucleotide polymerization using one DNA strand as a template according to 
Watson-Crick base paring (Figure 1.1) (Watson and Crick, 1953a; Watson and Crick, 
1953b; Crick, 1970). Within the living organism, the achievement of most of the 
biological functions depends on transcription of genes into ribonucleic acids (RNAs) 
and further translation of a portion of RNAs into proteins. 
 The transcription of DNA is performed by RNA polymerase using four 
ribonucleosides as substrates (adenosine, A; guanosine, G; cytidine, C; uridine, U) 
(Kornberg, 2007). Biosynthesized RNAs are classified according to their diverse 
functions. Messenger RNA (mRNA) further serves as the template of translation to 
direct protein biosynthesis. Transfer RNAs (tRNAs) act as an information bridge 
between mRNA and protein. Ribosomal RNAs (rRNAs), accounting for ~80% of the 
RNAs in prokaryote, is the major components of ribosome, the protein synthesis 
machine. In eukaryotic cells, additional small non-coding RNAs are also transcribed 
for various regulation purposes (Lee and Dutta, 2009). 
 In RNAs, genetic information is still encoded by the sequence of four 
ribonucleosides. However, the huge amount of functions to be performed requires the 
more complexity in both 3-dimensional structure and properties. Consequently, three 
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consecutive nucleosides in an mRNA are decoded as a codon to mediate the 
polymerization of each of 20 natural amino acids, with diverse chemical and physical 
properties conferred by the side chains of amino acids. Such a translation process is 
performed on the ribosome, a macromolecule composed of rRNAs and ribosomal 
proteins, with participation of numerous protein factors. In prokaryotic cells, mRNA 
is bound to the ribosome for translation before the transcription is complete. In 
eukaryotic cells, transcription is performed in the nucleus and the transcripts are 
subject to necessary modification (e.g. splicing, 5’- capping and 3’- poly(A) addition) 
with the help of small non-coding RNAs before their export to the cytoplasm for 
translation (Nishikura, 2006; Wahl et al., 2009). Recent studies revealed that 
co-translational recruitment of different factors to the ribosome helps the folding of 
proteins into their native states and the transportation of proteins to the places for their 
function performance (e.g. inner membrane proteins are targeted to the membrane by 
signal recognition particle)(Luirink et al., 2005). 
 
1.2 Prokaryotic ribosome 
 In prokaryotic cells, the 70S (S is the unit for sedimentation velocity) ribosome, a 
macromolecule with a mass of ~ 2.6 MDa, is formed by association of the 30S and the 
50S subunits, both of which are composed of rRNA and proteins (Figure 1.2; Table 
1.1). The small 30S subunit consists of a 16S rRNA of ~1500 nucleotides and 20 or 
21 ribosomal proteins, and the large 50S subunit consists of a 23S rRNA and a 5S 
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rRNA of ~3000 nucleotides in total, and 31-35 ribosomal proteins (Kaltschmidt and 
Wittmann, 1970; Yonath, 2010). It is believed that many of the enzymatic and 
functional sites on the ribosome are primarily constructed by rRNA with exquisitely 
defined conformation e.g. decoding center (DC), peptidyl transferase center (PTC) 
and GTPase-associated center (GAC). Ribosomal proteins are located mostly on the 
periphery of the ribosome and assumed to maintain the ribosome’s architecture and 
facilitate some of the functions of rRNA e.g. L11 in GAC (Qin et al., 2012) and S12 
in signal transduction between DC and GAC (Gregory et al., 2009). A series of sites 
have been defined in the ribosome for tRNA binding within both 30S and 50S 
subunits: aminoacyl- (A) site, peptidyl- (P) site and exit (E) site (Yonath, 2010; 
Schmeing et al., 2009a). During the translation process, incoming tRNA needs to bind 
to each of these sites in turn for a complete elongation cycle. 
 
1.3 Translation cycle  
During translation, mRNA binds to the ribosome and its coding sequence directs 
recruitment of aminoacyl-tRNA (aa-tRNA) and synthesis of nascent polypeptide. 
Overall the translation cycle can be divided into 4 stages: initiation, elongation, 
termination and recycling (Figure 1.3).  
The formation of 70S initiation complex (70SIC) is facilitated by three initiation 
factors (IF1–3). mRNA, initiator tRNA (fMet-tRNAfMet) and IF1–3 first bind to the 
30S subunit to form a 30S pre-initiation complex (30S PIC) (Laursen et al., 2005). 
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The IF1 binding site on the 30S subunit partially overlaps with the DC, reflecting its 
role as preventing the premature binding of any aa-tRNA to the ribosomal A-site 
(Moazed et al., 1995). IF3 prevents the premature docking of the 50S subunit onto the 
30S subunit before 30S IC formation (Grunberg-Manago et al., 1975; Sacerdot et al., 
1996). IF2 promotes binding of fMet-tRNAfMet, in the form of 
IF2.GTP.fMet-tRNAfMet, to the ribosomal P-site, mediated by strict base paring of 
three nucleotides on tRNA, denoted anti-codon, with the AUG start codon of mRNA 
(Gualerz and Pon, 1990; Boelen and Gualerzi, 2002; Tsai et al., 2012), which is 
facilitated and monitored also by IF1 and IF3 (Canonaco et al., 1986; Tedin et al., 
1999). The specific binding of mRNA on 30S is mediated by the complementary 
base-pairing between a short segment of RNA in the 5’-untranslated region (5’-UTR) 
of mRNA, denoted the Shine-Dalgarno sequence, and the anti-Shine-Dalgarno 
sequence in 16S rRNA, thus precisely place the AUG start codon on mRNA at the 
P-site of the 30S subunit (Shine and Dalgarno, 1974; Yusupova et al., 2006) (Figure 
1.4). The codon-anticodon interaction between mRNA and fMet-tRNAfMet induces the 
conformational transformation from 30S PIC to 30SIC, followed by the release of 
IF1–3 and association of the 50S subunit with 30SIC to form 70SIC, in which only 
ribosomal P-site is occupied by a tRNA (Grigoriadou et al., 2007a, b; Milón et al., 
2008; Milón et al., 2012). 
Translation elongation can be further dissected in to two stages, peptide bond 
formation and translocation. Peptide bond formation begins with the delivery of 
aa-tRNA to the empty ribosomal A-site catalyzed by elongation factor Tu (EF-Tu), in 
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the form of ternary complex (TC) EF-Tu.GTP.aa-tRNA (Rodnina et al., 1994; Pape et 
al., 1998) (Figure 1.5A). TC first binds to the highly flexible L7/L12 stalk (Schmeing 
et al., 2009a; Gao et al., 2009), a common binding site for all translational GTPase, 
then contacts the body of the ribosome at A/T site, with the anticodon on tRNA 
interacting with the codon on mRNA in the 30S subunit, and EF-Tu, together with the 
acceptor arm of tRNA, coming in proximity to GAC in the 50S subunit (Schmeing et 
al., 2009a). In such a binding status, tRNA displays a distorted conformation 
compared with what it has in unbound TC, which has been assumed to be functionally 
significant in tRNA accommodation into the A-site (Schmeing and Ramakrisnan, 
2009b; Cochella and Green, 2005). The recognition of cognate codon in the DC 
triggers both local and global conformational changes in the ribosomal complex and 
the activation of GTPse activity of EF-Tu bound within the GAC (Voorhees et al., 
2010). Rapid and irreversible GTP hydrolysis leads to a series of changes on the 
ribosome resulting in new peptide bond formation via peptidyl transfer from the P-site 
peptidyl-tRNA to the newly accommodated A-site aa-RNA, and the formation of 
pre-translocation (PRE) complex. 
Following peptide bond formation, PRE complex spontaneously fluctuates 
between two states, accompanied by three different kinds of dynamic processes: 1) a 
ratcheting movement of the 30S subunit relative to the 50S subunit and a swiveling of 
the head domain of the 30S subunit (Frank and Agrawal, 2000; Zhang et al., 2009); 2) 
fluctuation of tRNAs between A/A, P/P site (denoted classical state) and A/P, P/E site 
(denoted hybrid state), respectively (Chen et al., 2011a); 3) a folding-in of L1 stalk, 
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consisting of ribosomal protein L1 and 23S rRNA, permitting it to interact with the 
elbow region of P/E tRNA (Valle et al., 2003a). Elongation factor G (EF-G) binds to 
the ribosome in the form of EF-G.GTP and catalyzes the unidirectional movement of 
tRNAs, together with mRNA, from A- and P- site to P- and E-site, respectively, 
leading to the formation of post-translocation (POST) complex, in which 
peptidyl-tRNA is bound at the ribosomal P-site, and the ribosomal A-site is empty and 
ready for the next incoming aa-tRNA (Figure 1.5B). 
The elongation cycle is repeated to decode the consecutive 3-nucleotide codons 
until the ribosomal A-site encounters stop codons (UAA, UAG or UGA), a signal of 
translation termination. Release factor 1 (RF1, reading UAA and UAG) or 2 (RF2, 
reading UAA and UGA) is recruited to promote the hydrolysis of peptidyl-tRNA and 
subsequent peptide release from the ribosome (Laurberg et al., 2008; Weixlbaumer et 
al., 2008). A third release factor 3 (RF3) is also involved to facilitate the dissociation 
of RF1 and RF2 from the ribosome after peptide hydrolysis in a GTP-dependent 
manner (Freistroffer, 1997; Zhou et al., 2012). After RF3 dissociation, the remaining 
ribosomal complex dissociates, assisted by ribosome recycling factor (RRF) and EF-G, 
into the 50S subunit and the 30S complex carrying mRNA and a deacylated tRNA in 
the P-site (Hirashima and Kaji, 1973; Franckenberg et al., 2012). Further dissociation 
of mRNA and tRNA from the 30S subunit requires the action of IF3, thus is coupled 
to next round of translation initiation (Karimi et al., 1999; Hirokawa et al., 2008).  
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1.4 Crystallographic studies of the ribosome 
 Crystallography has long exhibited its power to elucidate the structure and 
function of biomolecules. An early view of the 70S ribosome by cryo-electron 
microscopy (cryo-EM) came in 1976 (Lake, 1976), and a reconstruction of the 70S 
ribosome with three tRNAs at a resolution of 25 Å was obtained in 1995 (Frank et al., 
1995). Availability of high-quality crystals and advances in both instrument and data 
refining method have pushed the resolution down below 10 Å, which permits further 
understanding of the ribosome and translation. Stark et al. reported the structure of 
70S-ribosome bound TC and described the interaction between EF-Tu and the 
ribosome (Stark et al., 1997). Then the interaction of tRNA in the ribosomal A/T site 
was also reported to suggest an active role of tRNA in accommodation (Valle et al., 
2002). High-resolution reconstruction of TC bound to 70S provided a more clear 
snapshot of TC interaction with the ribosome, displayed the conformational changes 
in tRNA, EF-Tu and GAC during codon recognition, and indicated possible 
mechanisms for EF-Tu catalyzed GTP hydrolysis and codon decoding (Stark et al., 
2002; Valle et al., 2003a; Schuette et al., 2009; Villa et al., 2009). Later, the 
development of time-resolved single particle cryo-EM and unbiased computational 
sorting of cryo-EM images made possible following a dynamic biological event. 
Application of these new techniques to tRNA translocation on the ribosome revealed 
several intermediate states of tRNA, besides the classical and hybrid states reported 
earlier, and defined the tRNA:70S interactions on the translocation pathway (Fischer 
et al., 2010). It was indicated that tRNA movements during translocation are coupled 
 9
with conformational changes of the ribosome, including the head and body of 30S and 
the L1 stalk. The ribosome is believed to act as a Brownian machine to direct 
translocation by coupling spontaneous conformational changes of various regions. 
 Despite its success in elucidating ribosomal structure and function, the relatively 
low resolution of cryo-EM makes it hard to rationalize the mechanism of translation 
at a molecular level. Higher resolution is provided by X-ray crystallography. The 
structures of the 30S subunit from T. thermophilus (Wimberly et al., 2000) and the 
50S subunit from H. marismortui (Ban et al., 2000) with resolutions of 3.0 and 2.4 Å , 
respectively, shed light on the organization of rRNA and ribosomal proteins in the 
ribosome and served as the basis for phasing and molecular-level interpretation of all 
subsequent ribosomal structures. In 2001, a crystal structure of the complete 70S 
ribosome bound with mRNA and three tRNAs was reported by Noller and 
collaborators, into the electron density map of which all of rRNAs, mRNA and tRNAs 
and most of ribosomal proteins can be fitted (Yusupov et al., 2001). This 
high-resolution picture of the ribosome complex, with a resolution of 5.5 Å, provided 
a clear view of the interface between 30S and 50S subunit, especially the intersubunit 
bridges, and the environments of three tRNA binding sites and the tRNA:ribosome 
interaction, thus implying the coupling of intersubunit movements with tRNA 
movements during translocation. 
 Since then, the X-ray structures have been reported of ribosome complexes 
engaged in mRNA decoding (Demeshkina et al., 2012; Jenner et al., 2010), 
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translocation (Gao et al., 2009; Dunkle et al., 2011) and termination (Korostelev et al., 
2008). Of particular relevance to the thesis here are two structures of 70S ribosome 
complexes containing bound TC. In 2009, a structure with TC stabilized in A/T state 
by kirromycin and paromomycin was published (Schmeing et al., 2009a), showing the 
details of tRNA distortion in A/T state when it simultaneously interacts with the A-site 
codon in the DC of the 30S subunit and EF-Tu. Such interactions, together with 
EF-Tu:70S interactions (at the GAC of the 50S subunit) and with changes of 
EF-Tu:tRNA interactions, led to the proposal of a possible signal transduction 
pathway for inducing the GTPase activation of EF-Tu and GTP hydrolysis on EF-Tu 
upon cognate codon:anticodon interaction (Schmeing and Ramakrishnan, 2009b). 
Important for the work presented below, the Schmeing’s (Schmeing et al., 2009a) 
structure showed that positions suitable for fluorophore or quencher labeling on i) A/T 
site bound tRNA, ii) ribosomal protein L11 and iii) EF-Tu form an approximately 
equilateral triangle, with distances suitable for FRET studies (see Chapter III for 
details). This serves as the basis for EF-Tu studies presented in Chapter III and IV. A 
second structure of TC stabilized on the ribosome by paromomycin and GDPCP, a 
non-hydrolysable GTP analog, was reported later (Voorhees et al., 2010), focusing on 
the details in GAC region and how EF-Tu is activated for catalyzing GTP hydrolysis. 
 
1.5 Kinetic studies examining ribosome function 
 Ensemble kinetic studies of the ribosome during translation primarily rely on 
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site-specific labeling of translation components, including tRNA and translation 
factors, with organic fluorophores. Monitoring fluorescent signal change during 
dynamic processes or fluorescence resonance energy transfer (FRET) signal between 
two fluorophores in proximity, together with some other assays (e.g. GTP hydrolysis, 
dipeptide formation and puromycin reactivity assays), allow comparison of relative 
timing of different functional steps, provide evidence for functionally competent 
intermediates, and provide extensive insights into the mechanism of translation.  
The works in our lab, utilizing the FRET signal between labeled 50S subunit and 
IF2 programmed on 30SIC, demonstrate the interaction of IF2 with GAC and the role 
of fidelity control played by IF3 in monitoring the initiation codon (Qin et al., 2009). 
A more recent report (Milón et al., 2012), using labeled IF1–3, fMet-tRNAfMet and 
mRNA, illustrates a real-time assemble scheme of 30S PIC formation and the 
checkpoints of mRNA selection. Rodnina and her colleague formulated a quantitative 
kinetic scheme for tRNA dynamics during its selection, demonstrating how the correct 
tRNA is differentiated from other tRNAs and how translation has evolved to optimize 
the speed and accuracy of codon decoding (Pape et al., 1998; Gromadski and Rodnina, 
2004a; Wohlgemuth et al., 2010). Pan et. al. (Pan et al., 2007), by using tRNAs with 
fluorophore labels at the elbow region, successively isolated a kinetically competent 
intermediate on the translocation pathway, suggesting that the movements of P- and 
A-site tRNA on conversion from classical to hybrid state could be decoupled. 
Translation termination was also investigated by using an short mRNA labeled at the 
3’-end, showing how stop codon is precisely selected by RF1 against sense codon and 
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how stop codon decoding is correlated with catalyzed peptide release (Hetrick et al., 
2009). 
 
1.6 Monitoring ribosomal translation with smFRET 
 Biochemical and structural studies have demonstrated the complexity of 
translation as a multi-step and multi-component process and the highly dynamic 
nature of the ribosome during translation. Although ensemble kinetic studies have 
greatly advanced our knowledge of the conformational changes of the ribosome and 
its communication with translation factors, complete understanding of the mechanism 
of translation on the molecular level has been confined by the temporal and 
population averaging nature of current assays. To address these limitations, the 
capability to characterize the single ribosome molecules was first demonstrated in 
2003 (Vanzi et al., 2003). In this report, ribosome elongation complexes programmed 
with poly(U) were non-specifically adsorbed to the mica surface and connected to a 
fluorescently labeled polystyrene bead via biotin-neutravidin interaction at the 3’-end 
of mRNA. Epifluorescence microscopy was used to track the contraction of the 
diffusion range of the beads because of poly(Phe) synthesis and the slide of the 
ribosome towards the 3’-end of mRNA. 
 After a decade of development, labeled ribosomal complexes in different 
functional states can be specifically immobilized on the surface via various strategies, 
with their translation functions fully retained, and single molecule FRET (smFRET) 
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measurement was achieved based on total internal reflection fluorescence (TIRF) 
(Marshall et al., 2008; Perez and Gonzalez Jr, 2011). An evanescent wave, which is 
generated when the incident light is totally internally reflected at the interface, is used 
to illuminate a selected area with a depth of ~100 nm into the sample. Thousands of 
ribosome molecules could be simultaneously detected with the signal for each single 
ribosome analyzed separately. Together with data sorting and synchronization, the 
problem of heterogeneity in ensemble experiments was thus overcome. On the one 
hand, multiple cycles of translation elongation have been observed by either placing 
both FRET donor and acceptor on the immobilized ribosome complex to reduce 
fluorescence background (Aitken and Puglisi, 2010), or introducing zero-mode 
waveguide technique to limit the regional concentration of labeled components 
(Uemura et al., 2010). On the other hand, smFRET has been applied to resolve the 
elementary steps during translation and detect functionally competent intermediates 
along the reaction coordinate (Chen et al., 2011a, b; Fei et al., 2008; Munro et al., 
2007). 
 smFRET studies by tRNA:tRNA FRET have identified three intermediates during 
A-site codon decoding, corresponding to i) initial codon recognition, ii) 
GTPase-activated and iii) fully accommodated states, respectively, and allowed 
comparisons of different patterns of intermediate state sampling between cognate and 
near-cognate tRNA binding (Blanchard et al., 2004). It was shown that tRNA thermal 
fluctuation during codon decoding was utilized for the discrimination between 
cognate and near-cognate tRNA (Geggier et al., 2010; Lee, 2007; Mishra et al., 2010). 
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The effects of several antibiotics, including tetracycline, thiostrepton and kirromycin, 
on tRNA selection were also investigated, with the observations consistent with those 
observed in ensemble studies (Blanchard et al., 2004; Geggier et al., 2010; Gonzalez 
et al., 2007). 
 
1.7 EF-Tu in translation elongation 
 Elongation factor thermally unstable (EF-Tu) is encoded in two genes in E. coli, 
tufA and tufB, and in this thesis, it’s the tufA gene and its expression product that are 
utilized and investigated. EF-Tu, with a cellular concentration ~ 10 fold higher than 
that of the ribosome (Furano, 1975), consists of 393 amino acids, including three 
cysteine residues at position 81, 137 and 255. Among these three cysteines, Cys81 has 
been found to be highly conserved within bacteria and functionally critical for 
aa-tRNA binding, but not for GTP or GDP binding (Laurentiis et al., 2011). 
 EF-Tu is organized into three domains. Domain 1 contains the binding site for the 
nucleotide with an affinity for GDP 100 times higher than for GTP. Before forming a 
TC, the GDP on EF-Tu is replaced by GTP, catalyzed by elongation factor EF-Ts and 
driven by high cellular GTP concentration. Such off-the-ribosome nucleotide 
exchange is accompanied by a conformational change within domain 1 relative to 
domains 2 and 3 (Kjeldgaard and Nyborg, 1992; Polekhina et al., 1996). Domains 2 
and 3 regulate the interaction of EF-Tu with EF-Ts and antibiotics, maintain the bias 
in favor of GDP binding in domain 1, and mediate EF-Tu interaction with the 
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ribosome and aa-tRNA (Cetin et al., 1998). To form the TC, EF-Tu binds to an 
aa-tRNA with the interface of domain 1 and 2 contacting the acceptor stem-loop and 
amino acid, and domain 3 contacting the T stem (Nissen et al., 1995). The nucleotide 
sequence in tRNA has evolved to compensate for the diverse thermodynamic 
contributions of amino acid side chains, making EF-Tu:aa-tRNA affinity similar for 
all tRNAs in such a way that every aa-tRNA can form a stable TC with EF-Tu·GTP 
and be easily released from EF-Tu during accommodation (Dale et al., 2004). 
EF-Tu:aa-tRNA affinity can be modulated by mutating the nucleotides within the T 
stem of tRNA, which have direct contacts with EF-Tu (Schrader et al., 2011). 
Although it’s now well accepted that EF-Tu binds to aa-tRNA in a 1:1 ratio, several 
groups have reported that two EF-Tus can simultaneously bind to one aa-tRNA and 
participate in the decoding process (Bilgin and Ehrenberg, 1995; Ehrenberg, 1990; 
Rodnina and Wintermyer, 1995a). 
 Upon recruitment of a TC to the ribosome complex, EF-Tu consumes one GTP 
molecule and releases the aa-tRNA to the ribosomal A-site (see Section 1.3 for more 
details), with a dramatic conformational change from the GTP- to GDP-bound form 
(Kjeldgaard and Nyborg, 1992; Polekhina et al., 1996). The antibiotic kirromycin 
targets EF-Tu and inhibits elongation by stabilizing EF-Tu on the ribosome in a 
GTP-like conformation after GTP hydrolysis (Schmeing et al., 2009a). The 
conformational change of EF-Tu on the ribosome triggers its release from the 
ribosome and the recruitment of EF-G. 
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1.8 Fidelity control throughout protein synthesis and antibiotics 
 When a properly aminoacylated tRNA is delivered to the ribosome in the form of 
a TC, several mechanisms at different functional stages operate together to ensure the 
correct selection of cognate tRNA (Zaher and Green, 2009a). tRNA selection in the 
decoding center of the 30S subunit primarily relies on the exact base pairing between 
the codon programmed at the ribosomal A-site and the anticodon in tRNA. However, 
the energetic difference resulting from the incorrect base pairing is not significant 
enough to account for the observed precision of tRNA incorporation. The high fidelity 
of tRNA selection is kinetically accomplished by the induced-fit mechanism 
(Gromadski and Rodnina, 2004a), which consists of two stages, denoted initial 
selection and proof-reading, separated by the irreversible EF-Tu mediated GTP 
hydrolysis. In the codon recognition step, the signal of cognate codon:anticodon 
interaction in the DC of the 30S subunit induces both local and global conformational 
rearrangements, and is transduced remotely, via an unknown mechanism, to the GAC 
in the 50S subunit, leading to EF-Tu activation and GTP hydrolysis. In contrast, 
incorrect base pairing leads to ~ 600-fold slower or no GTP hydrolysis for 
near-cognate or non-cognate tRNA, respectively. Consequently, most of the 
near-cognate tRNAs and all of the non-cognate tRNAs are rejected in the initial 
selection. After GTP hydrolysis, cognate tRNA is accommodated into the A-site, 
while the improper codon:anticodon interaction of near-cognate tRNA destabilizes the 
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tRNA binding to the ribosome and leads to tRNA dissociation during the 
proof-reading step.  
 When an incorrect amino acid is incorporated into the growing polypeptide chain, 
the codon:anticodon mismatch error can be amplified in the subsequent aa-tRNA 
selection steps, ultimately leading to the premature translation termination (Zaher and 
Green, 2009b). RF3 also exhibits a substantial effect in maintaining the high fidelity 
of protein synthesis (Zaher and Green, 2011). The ribosome apparatus has evolved to 
be optimized for speedy and accurate protein synthesis (Johansson et al., 2012; 
Wohlgemuth et al., 2010), and the cooperation of various quality control mechanisms 
achieves an overall in vivo error rate of 6 × 10-4 to 5 × 10-3 per amino acid 
incorporated (Bouadloun et al., 1983; Edelmann and Gallant, 1977). 
 Because of its fundamental function in gene expression, the ribosome is a primary 
target of antibiotics, and some of them have an effect in the quality control of protein 
synthesis. Streptomycin and paromomycin from aminoglycoside family are two 
well-documented ones, both of which could induce misreading, but with different 
mechanisms (Gromadski and Rodnina, 2004b). Streptomycin contacts both S12 and 
G530 loop of the shoulder and helices 27 and 44 in the central part of the 30S subunit, 
and holds the 30S subunit in a particular conformation, which, in turn, stabilizes both 
cognate and near-cognate aa-tRNA on the ribosome and blurs their differences in the 
rates of EF-Tu-dependent GTP hydrolysis, thus diminishing the selection power of the 
initial selection step. In contrast, paromomycin stabilizes the ribosome in a 
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high-activity conformation, which has no effects on the cognate aa-tRNA recognition, 
but significantly increases the rate of EF-Tu-dependent GTP hydrolysis in the case of 
near-cognate aa-tRNA to a level comparable to that of cognate aa-tRNA, thereby  
facilitating the incorporation of near-cognate aa-tRNA (Gromadski and Rodnina, 
2004b). 
 
1.9 Emissive nucleoside mimetics 
 Besides the labeling of biomolecules with organic fluorescent probes, an 
alternative way to study the conformational change or dynamic processes of 
biomolecules in a biological event by using fluorescence spectroscopy is to 
incorporate the emissive analogs of the building blocks into the biomolecules. 
Emissive nucleoside mimetics have demonstrated their abilities in probing the 
secondary structure and the structure dynamics of nucleic acids (Sinkeldam et al., 
2010). Assays based on such emissive nucleoside analogs have recently been 
developed to study the ribosome interactions with exogenous proteins and antibiotics 
by either inserting the emissive nucleoside mimetic into a RNA segment 
complementary to the rRNA (Srivatsan et al., 2008) or synthesizing a model sequence 
of rRNA containing the emissive nucleoside analog (Sakakibara et al., 2012; Xie et al., 
2009; Xie et al., 2010).  
Quite recently, a fluorescent ribonucleoside alphabet derived from 
thieno[3.4-d]-pyrimidine was reported with structural resemblance to the naturally 
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occurring ribonucleoside (Figure 1.6) (Shin et al., 2011). These isomorphic analogs 
result in minimal structural and functional perturbations to the oligonucleotides into 
which they are incorporated, have desirable photophysical properties suitable for 
fluorescent spectroscopy studies, and overcome the common drawback of emission 
quenching of emissive nucleoside analogs upon incorporation into oligonucleotides. 
These advantages of such thieno-modified emissive nucleoside mimetics offer the 
potential for systematic real-time studies of the translation apparatus, utilizing both 
their fluorescent response to the environmental change and energy transfer with other 
fluorophores. 
 
1.10 Frameshifting in translation 
 During translation elongation, mRNA repetitively undergoes a movement of three 
nucleotides relative to the ribosome to place successive codons at the ribosomal A-site 
for decoding, with the average frequency of spontaneous frameshifting on the order of 
10-5 to 10-4 (Kurland, 1979). A second kind of controlled mRNA displacement relative 
to the ribosome involves the change of open reading frame, denoted programmed 
frameshifing, which is utilized for the regulation of gene expression (Dinman, 2012) 
and replication of numerous viruses (Brierley and Dos Ramos, 2006). The two most 
common programmed frameshiftings are +1 and -1 shifting, in which the mRNA 
displacement relative to the ribosome is one nucleotide downstream or upstream, 
respectively. +1 frameshifting is directed by homopolymeric runs of 3 or 4 
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nucleotides within mRNA, while the -1 shifting is mediated by a slippery sequence of 
X_XXY_YYZ (X can be any nucleotide, Y is A or U and Z is not G in the eukaryote) 
in the original reading frame followed by a downstream secondary structure, usually a 
pseudoknot. Although genetic and cell biological studies have provided insight into 
the programmed frameshifing (Dinman, 2012; Giedroc and Cornish, 2009), especially 
with respect to translation components other than mRNA that are involved in reading 
frame maintenance, such as the ribosomal E-site (Devaraj et al. 2009) and tRNA 
modification (Gustilo et al., 2008), real-time observation of programmed 
frameshifting has not been achieved and its mechanism in the molecular level is still 
elusive. 
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Table 1.1. Components of E. coli ribosomes. 
Ribosome/subunit 70S 50S 30S 
Molecular weight (kD) 2520 1590 930 
rRNA components 
23S, 16S and 
5S 
23S and 5S 16S 
Number of nucleotides in rRNA 4566 
2904 for 23S 
120 for 5S 
1542 for 16S 
rRNA molecular weight (kD) 1664 1104 560 
Number of ribosomal proteins 55 34 21 
Protein molecular weight (kD) 857 487 370 
 
This table is adapted from (Kaltschmidt and Wittmann, 1970; Voet et al., 2006). 
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Figure 1.1. Central dogma of molecular biology (Modified from Crick, 1970). 
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Figure 1.2. Three-dimensional structures of the two ribosomal subunits. Two subunits 
are from eubacteria with a tRNA molecule placed between them. The rRNA is shown 
in brownish colors, and each of the ribosomal proteins is shown in a different color. 
A-, P- and E- sites are for tRNA binding. The approximate site of the peptidyl 
transferase center is marked in red. Insert: Backbone of a tRNA molecule; circles 
designate the regions interacting with each of the ribosomal subunits. This figure is 
taken from (Yonath, 2010). 
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Figure 1.3. Overview of translation cycle. This figure is taken from (Schmeing and 
Ramakrishnan, 2009b). 
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Figure 1.4. mRNA bound to the ribosome initiation complex. SD sequence (red in 
mRNA sequence) interaction with anti-SD sequence (red in 16S RNA sequence) 
places the AUG start codon (dark yellow in mRNA sequence) at ribosomal P-site. 
This figure is taken from (Yusupova et al., 2006). 
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Figure 1.5. Representative schemes of peptide bond formation (A) and translocation 
(B). Figure A and B are taken from (Wohlgemuth et al., 2010) and (Pan et al., 2007), 
respectively. 
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Figure 1.6. Emissive RNA alphabet. This figure is reprinted with permission from 
(Shin, D., Sinkeldam, R. W., and Tor, Y. (2011). Emissive RNA alphabet. J Am 
Chem Soc 133, 14912–14915.). Copyright (2011) American Chemical Society.  
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CHAPTER 2  
MATERIALS AND METHODS 
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2.1 Materials 
2.1.1 Buffers 
All of the following buffers were prepared and the pH was adjusted at 25°C. All 
of the experiments in this thesis were performed in buffer A unless otherwise 
specified.  
Buffer A: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2 
and 1 mM DTT. 
Buffer B: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2 
and 1 mM DTT, 100 μM GTP, 2 mM phosphoenolpyruvate, 10 μg/ml pyruvate 
kinase. 
Buffer C: 20 mM Tris-HCl pH 7.6, 200 mM NH4Cl, 10 mM MgAc2. 
IF3 lysis buffer: 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 10 mM 
2-mercaptoethanol, 0.2 mM PMSF. 
IF3 purification buffer A: 10 mM Tris-HCl pH 8.0, 200 mM NaCl, 5% glycerol, 1 
mM 2-mercaptoethanol. 
IF3 purification buffer B: 10 mM Tris-HCl pH 8.0, 500 mM NaCl, 5% glycerol, 1 
mM 2-mercaptoethanol. 
L11 dialysis buffer: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 6 mM 
2-mercaptoethanol, 10 mM NaCl. 
L11 purification buffer A: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 
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6 mM 2-mercaptoethanol, 10 mM NaCl, 10 mM MgCl2. 
L11 purification buffer B: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 
6 mM 2-mercaptoethanol, 400 mM NaCl, 10 mM MgCl2. 
L11 labeling buffer: 25 mM Tris-HCl pH 7.0, 100 mM NaCl, 2 mM EDTA. 
EF-Tu purification buffer A: 50 mM Tris-HCl pH 7.6, 60 mM NH4Cl, 7 mM 
MgCl2, 7 mM 2-mercaptoethanol, 15 μM GDP, 15% glycerol.  
EF-Tu purification buffer B: 50 mM Tris-HCl pH 7.6, 60 mM NH4Cl, 7 mM 
MgCl2, 300 mM KCl, 7 mM 2-mercaptoethanol, 15 μM GDP, 15% glycerol. 
EF-Tu purification buffer C: 50 mM Tris-HCl pH 7.6, 60 mM NH4Cl, 7 mM 
MgCl2, 300 mM KCl, 20 mM imidazole, 7 mM 2-mercaptoethanol, 15 μM GDP, 15% 
glycerol. 
EF-Tu elution buffer: 50 mM Tris-HCl pH 7.6, 60 mM NH4Cl, 7 mM MgCl2, 300 
mM KCl, 300 mM imidazole, 7 mM 2-mercaptoethanol, 15 μM GDP, 15% glycerol. 
EF-Tu storage buffer: 50 mM Tris-HCl pH 7.6, 100 mM NaCl, 10 mM MgCl2, 15 
μM GDP. 
Hybridization buffer: 100 mM Tris-HCl pH 7.5, 1 M NaCl, 10 mM EDTA. 
TMA buffer: 10 mM Tris-HCl pH 7.6, 0. 1 mM EDTA pH 8.0, 0.9 M 
tetramethylamonium chloride. 
Aminoacylation buffer A: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 20 mM MgCl2, 
1 mM EDTA pH 8.0, 7 mM 2-mercaptoethanol, 10 mM KCl, 0.01 unit/μl 
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thermostable inorganic pyrophosphatase, 720 μM formyl donor, 67 μM [35S]fMet 
mixture, 0.75 mg/ml E coli. aminoanyl-tRNA synthetases. 
Aminoacylation buffer B: 100 mM Tris-HCl pH 8.0, 10 mM ATP, 50 mM MgCl2, 
2.5 mM EDTA pH 8.0, 3 mM 2-mercaptoethanol, 200 μM [3H]Phe mixture, 1.5 
mg/ml yeast aminoanyl-tRNA synthetases.  
Aminoacylation buffer C: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 5 mM MgAc2, 
250 μM EDTA pH 8.0, 7 mM 2-mercaptoethanol, 150 μM [3H]Phe mixture, 1 μM E 
coli. Phe-tRNA synthetases. 
Aminoacylation buffer D: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 20 mM MgCl2, 
1 mM EDTA pH 8.0, 7 mM 2-mercaptoethanol, 0.005 unit/μl inorganic 
pyrophosphatase, 100 μM [3H]Val mixture or 67 μM [3H]Arg mixture or 100 μM 
[3H]Lys mixture, 0.75 mg/ml E coli. aminoanyl-tRNA synthetases. 
Aminoacylation buffer E: 30 mM Hepes-HCl pH 7.0, 30 mM KCl, 15 mM MgCl2, 
5 mM DTT, 4 mM ATP, 100 μM [3H]Val, 0.01 unit/μl thermostable inorganic 
pyrophosphatase, 0.75 mg/ml of E coli. aminoacyl-tRNA synthetase. 
 
2.1.2 Reagents 
All of the aqueous solutions and buffers were prepared using double-deionized 
water from Milli-A Water System (Millipore) and treated with a BioPak filter 
(Millipore) to remove the DNase, RNase and protease. 
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The following materials were purchased from the indicated suppliers: IPTG, GDP, 
GTP, GDPNP, streptomycin, paromomycin, kirromycin, poly(U), puromycin, glucose, 
glucose oxidase, phenylmethanesulfonylfluoride (PMSF), streptavidin agarose bead, 
tris(2-carboxyethyl)phosphine hydrochloride (TCEP), N-hydroxysuccinimide ester, 
folinic acid, glutathione, 6-hydroxy-2,5,7,8-tetramethyl- chromane-2-carboxylic acid 
and bovine pancreatic RNase A (Sigma); Talon Superflow Metal Affinity Resin 
(Clontech); QSY9 maleimide, dNTP, S.O.C. medium and Top 10 competent cells 
(Invitrogen); Cy3 maleimide, Cy5 maleimide, NAP-5 column and pTZ18R plasmid 
(GE Healthcare); phosphoenolpyruvate (PEP), pyruvate kinase (PK), RNase T1, 
catalase and bulk tRNA from E coli. MRE600 cells (Roche);  proflavin (MB 
Biomedicals); Phusion DNA polymerase and DpnI (New England Biolabs); PCR 
purification kit and Ni-NTA Superflow resin (QIAGEN); BL21(DE3) competent cells 
(Stratagene); ampicillin, trichloroacetic acid (TCA), saturated phenol pH 4.3 and 
saturated phenol pH 6.6 (Fischer Scientific); AG 50W-X8 cation exchange resin, 
Silver Stain Plus kit (Bio-Rad); thermostable inorganic pyrophosphatase (New 
England BioLabs); Amicon Ultra-4 ultrafiltration units, Ultrafree-MC GV centrifugal 
filter unit, and nitrocellulose filters (Millipore); LI Silver Stain kit (Nanoprobes); E. 
coli tRNAfMet, E. coli tRNAPhe, E. coli tRNAVal, E. coli tRNAArg, E. coli tRNALys, and 
yeast tRNAPhe (Chemical Block, Moscow). 
 
2.2 Methods 
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2.2.1 Preparation of proteins 
Cloned E. coli His-tagged proteins IF1, IF2, EF-G and labeled phosphate binding 
protein (MDCC-PBP) were prepared and purified as previously reported (Pan et al., 
2008). E. coli aminoacyl-tRNA synthetases were prepared following an established 
procedure (Kemkhadze et al., 1981). Yeast aminoacyl-tRNA synthetases were 
prepared based on the published procedure (Lagerkvist and Waldenstrom, 1964). 
 
2.2.1.1 Purification of IF3 
 pET21a plasmid carrying His-tagged IF3 is a kind gift from Dr. Ueda, University 
of Tokyo (Shimizu et al., 2001). All steps below were performed at 4 °C. 10 g of 
frozen BL21(DE3) pET21a IF3 cells were kept on ice for 10min, and then 
resuspended in 30 mL of IF3 lysis buffer followed by two passes through a French 
Press (12,000–14,000 psi). The resulting mixture was subject to centrifugation (10k 
rpm, 30 min, SS-34 rotor) to pellet the cell debris. The supernatant was loaded onto an 
8 ml Ni-NTA column (18 mm in diameter) pre-washed with 60 ml of water and 
pre-equilibrated with 60 ml of IF3 lysis buffer. The column was washed by 60 ml of 
IF3 purification buffer A followed by 30 ml of IF3 purification buffer B. IF3 protein 
was eluted by use of a hyperbolic imidazole gradient in IF3 purification buffer B (5 
mM imidazole, 40 ml; 10 mM imidazole, 20 ml; 20 mM imidazole, 10 ml; 300 mM 
imidazole, 50 ml) and collected in fractions. Fractions with large amounts of IF3 were 
identified by 18% SDS-PAGE gel and pooled for dialysis against buffer A. IF3 was 
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concentrated by an Amicon Ultra ultrafiltration units [molecular weight cutoff 
(MWCO): 10,000] and the concentration was determined by Bradford assay 
(Bradford, 1976). 
 
2.2.1.2 Purification and labeling of L11(C38S/S87C)  
 L11(C38S/S87C) double mutant from 12 g of BL21(DE3) pLysS 
L11(C38S/S87C) cells (Chen et al., 2011a) was first purified using an 8 ml Ni-NTA 
column (18 mm in diameter), following the procedure used for IF3 and using the 
same buffers for IF3. All proteins eluted with 300 mM imidazole were dialyzed 
against L11 dialysis buffer overnight and L11 purification buffer A for 3 hours at 4 °C. 
After concentrated using Amicon Ultra ultrafiltration units (MWCO: 10,000), crude 
L11 product was further purified on a SourceS column (4.6 × 100 mm) and pure L11 
was eluted using a linear gradient from L11 purification buffer A to L11 purification 
buffer B. Then an Amicon Ultra ultrafiltration units (MWCO: 10,000) was used to 
remove the urea and replace the buffer with buffer A (6 times), after each cycle of 
which L11 sample was kept on ice for at least 30 min to facilitate protein refolding. 
L11 concentration was determined by Bradford assay (Bradford, 1976), with the 
concentration multiplied by a correction factor of 0.6 (Wang et al., 2007). 
L11 labeling with either Cy3 or Cy5 was performed as described (Chen et al., 
2011a). Nap-5 column (bed volume 0.5 ml) was used to exchange the buffer from 
buffer A to L11 labeling buffer following the manufacture instructions. L11 (100 μM) 
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was incubated at room temperature for two hours in the presence of TCEP (300 μM) 
and Cy5 maleimide (1.1 mM) in 900 μl of L11 labeling buffer. The reaction was 
quenched with 3 μl of 14.3 M 2-mercaptoethanol, and labeled L11 was purified on 
Source S column as in L11 purification. Fractions were monitored at A280 and A550, 
and pooled for dialysis against buffer A, followed by concentration using an Amicon 
Ultra ultrafiltration units (MWCO: 10,000). L11 concentration was determined by 
Bradford assay as above and dye concentration was determined by A550 for Cy3 and 
A650 for Cy5 (extinction coefficients: 150,000 and 250,000 M-1 cm-1 for Cy3 and Cy5, 
respectively). Typical dye/L11 ratio was 0.9. 
 
2.2.2 Preparation of EF-Tu variants and their derivatives 
2.2.2.1 Purification of EF-Tu variants 
Expression vectors for C-terminal His-tagged E. coli EF-Tu variants were based 
on the pET15b vector. pET15b EF-Tu plasmids (50–80 ng) (Perla-Kajan et al., 2010) 
were transformed into BL21(DE3) competent cells, and the strains were grown in 
Super Optimal Broth (S.O.C.) medium at 37 °C for one hour. The cell cultures were 
plated onto LB-Agar plate with 100 μg/ml of ampicillin and grown overnight at 37 °C. 
Single colony on the plate was innoculated into 6 ml of LB medium with 100 μg/ml 
of ampicillin for overnight growth at 37 °C. The cell culture was transferred into 1 L 
of LB medium with 100 μg/ml of ampicillin for growth until A260 reached ~0.6–0.8. 
Protein expression was started by addition of 1mM IPTG and lasted for 3 hours at 37 
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°C. 
The purification of the expressed proteins was performed as previously described 
with some changes (Perla-Kajan et al., 2010). BL21(DE3) pET15b EF-Tu cells (6 g) 
were resuspended in 25 ml of EF-Tu purification buffer A and the mixture was 
magnetically stirred for 30 min at 4 °C. A second incubation at room temperature for 
20 min was performed after addition of lysozyme to 0.75 mg/ml. Cell was broken by 
French press twice (12,000–14,000 psi) and centrifuged (4 °C, 20k rpm with SS34 
rotor, 20 min) to remove the cell debris. The supernatant was mixed with 
Co(II)-Sepharose (Talon) resin (bed volume 3 ml), pre-washed twice with 30 ml of 
EF-Tu purification buffer A, and shaken at 4 °C for 1 hour. Resins bound with EF-Tu 
were pulled down by centrifugation (4 °C, 700 xg, 5 min), washed twice with 30 ml 
of EF-Tu purification buffer A, and transferred to a small gravity column (18 mm in 
diameter). The column was washed sequentially with 10 ml of EF-Tu purification 
buffer A, 10 ml of EF-Tu purification buffer B and 10 ml of EF-Tu purification buffer 
C. EF-Tu was eluted using EF-Tu elution buffer, and Amicon Ultra ultrafiltration units 
(MWCO: 10,000) were used to concentrate the samples, remove imidazole and 
replace the buffer with EF-Tu storage buffer. EF-Tu concentration was determined by 
Bradford assay. 
 
2.2.2.2 Labeling of EF-Tu with quencher or fluorophore 
EF-Tu labeling was carried out in 150 µl EF-Tu storage buffer by incubating 
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EF-Tu (0.8 mg, 0.1 mM), QSY9, Cy3 maleimide or Cy5 maleimide (1.35 mM) and 
TCEP (1 mM) at room temperature for 6 hours. The reaction was quenched by 
addition of 2-mercaptoethanol (final concentration: 300 mM). The mixture was 
diluted to 0.5 ml with EF-Tu storage buffer and loaded onto a NAP-5 column (bed 
volume 0.5 ml) at room temperature to remove free QSY9. 1 ml of EF-Tu storage 
buffer was used to elute the EF-Tu. Three fractions of volumes 200, 400 and 400 µl 
were collected, and labeled EF-Tu was eluted in the middle 400 µl. EF-Tu 
concentration was determined by Bradford assay. Cy3 or Cy5 concentration was 
determined by A550 or A650 as in section 2.2.1.2. QSY9 concentration was determined 
using a standard curve of free QSY9 measured at A562 (extinction coefficient: 88,000 
cm-1 M-1).  
 
2.2.2.3 Functional analysis of EF-Tu variants 
EF-Tu interaction with aa-tRNA was monitored by the ability of EF-Tu to protect 
aa-tRNA against RNase degradation as described (Pan et al., 2008). Ternary 
complexes with 0.10–0.15 μM of yeast [3H]Phe-tRNAPhe and different concentrations 
of EF-Tu were made in 50 μl buffer B (see Section 2.2.6.2) and chilled on ice for 30 
min. 5 μl of 0.05 mg/ml RNase A was added to ternary complex to digest the tRNA at 
4 °C for 15 sec, and then quenched with 200 μl of 10% TCA. Filter binding with a 
nitrocellulose filter was used to collect protected [3H]Phe-tRNAPhe followed by three 
washes with chilled 5% TCA. Filters were dried, dissolved with 1 ml of ethyl acetate, 
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and counted in scintillation liquid. 
The poly(Phe) assay was carried out in buffer C. All concentrations below are 
final concentrations after mixing. Initiation complex was made by mixing 70S 
ribosome (0.3 μM), poly(U) (0.3 g/L), [3H]-AcPhe-tRNAPhe (0.36 μM) at 37 °C for 5 
min. 2-Mercaptoethanol (2 mM), PEP (0.4 mM), PK (4 mg/L), GTP (0.5 mM), 
[3H]-Phe-tRNAPhe (4.5 μM) and EF-G (0.5 μM) were then added, and the mixture was 
fractionated into 6 μl aliquots. Reaction was started by adding 0.5 μM of EF-Tu (2 μl) 
to the aliquots. After incubation at 37 °C for 30 min, the reaction mixtures were 
quenched with 0.3 ml of 5% TCA, heated to 95 °C for 15 min and cooled on ice for 1 
hour. Filter binding was performed using a nitrocellulose filter followed by three 
washes with chilled 5% TCA, and the radioactivity of [3H]-Phe-tRNAPhe was 
determined. 
Determination of quenching efficiency was performed in buffer B. 0.17 μM of 
Phe-tRNAPhe (Cy3) was incubated with different concentrations of free QSY9 or 
EF-TuQSY variants at 37 °C for 10 min, and fluorescent emissions of the resulting 
mixtures were determined at room temperature (see Section 2.2.7.1). 
 
2.2.3 Preparation of mRNAs 
All modified mRNAs containing thG, thA, thU or thC are from Prof. Yitzhak Tor 
and Dr. Dongwon Shin at University of California, San Diego. 
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2.2.3.1 Preparation of mRNA 022 MFTI and 022 CUC 
mRNA 022 and 022CUC were prepared and purified as previously reported (Pan 
et al., 2008). In 400 μl buffer provided in the T7 transcription kit, plasmid (150 ng/μl) 
was mixed with NTP (100 mM for each of ATP, CTP, GTP and UTP), DTT (100 mM) 
and 40 μl of T7 enzyme. The mixture was incubated at 42°C for 2 hours, followed by 
addition of 20 μl of provided DNase I and 15 min incubation at 37°C. The aqueous 
layer after one extraction with 1:1 phenol pH 4.3/chloroform mixture and one 
extraction with chloroform, was mixed with 1 volume of chilled 5 M LiCl, followed 
by incubation on ice for 1 hour, and the precipitate was collected by centrifugation 
(Heraeus Instrument D-37520, 15k rpm, 20 min). mRNA pellet was resuspended in 
DDI H2O and further purified by addition of 2.5 volumes of EtOH for precipitation, 
washed with 70% ethanol and subjected to a second resuspension and EtOH 
precipitation. mRNA purity was confirmed by electrophoretic analysis on a 2% 
agarose gel (Figure 2.1). 
 
2.2.3.2 Preparation of mRNA MRF and MVF 
For mRNA MRF, the corresponding coding sequence with a T7 promoter 
sequence (GGG AAU UCG AAA UAG AAG UCU UCU UUU UGG A AAA AUU 
UAA AAG UUA AUA AGG AUA CAU ACU AUG CGU UUC UUC CGU UUC 
UUC CGU AAA UUC CGU GUG CGU UUU UUC AAA UUU GUG UUC CGU 
UAA CGC GUC UGC AGG CAU GCA AGC UAA AAA AAA AAA AAA AAA 
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AAA AAA AAA GCU U; IDT, IA) was ligated into plasmid pTZ18R. Overexpression 
and purification were performed following the procedures similar to mRNA 022 
MFTI. mRNA MVF was prepared the same as mRNA MRF with the corresponding 
synthesized sequence (GGG AAU UCG AAA UAG AAG UCU UCU UUU UGG A 
AAA AUU UAA AAG UUA AUA AGG AUA CAU ACU AUG GUG UUC UUC 
CGU UUC UUC CGU AAA UUC CGU GUG CGU UUU UUC AAA UUU GUG 
UUC CGU UAA CGC GUC UGC AGG CAU GCA AGC UAA AAA AAA AAA 
AAA AAA AAA AAA AAA GCU U; IDT, IA). 
 
2.2.3.3 Preparation of mRNA MVYF and MKF 
mRNA MVYF was prepared by mutation of the mRNA 022 MFTI sequence via 
PCR (Chiu et al., 2004), using the following primers: forward, 5’-TTA ACT TTT 
AAA TTT TTG AAT TCC CTA TAG TGA GTC GTA TTA AAT TC-3’; overreverse, 
5’-CAG GTA TAC ATA CTA TGG TCT ACT TTA CTA CGA TCT TCT TCA CTT 
AAC GCG TCT GCA GGC ATG-3’; reverse, 5’-CTT CAC TTA ACG CGT CTG 
CAG GCA TG-3’; overforward, 5’-AAG ATC GTA GTA AAG TAG ACC ATA GTA 
TGT ATA CCT GTT AAC TTT TAA ATT TTT GAA TTC CCT ATA GTG AGT CGT 
ATT AAA TTC-3’. Two PCR samples were prepared with primer forward and 
overreverse or primer reverse and overforward, respectively. After PCR, parent 
plasmid was digested by incubation with DpnI enzyme (0.2 Unit/μl) at 37°C for 1 
hour and the PCR products were purified using a QIAGEN PCR purification kit. Two 
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PCR products were combined for hybridization of single strand DNA in hybridization 
buffer using PCR again, and the resulting plasmids were transformed into TOP 10 
competent cells for small scale expression. Plasmid was extracted using QIAGEN 
Miniprep kit and the target mutation was confirmed by DNA sequencing. Correct 
plasmid was transformed into TOP 10 competent cells for large scale expression and 
purification as for mRNA 022 MFTI. 
mRNA MKF was prepared following a similar procedure to mRNA MVYF using 
the following primers: forward, the same as mRNA MVYF; overreverse, 5’-CAG 
GTA TAC ATA CTA TGA AAT TCC GTA CTA CGA TCT TCT TCA CTT AAC GCG 
TCT GCA GGC ATG-3’; reverse, the same as mRNA MVYF; overforward, 5’-AAG 
ATC GTA GTA CGG AAT TTC ATA GTA TGT ATA CCT GTT AAC TTT TAA ATT 
TTT GAA TTC CCT ATA GTG AGT CGT ATT AAA TTC-3’. 
 
2.2.4 Preparation of tRNAs 
2.2.4.1 Preparation of formyl donor 
 Formyl donor was made as described (Dubnoff and Maitra, 1971). 25 mg of 
folinic acid was dissolved in 2.0 ml of 50 mM 2-mercaptoethanol. Following addition 
of 0.22 ml of 1.0 M HCl, the mixture was allowed to react for 3 hours at room 
temperature. Some precipitation may occur during the reaction, which could be 
dissolved on gentle heating in a water bath set to 37 °C. Formyl donor concentration 
was determined by A355 (at 355 nm, 1 μmol/ml = 25 A355). The product was then 
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aliquoted for storage in the freezer. Before being used for tRNAfMet aminoacylation, 
the pH of formyl donor was activated by adjusting its pH to neutrality with 1/4 
volume of 1 M Tris-HCl, pH 8.0 and incubating at room temperature for 20 minutes. 
 
2.2.4.2 Purification of E. coli tRNAfMet from bulk tRNAs 
 24 nmol (400 μl) of streptavidin agarose beads was washed twice with 400 μl 
of 10 mM Tris-HCl pH 7.6, using Ultrafree-MC GV centrifugal filter units (1 min at 
5580 xg). The collected beads were incubated, in the presence of 8 nmol of oligo 
(5’-ATG AGC CCG ACG AGC TAC CAG GCT GCT C-3’-biotin) in 400 μl of 10 
mM Tris-HCl pH 7.6 buffer, at room temperature for 30 min, shaken by hand every 5 
min and washed twice with 400 μl of 10 mM Tris-HCl pH 7.6 to remove the unbound 
oligos, as monitored by A260. 200 units of bulk tRNA from E coli. MRE600 cells (360 
nmol bulk tRNA; ~3.6 nmol tRNAfMet) in 300 ul of DDI water were heated at 80 °C 
for 10 min, quickly mixed with 300 ul of TMA buffer, and immediately added to oligo 
bound beads. The resulting mixture was heated at 65 °C for 10 min, followed by 
gradual temperature decrease to 37 °C and 30 min incubation at 37 °C. Unbound 
tRNAs were removed by 7 washes with 400 μl of 10 mM Tris-HCl pH 7.6. Bound 
tRNAs were eluted by a stepwise incubations at 45°C, 55°C and 65°C, respectively. 
At each temperature, beads were heated for 7 min in the presence of 400 μl of 10 mM 
Tris-HCl pH 7.6, centrifuged at 10k rpm for 1 min, and washed twice with 400 μl of 
10 mM Tris-HCl pH 7.6 by centrifugation. Each centrifugation was performed in the 
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presence of 2 μl of 1 M MgCl2, and the flow-through was collected separately. For 
those fractions containing tRNAfMet as measured by A260, 1/10 volume of 1 M 
Tris-HCl pH 9.0 was added and the mixtures were incubated at 37°C for 3 hours. 
tRNAs were obtained by EtOH precipitation with addition of 2.5 volumes of EtOH. 
To roughly estimate the aminoacylation efficiency, tRNAfMet 
formylaminoacylation was done in a 10 μl scale for the tRNA product eluted at each 
temperature (see section 2.2.4.3), with a negative control performed in the absence of 
aminoacyl-tRNA synthetases. After incubation, 400 μl of 5% TCA was added and the 
samples were left on ice for 1 hour. Filter binding was performed using a 
nitrocellulose filter followed by three washes with chilled 5% TCA, and the 
radioactivity of [35S]-fMet-tRNAfMet was determined. tRNAfMet was in factions eluted 
at 65 °C. 
 
2.2.4.3 Formylaminoacylation of tRNAfMet  
Procedures described in Pan et al. (Pan et al., 2007) were used to 
formylaminoacylate commercial tRNAfMet from E. coli. 36 nmol of tRNAfMet was 
incubated in 2000 μl of aminoacylation buffer A at 37°C for 45 min. The reaction was 
quenched with 200 μl of 20% KAc pH 5.0, extracted once with phenol (Tris-saturated, 
pH 4.3) and once with chloroform, both in 1:1 volume ratio, and, after addition of 
1/10 volume of 20% KAc pH 5.0, was precipitated with 2.5 volumes of EtOH. 
Formylaminoacylated tRNA was further purified on FPLC with a self-packed column 
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(5×50 mm) using Q-Sepharose resin. tRNAs on the column were washed with 15 ml 
of 50 mM NaAc pH 5.0, and eluted by a gradient of 0–1 M NaCl in 50 mM NaAc pH 
5.0. tRNA concentration was determined by A260 and [35S]-fMet-tRMAfMet 
concentration by radioactivity counting. A typical aminoacylation efficiency of 
850–1200 pmol/A260 was normally obtained. tRNAfMet purified from bulk tRNA was 
formylaminoacylated in a similar procedure except that 4 nmol of tRNAfMet was used 
in every 2000 μl of aminoacylation mixture, to a level of 1250-1800 pmol/A260. 
Commercial tRNAfMet was used in all of the experiment in Chapter III and IV. 
Purified tRNAfMet was used for most of the experiments in Chapter V and commercial 
tRNAfMet was used for some of the experiments. In control experiments, no difference 
was observed between using commercial and purified tRNAfMet within the 
experimental error. 
 
2.2.4.4 Aminoacylation of tRNAPhe 
Commercial tRNAPhe from yeast was aminoacylated using a procedure similar to 
commercial tRNAfMet except for in the aminoacylation buffer B and the use of yeast 
PheRS (Pan et al., 2007). A typical aminoacylation stoichiometry was 550–700 
pmol/A260. 
Commercial E coli. tRNAPhe was aminoacylated similar to yeast tRNAfMet except 
that: 1) aminoacylation buffer C was used; 2) incubation was 20 min at 37°C (Pan et 
al., 2007). E coli. tRNAPhe could be aminoacylated to a level of 550–700 pmol/A260. 
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2.2.4.5 Preparation of yeast AcPhe-tRNAPhe 
1.2 nmol yeast [3H]-Phe-tRNAPhe was lyophilized and re-dissolved in 50 μl 0.1 M 
NaAc pH 5.0. 0.0484 g N-hydroxysuccinimide ester was dissolved in 480 μl of dry 
DMSO, 400 μl of which was added to the [3H]-Phe-tRNAPhe solution. After 
incubation on ice for 2 hours, the sample was mixed with 50 μl of 20% KAc pH 6.5, 
EtOH precipitated, and centrifuged at 15k rpm for 20 min (Heraeus Instrument 
D-37520). Precipitation was repeated twice and the tRNA was resuspended in 150 μl 
of H2O. A fraction of 10 μl was aliquoted out and added into 1 M NH4OH as a control 
for overall [3H]-Phe-tRNAPhe radioactivity counting, and the remaining sample was 
diluted 25-fold in H2O. To pack a small column, 200 μl of cation exchange resin AG 
50W-X8 resuspended in 0.01 M HCl was loaded onto small spin column and washed 
5 times with 500 μl of H2O. Diluted sample in 500 μl portions was loaded onto a 
packed column, and washed 5 times with 500 μl of H2O and 5 times with 1 M 
NH4OH, all of the flow-through being collected separately. 50 ul aliquot from each 
fraction and the control were incubated at 75°C for 5 hours, mixed with 500 μl of H2O 
to dissolve everything, and counted in scintillation liquid to identify the fractions 
containing the product. Ac-[3H]-Phe-tRNAPhe was eluted with H2O, and EtOH 
precipitated with addition of 2.5 volumes of EtOH and dissolved in H2O at a final 
concentration of ~ 5 μM. 
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2.2.4.6 Aminoacylation of E. coli tRNAVal, tRNAArg and tRNALys 
E. coli tRNAVal, tRNAArg and tRNALys were aminoacylated by using a similar 
procedure to tRNAfMet, except that 1) aminoacylation buffer D was used; 2) the 
incubation time for tRNALys was 10 min. Typical aminoacylation stoichiometries were 
500–700 pmol/A260 for tRNAVal, 1000–1200 pmol/A260 for tRNAArg, 500–650 
pmol/A260 for tRNALys.  
 
2.2.4.7 Aminoacylation of tRNAVal2B variants 
tRNAVal2B variants were kind gifts from Dr. Olke C. Uhlenbeck (Northwestern 
University). tRNAVal2B was aminoacylated following reported procedures (Dale et al., 
2004) with some modifications. 1.2 nmol tRNA was incubated in 600 μl of 
aminoacylation buffer E at 37°C for 15 min. The reaction was quenched by 60 μl of 
20% KAc pH 5.0, and extracted once with phenol (Tris-saturated, pH 4.3) and once 
with chloroform, both in 1:1 volume ratio. tRNA was EtOH precipitated with addition 
of 2.5 volumes of EtOH and used with no further purification. [3H]-Val-tRNAVal2B 
concentration was determined by radioactivity counting. 
 
 2.2.4.8 tRNA labeling with proflavin 
A modified procedure for the preparation of fMet-tRNAfMet(prf) (Pan et al., 2007) 
was utilized to perform tRNA labeling with proflavin. To reduce the dihydrouridine 
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residues in the tRNA D-loop, 36 nmol of tRNA in 324 μl of 40 mM Tris-HCl pH 7.5 
was rapidly mixed with 36 μl of 100 mg/ml NaBH4 in 0.01 M KOH, followed by 1 
hour incubation on ice and H2 release every 10 min. The reduction reaction was 
terminated by drop-wise addition of 60 μl of 6 N HAc, and the product was purified 
by EtOH precipitation for three times in the presence of 1/10 volume of 20% KAc pH 
5.0 and 2.5 volumes of EtOH. Reduced tRNA was aminoacylated and purified by 
FPLC as described above, resuspended in 100 μl of H2O, and mixed with 1 ml of 0.52 
mg/ml proflavin in 0.1 M HCOONa pH 3.7 for 45 min incubation at 37°C. After 
incubation, the solution was adjusted to about pH 7.5 by addition of 1/10 volume of 1 
M Tris, and extracted twice with phenol (Tris-saturated, pH 6.5). Labeled tRNA was 
EtOH precipitated twice after addition of 1/10 volume of 20% KAc pH 6.5 and 2.5 
volumes of EtOH. Aminoacylation and labeling efficiencies were generally obtained 
as following: 700–900 pmol/A260 and 0.9–1.1 prf/tRNA for tRNAfMet; 250–400 
pmol/A260 and 0.8–1.0 prf for E coli. tRNAPhe; 250–400 pmol/A260 and 1.0–1.2 
prf/tRNA for tRNAVal; 800–1000 pmol/A260 and 0.9–1.1 prf/tRNA for tRNAArg; 
200–350 pmol/A260 and 1.0–1.2 prf/tRNA for tRNALys. 
 
2.2.4.9 tRNAPhe labeling with Cy3  
Yeast tRNAPhe was labeled with Cy3 (Pan et al., 2009) or Cy5 (Kaur et al., 2011) 
as previously reported. tRNAPhe was reduced and aminoacylated as above described, 
then purified using phenyl RP-HPLC (RP-C18 column, 4.6 × 250 mm, Alltech) with a 
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gradient of 0% to 30% ethanol in 20 mM NH4Ac pH 5.0, 10 mM Mg(Ac)2 and 400 
mM NaCl. Pooled fractions were EtOH precipitated with 20% KAc pH 5.0 and 2.5 
volumes of EtOH, and resuspended in 10 μl of 0.1 M HCOONa pH 3.7. Labeling was 
performed by mixing reduced and aminoacylated tRNA with 2 μl of 270 mM of Cy3 
or Cy5 hydrazide in DMSO, followed by a incubation at 37°C for 2 hours. Then the 
sample was lyophilized, EtOH precipitated as above for three times with 1/10 volume 
of 20% KAc pH 5.0. Phe-tRNAPhe(Cy3 or Cy5) was obtained with an aminoacylation 
efficiency of ~900 pmol/A260 and ~0.5 Cy3/tRNA. 
 
2.2.4.10 Preparation of highly labeled tRNAPhe with Cy5  
Yeast tRNAPhe was highly labeled with Cy5 as above described except that: 1) 
reduced and aminoacylated tRNAPhe was purified on FPLC; 2) 20% KAc pH 6.5 was 
used all the times. Phe-tRNAPhe(Cy5) was obtained with an aminoacylation efficiency 
of ~500 pmol/A260 and a labeling efficiency of ~0.8 Cy5/tRNA. 
 
2.2.5 Preparation of the 70S ribosomal complex and ternary complex 
Tightly-coupled wild-type 70S ribosomes from E.coli MRE600 cells and mutant 
70S ribosomes lacking L11 from E.coli AM77 cells were prepared and purified as 
previously reported (Pan et al., 2008).  
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2.2.5.1 Preparation of the 70S ribosome labeled with Cy3 or Cy5 
The reconstitution of 70S ribosomes containing L11Cy3 (70SCy3) or L11Cy5 (70SCy5) 
was performed as described (Chen et al., 2011a). 100 μl of 30 μM labeled L11 and 40 
μl of 50 μM 70S lacking L11 were first incubated at 37°C for 5 min separately, then 
combined for a further incubation at 37°C for 15 min. After an increase of magnesium 
concentration to 20 mM, the mixture was subject to centrifugation through a sucrose 
cushion in buffer A with 1.1 M sucrose and magnesium concentration increased to 20 
mM (SORVALL S120-AT2 rotor, 110K rpm, 40 min, 4 oC) to pull down the labeled 
70S. The pellet was suspended in buffer A. 70S concentration was determined by A260 
and dye concentration was determined by A550 for Cy3 or A650 for Cy5, respectively. A 
typical labeling efficiency is 0.8–1.0 dye/70S. 
 
2.2.5.2 Preparation of ribosomal complexes and ternary complex 
All ribosome complexes were prepared in buffer A at 37 oC. 70SIC was made by 
incubating 70S ribosome (0.8–4 μM) with mRNA (4-fold excess over 70S for all 
experiments in Chapter III and IV; half of 70S for experiments presented in Chapter V, 
Figure 5.2–5.3; 2-fold excess over 70S for all other experiments in Chapter V), IF1–3 
(1.5-fold excess over 70S), GTP (1 mM) and [35S]-fMet-tRNAfMet (1.5-fold excess 
over 70S) for 25 min. For experiments using fMet-tRNAfMet(prf), MDCC-PBP or 
GDPNP in Chapter III and IV and all experiments in Chapter V except for 
experiments presented in Figure 5.2C,D and 5.3B, 70SIC was purified by 
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centrifugation through a 1.1 M sucrose cushion in buffer A (SORVALL S120-AT2 
rotor, 110K rpm, 40 min, 4 oC). In all other experiments, the ultracentrifugation step 
was omitted. Purified 70SIC was quantified (Figures 5.2A,B and 5.3A) as 
co-sedimenting [35S]-fMet-tRNAfMet per mRNA, where mRNA stoichiometry was 
assumed to be half of 70S. 
TC was formed by incubating aminoacyl-tRNA (0.8–8 μM) with EF-Tu (4-fold 
excess over aa-tRNA), GTP (1 mM), phosphoenolpyruvate (1.5 mM) and pyruvate 
kinase (10 μg/mL) for 10 min. No PEP and PK were added when GDPNP was used. 
For Pi release experiments, GTP concentration was 50 µM, and no PEP and PK were 
added. TC solution was premixed with MDCC-PBP (2.5 µM), 7-methylguanosine 
(200 µM) and nucleoside phosphorylase (0.2 Unit/ml) before kinetic experiments. 
PRE complex was formed by incubating 70SIC (0.5–2 μM, as measured by A260 of 
70S) with TC (2-fold ratio to 70S) for 1 min. Purified PRE complex was prepared by 
centrifugation through a 1.1 M sucrose cushion in buffer A with 20 mM MgCl2, 
performed as 70SIC, and quantified (Figures 5.2C,D and 5.3B) as co-sedimenting 
[3H]-Val (thG4- or thG6-programmed ribosomes), [3H]-Arg (thG5-programmed 
ribosomes) or [3H]-Lys (thA1-, thA4-, thA5- or thA6-programmed ribosomes). All 
experiments reported in this thesis used purified PRE complexes, except for those 
shown in Figure 5.2E, for which the ultracentrifugation step was omitted. 
 POST complex was prepared and quantified (Figures 5.2E,F and 5.3C) using two 
different procedures. PRE complexes programmed with thG4, thG6 or MVF (0.8 μM, 
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as measured by A260 of 70S) were incubated with EF-G.GTP (2 μM) and puromycin 
(2.5 mM) at 37 oC for 30 s, the reaction was quenched with 1 volume of 0.3 M NaAc, 
pH 5.0, fMet-[3H]-Val-puromycin was quantitatively extracted with ethyl acetate and 
the radioactivity in the extract was determined. A different procedure was required for 
PRE complexes programmed with thG5, MRF, thA1, thA4, thA5, thA6 or MKF, because 
of the insolubility of fMet-[3H]-Arg-puromycin and fMet-[3H]-Lys-puromycin in 
ethyl acetate. Here PRE complex (5 μM, as measured by A260 of 70S) was incubated 
with EF-G.GTP (10 μM) and puromycin (15 μM) at 20 oC for 30 s, and the reaction 
was quenched by adding 5 volumes of buffer A adjusted to pH 5. These conditions 
were sufficient for full puromycin reaction with translocated fMet-[3H]-Arg-tRNAArg 
or fMet-[3H]-Lys-tRNALys, resulting in fMet-Arg-puromycin or fMet-Lys-puromycin 
formation. The resulting mixture was subject to ultracentrifugation through a 1.1 M 
sucrose cushion in buffer A with 20 mM MgCl2, performed as above. 
fMet-Arg-puromycin or fMet-Lys-puromycin remained in the supernatant during 
centrifugation. Unreactive fMet-Arg-tRNAArg or fMet-Lys-tRNAALys co-sedimented 
with the ribosome. Radioactivity in the pellet was determined. 
The relative amount (RA) of EF-G- and mRNA-dependent POST complex 
formation was obtained by correcting the results obtained for differences in the 
efficiencies of formation of the 70SIC (Figure 5.2E) and PRE (Figures 5.2E–F and 
5.3C) complexes and normalizing to the value found for unmodified mRNA. This was 
accomplished by measuring the amounts of [3H]-Val, [3H]-Arg, [3H]-Lys or found in 
either the ethyl acetate extract (thG4, thG6, or MVF) or sucrose cushion pellet (thG5, 
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MRF, thA1, thA4, thA5, thA6 or MKF) in four different samples formed in the presence 
(a) or absence (c) of EF-G in the presence of mRNA, or in the presence (b) or absence 
(d) of EF-G, in the absence of mRNA, and calculating the efficiencies using Equation 
2.1A (thG4, thG6 or MVF) or 2.1B (thG5, MRF, thA1, thA4, thA5, thA6 or MKF).  
RA = 1-[(c-d)/(a-b)] (2.1A);  RA = 1-[(a-b)/(c-d)] (2.1B)  
Data for thG4, thG6 and thG5 were used for sample calculation of relative 
translocation. The relative amounts of [3H]-Val per ribosome in the ethyl acetate 
extract were: (a) 0.057, 0.030 and 0.052 for MVF, thG4 and thG6, respectively; (c) 
0.009, 0.006 and 0.012 for MVF, thG4 and thG6, respectively. The values of [3H]-Val 
per ribosome for (b) and (d) were 0.002 and 0.001, respectively. From Equation 2.1A, 
the translocation efficiencies were 0.85, 0.82 and 0.78 for MVF, thG4 and thG6, 
respectively, which were all normalized to the efficiency of MVF. Therefore, the 
relative POST complex formation efficiencies, as shown in Figure 5.2E, were 1.0, 
0.96 and 0.92 for MVF, thG4 and thG6, respectively. The relative amounts of [3H]-Arg 
per ribosome in sucrose cushion pellet were: (a) 0.032 and 0.040 for MRF and thG5, 
respectively; (c) 0.100 and 0.084 for MRF and thG5, respectively. The values of 
[3H]-Arg per ribosome for (b) and (d) were 0.010 and 0.015, respectively. From 
Equation 2.1B, the translocation efficiencies were 0.75 and 0.57 for MRF and thG5, 
respectively, which were both normalized to the efficiency of MRF. Therefore, the 
relative POST complex formation efficiencies, as shown in Figure 5.2F, were 1.0 and 
0.76 for MRF and thG5, respectively. 
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2.2.5.3 Purification of ternary complex  
To evaluate the quenching efficiency between E348C-EF-TuQSY9 and 
Phe-tRNAPhe(Cy3), TC [formed by combining 2 nmol of E348C-EF-TuQSY9 and 0.7 
nmol of Phe-tRNAPhe (Cy3)] was purified on Co(II)-Sepharose (Talon) resin (bed 
volume 0.5 ml). TC and resin pre-washed with buffer A with no DTT were mixed and 
shaken at 4 oC for 30 min, pulled down by centrifugation (Heraeus Instrument 
D-37520, 8000 rpm, 2 min), and transferred to a small spin column. The resin was 
washed sequentially with 4 ml of buffer A with no DTT, 2 ml of buffer A with no DTT 
but 300 mM KCl and 10 mM imidazole. TC was eluted with 2 ml of buffer A with no 
DTT but 300 mM KCl and 300 mM imidazole. All of the washes and elutions were 
collected in 500 μl fractions. TC was normally in the first fraction of the elution and 
its concentration was determined by scintillation counting. 
 
2.2.6 Fluorescence experiments 
2.2.6.1 Static fluorescence experiments 
Steady-state fluorescence was measured on a Fluorolog-3 spectrofluorometer 
(Horiba Jobin Yvon). The emission spectrums were recorded with an excitation at 530 
nm for Cy3, 360 nm for thA and thG. Excitation spectrums of modified nucleosides 
were performed by monitoring the emission at 410 nm for thA and 450 nm thG. 
Distances between FRET donor and acceptor were calculated using the equation 
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shown as below:  
Distance = R0*(1/E-1)1/6 
where R0 is the Förster distance (Medintz et al., 2003) and E is measured FRET 
efficiency. 
 
2.2.6.2 Stopped-slow experiments 
Kinetic experiments were performed in buffer A at 25 oC on KinTek SF-300X 
stopped-flow spectrofluorometer. Cy3 was excited at 530 nm and monitored using 
either a 570-nm long-pass filter for experiments employing QSY9 or a 570 ± 10-nm 
band-pass filter for all other experiments. Cy5 fluorescence was monitored using a 
680 ± 10-nm band-pass filter. Proflavin was excited at 462 nm and monitored using a 
515 ± 15-nm band-pass filter. MDCC-PBP was excited at 436 nm and monitored 
using a 455 nm long-pass filter. thG was excited at 360 nm and monitored using a 450 
± 10-nm band-pass filter. thA was excited at 360 nm and monitored using a 410 ± 
10-nm band-pass filter. In each independent kinetic experiment, traces of fluorescence 
intensity changes were obtained as an average of at least 4 shots. Each experiment 
was performed twice. Apparent rate constants (kapps) were obtained by either single 
(Equation 2.2) or double (Equation 2.3) exponential fitting of each independent 
experiment using Origin (OriginLab), respectively. Global fittings of selected data 
sets were carried out using Scientist (MicroMath Research). 
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F = F0 + F1e-k1appt  (Equation 2.2) 
F = F0 + F1e-k1appt + F2e-k2appt  (Equation 2.3) 
 
2.2.6.3 Single-molecule experiments 
smFRET studies were carried out at 23 °C. 70S ICs formed using a 
5’-biotinylated mRNA (Dharmacon RNAi Tech.) were immobilized on a 
biotin/PEG-streptavidin coated glass surface (Roy et al., 2008). After washing away 
unbound complexes, collection of real-time fluorescence traces began 5 s prior to 
injecting 10 nM ternary complexes, which were preformed from EF-Tu, GTP and 
charged tRNAs. Recording continued for 60 s without further washing. An enzymatic 
deoxygenation system of 3 mg/ml glucose, 100 µg/ml glucose oxidase, 40 μg/ml 
catalase, and 1.5 mM 6-hydroxy-2,5,7,8-tetramethyl-chromane-2-carboxylic acid (by 
dilution from a DMSO solution) was present in the final single-molecule imaging 
solutions to diminish fluorophore photobleaching and blinking. A custom-built 
objective-type total internal reflection fluorescence (TIRF) microscope was used to 
collect Cy3 and Cy5 (due to FRET from Cy3) fluorescence intensities on excitation 
by a 532 nm laser (Chen et al., 2011a). The 11 ms integration time was achieved by 
cutting the exposure area down to 128 pixels × 512 pixels without further binning. 
Other details of materials preparation, experimental setup, and data analysis were as 
previously described (Chen et al., 2011a). 
FRET probability density plots were two-dimensional contour maps plotted from 
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time-resolved FRET histograms. For each plot, FRET traces were synchronized at the 
same specific event, such as the first or the last time points of FRET events. The 
FRET value was set to 0 when there are no Cy3 and Cy5 fluorescence signals. 
Synchronized FRET traces were averaged traces from FRET traces synchronized 
at the same specific event, such as the first or the last time points of FRET events 
(Veigel et al., 2002; Stevens et al., 2012). Before averaging, for the 
pre-synchronization process, FRET traces were synchronized at the time points of 
FRET appearance and were extended after FRET disappearance using the FRET value 
of the last time point of FRET event. Similarly, for the post-synchronization process, 
FRET traces were synchronized at the time points of FRET disappearance and were 
back-extended before FRET appearance using the FRET value of the first time point 
of the FRET event. 
 
2.2.7 Quenched-flow experiments  
 Kinetics of fMetPhe dipeptide formation were measured following previous 
procedures (Pan et al., 2008) by mixing IC (1.2 µM) and TC (0.3 µM) containing 
[3H]-Phe-tRNAPhe at 25°C on quench-flow machine (KinTek Chemical Quench-Flow 
Model RQF-3). Reaction was quenched with 5 M NH4OH at different time points (e.g. 
0.01, 0.02, 0.05, 0.1, 0.2, 0.4, 0.5, 0.7. 3, 5, 7, 10, 15, 30, 45, 60 sec). Quenched 
samples were lyophilized and resuspended in 500 µl of H2O. 50 µl aliquot from each 
sample was scintillation counted as positive control to measure total radioactivity. The 
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remaining samples were loaded onto cation exchange resin AG 50W-X8 (bed volume 
400 µl) pre-washed with 5× 400 ul of 0.01 M HCl and 5× 400 ul of H2O. Dipeptide 
was eluted with 2 ml of H2O. Dipeptide was in both flow-through of sample loading 
and elution, and they are combined for scintillation counting determination of 
dipeptide. . 
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Figure 2.1. Electrophoretic analysis of purified mRNA. The gel contains 2% agarose. 
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022 MFTI:                                                           
GGG AAU UCA AAA AUU UAA AAG UUA ACA GGU AUA CAU ACU AUG 
UUU ACG AUU ACU ACG AUC UUC UUC ACU UAA CGC GUC UGC AGG 
CAU GCA AGC UAA AAA AAA AAA AAA AAA AAA AAA AAA GCU U 
 
022 CUC: 
GGG AAU UCA AAA AUU UAA AAG UUA ACA GGU AUA CAU ACU AUG 
CUC ACG AUU ACU ACG AUC UUC UUC ACU UAA CGC GUC UGC AGG 
CAU GCA AGC UAA AAA AAA AAA AAA AAA AAA AAA AAA GCU U 
 
MRF: 
GGG AAU UCA AAA AUU UAA AAG UUA AUA AGG AUA CAU ACU AUG 
CGU UUC UUC CGU UUC UAU CGU UUC 
 
MVYF: 
GGG AAU UCA AAA AUU UAA AAG UUA ACA GGU AUA CAU ACU AUG 
GUC UAC UUU ACU ACG AUC UUC UUC ACU UAA CGC GUC UGC AGG 
CAU GCA AGC UAA AAA AAA AAA AAA AAA AAA AAA AAA GCU U 
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MVF: 
A GGU AUA CAU ACU AUG GUG UUC CGU AAA UAU UUG CCC GGG CCC 
GGG AAAA CCC GGG CCC GGG CCC TT TTT TCT GCA 
 
MKF:  
GGG AAU UCA AAA AUU UAA AAG UUA ACA GGU AUA CAU ACU AUG 
AAA UUC CGU ACU ACG AUC UUC UUC ACU UAA CGC GUC UGC AGG 
CAU GCA AGC UAA AAA AAA AAA AAA AAA AAA AAA AAA GCU U 
 
Figure 2.2. Unmodified mRNA sequence. AUG initiation codons are underlined. 
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CHAPTER 3 
LABELED EF-TUS FOR RAPID KINETIC STUDIES OF 
PRE-TRANSLOCATION COMPLEX FORMATION 
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3.1 Abstract 
 As one of the two universally conserved translation elongation factors, EF-Tu 
delivers aminoacyl (aa)-tRNA in the form of a ternary complex (TC) to the ribosome 
to decode the codon programmed at the ribosomal A-site. Here, a QSY9 derivative of 
E348C-EF-Tu was prepared and shown to be fully functional in translation elongation. 
Together with fluorophore derivatives of aa-tRNA and L11, labeled EF-Tu was 
utilized for the development of two new assays to study the relative dynamics within 
the EF-Tu:L11:tRNA triangle. Our results showed that EF-Tu comes into proximity to 
L11 when delivering aa-tRNA to the ribosome, and leaves L11 and releases aa-tRNA 
after EF-Tu mediated GTP hydrolysis. These assays were used to examine the effects 
of two misreading antibiotics, streptomycin (Str) and paromomycin (Par), on tRNA 
selection at the ribosomal A-site in both initial selection and proof-reading stages. It 
was also shown that the contacts between T stem-loop of aa-tRNA and EF-Tu have 
crucial effects in tRNA release from EF-Tu and accommodation into the A-site.  
 
 
 
 
 
 
 63
3.2 Introduction 
EF-Tu is, along with EF-G, one of two G-protein factors that are required for 
nascent polypeptide elongation by the prokaryotic 70S ribosome (Kavaliauskas et al., 
2012). These factors are crucial for controlling the speed and accuracy of the 
polymerization of amino acids into polypeptides encoded by mRNA. 70S ribosomes 
are formed by the association of the 30S and the 50S subunits, within which the 
mRNA codon : tRNA anticodon interaction and peptide bond formation occur, 
respectively. During an elongation cycle, a tRNA binds sequentially to several sites in 
the 70S ribosome. These sites are named according to several major defined locations 
within the 30S and the 50S subunits, as follows: A/T, A/A (or just A), A/P, P/P (or just 
P), P/E, and E/E (or just E) (Schmeing et al., 2009).  In the first elongation cycle, 
EF-Tu acts as a chaperone in accelerating the binding of a cognate aa-tRNA, in the 
form of a EF-Tu.GTP.aa-tRNA ternary complex (TC), to the ribosomal A/T-site of a 
70S initiation complex (70SIC), which contains initiator fMet-tRNAfMet bound in the 
P-site. TC binding to the ribosome brings EF-Tu into proximity with ribosomal 
protein L11 within the GTPase associated center (GAC) of the 50S subunit, to which 
all ribosomal G-proteins bind (Allen et al., 2005). Formation of Watson-Crick base 
pairs between the anticodon loop of cognate aa-tRNA and the three-nucleotide codon 
sequence in mRNA at the decoding center of the 30S subunit leads to changes in 
ribosome conformation and an activation of the EF-Tu GTPase activity. GTP 
hydrolysis is followed by Pi release, movement of aa-tRNA from the A/T to the A/A 
site, a process also known as “accommodation” into the A-site, peptide bond 
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formation between fMet-tRNAfMet and aa-tRNA, and EF-Tu.GDP release from both 
peptidyl-tRNA and the ribosome, resulting in pretranslocation (PRE) complex 
formation. Structural studies show a dramatic conformational difference between the 
GTP- and GDP-bound forms of EF-Tu (Kjeldgaard and Nyborg, 1992; Polekhina et 
al., 1996). The antibiotic kirromycin inhibits elongation by "freezing" EF-Tu.GDP on 
the ribosome in a GTP-like conformation (Schmeing et al., 2009a). 
Selection of the correct isoacceptor tRNA takes place in two steps, one preceding 
and one following GTP hydrolysis. During initial selection, all non-cognate and the 
major fraction of near-cognate TCs dissociate. After GTP hydrolysis, almost all 
remaining near-cognate tRNAs are rejected in the so-called proofreading step; a small 
fraction goes forward and participates in peptide bond formation. The selectivity of 
the decoding process for cognate tRNA is reduced by aminoglycosides (Vicens and 
Westhof, 2003).  
Although the movement of tRNA through the ribosome during PRE complex 
formation has been extensively studied by kinetic, structural and modeling studies 
(Pape et al., 1998; Pan et al., 2007; Schmeing and Ramakrishnan, 2009b), tools 
allowing description of the dynamic properties of EF-Tu as it interacts with both the 
ribosome and aa-tRNA have heretofore been unavailable. Here we describe the 
preparation and utilization of functionally active fluorescent and fluorescence 
quencher derivatives of EF-Tu that address this deficiency. In conjunction with either 
ribosomes containing fluorescent-labeled L11, or with fluorescent-labeled forms of 
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aa-tRNA, these derivatives allow the development of real-time fluorescence 
resonance energy transfer (FRET) assays that monitor EF-Tu proximity to L11 (FRET 
assay 1) and contact with aa-tRNA (FRET assay 2). These assays, along with a 
previously described assay measuring aa-tRNA movement from the A/T-site to the 
A-site (Pan et al., 2008) permit us to measure the rates of several key substeps of PRE 
complex formation, including i) initial TC interaction with the A/T site, ii) movement 
of EF-Tu.GDP away from its initial binding site during accommodation, and iii) 
release of EF-Tu.GDP from aa-tRNA. In addition, they allow us to determine how the 
rates of these processes are influenced by mechanistically important variables, such as 
substitution of near-cognate for cognate mRNA in the presence or absence of 
aminoglycoside antibiotics, and the strength of EF-Tu interaction with aa-tRNA.  
 
3.3 Results 
3.3.1 Nomenclature 
The labeled protein synthesis components employed in this work are named and 
described in Table 3.1. QSY9 is an efficient quencher of Cy3 fluorescence. 
 
3.3.2 Probe-labeled EF-Tu variants and their formation of TCs with Phe-tRNAPhe 
We chose positions for probe introduction into E. coli EF-Tu based on the 
structure of a kirromycin- and paromomycin-stabilized ribosome complex containing 
 66
bound EF-Tu.GDP and aa-tRNA (Protein Data Bank accession codes 2WRN, 2WRO, 
2WRQ, and 2WRR) (Figure 3.1). Three EF-Tu residues, K324, G325, and E348 
(using E. coli EF-Tu numbering), met the criteria of i) falling within <50 Å of residue 
87 in L11 (Chen et al., 2011b) and of residues 16/17 of A/T-bound tRNA (Kaur et al., 
2011); ii) pointing toward solvent, and iii) not being highly conserved (Perla-Kajan et 
al., 2010). They were thus suitable for probe introduction via replacement by a Cys 
residue and reaction with a QSY9 or Cy3 maleimide derivative.  
EF-Tu contains three endogenous Cys residues (C81, C137 and C255), which can 
potentially be labeled, possibly leading to decreased EF-Tu functional activity and/or 
interference with interpretation of FRET signals. As expected based on lack of 
conservation, Cys 137 and Cys 255 could be replaced by Ala or Val, respectively, 
without affecting aa-tRNA binding (unpublished from Dr. Darius Kavaliauskas and 
Prof. Charlotte R. Knudsen). Efforts to replace Cys 81 consistently led to loss of 
EF-Tu activity (unpublished from Dr. Darius Kavaliauskas and Prof. Charlotte R. 
Knudsen; also in Figure 3.2B), consistent with a previous study of the functional role 
of Cys 81 (Anborgh et al., 1992). In contrast, a more recent study claimed that 
aa-tRNA binding to EF-Tu was retained when Cys 81 is replaced by Ala (Laurentiis et 
al., 2011). However, in this latter work concentrations of both aa-tRNA and EF-Tu 
were in great excess over the dissociation constant, so that even comparatively large 
decreases in affinity would not have been detected. 
In view of our results, EF-Tu variants containing cysteines at positions K324, 
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G325, and E348 were prepared by single mutation of wt-EF-Tu. The Cys at position 
324, 325, or 348 was much more reactive toward derivatization than the endogenous 
Cys residues. As a result, stoichiometric labeling at these positions could be obtained 
with only minor labeling of the endogenous residues (Table 3.2) that was 
inconsequential for subsequent EF-Tu:tRNA or EF-Tu:L11 FRET measurements (see 
Figures 3.2A and 3.5B).  
Two QSY9-labeled derivatives of single EF-Tu variants, E348C-EF-TuQSY9 and 
K324C-EF-TuQSY9, showed similar high affinities for Phe-tRNAPhe(Cy3) as measured 
by the quenching of Phe-tRNAPhe(Cy3) fluorescence (Figure 3.2A) or protection of 
Phe-tRNAPhe(Cy3) from hydrolysis (Figure 3.2B), and both supported 
poly(U)-dependent poly(Phe) synthesis by ribosomes to equal extents (Figure 3.2C). 
A third QSY9-labeled derivative, G325C-EF-TuQSY9, showed clearly weaker affinity 
for Phe-tRNAPhe(Cy3) in the fluorescence quenching assay (Figure 3.3A) and in this 
same assay the apparent quenching by E348C-EF-TuQSY9 was greater than by 
K324C-EF-TuQSY9. On the basis of these results, E348C-EF-TuQSY9 was selected for 
subsequent studies.  
 Phe-tRNAPhe(Cy3) fluorescence is decreased 82% within the TCs it forms with 
E348C-EF-TuQSY9 (Fig. 3.3A). Based on the FRET Ro values for the pairs Cy3/QSY9 
(55Å) (Medintz et al., 2003), this decrease corresponds to dye-dye distances of ~ 43 Å 
for the TC formed by E348C-EF-TuQSY9, assuming that the dye rotates freely. This 
distance is in reasonable accord with an expected distance of 34 Å (Cα,348, EF-Tu; to 
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16 N1, tRNA) measured in ternary complexes (Nissen et al., 1999), allowing for some 
increase due to the dye dimensions. Measuring the rate of Phe-tRNAPhe(Cy3) 
quenching as a function of  E348C-EF-TuQSY9 concentration allowed estimation of 
kon = 1.3 ± 0.1 µM-1s-1 and koff = 0.17 ± 0.07 s-1 for TC formation (Figure 3.3B), 
consistent with previous estimates of the Kd value using unlabeled EF-Tu (Pan et al., 
2008).  
 
3.3.3 Interaction of TCs containing labeled EF-Tu with 70SICs 
Rapid mixing in a quenched-flow apparatus of the TC formed from 
E348C-EF-TuQSY9.GTP and Phe-tRNAPhe, denoted TCQSY9, with a 70SIC programmed 
with mRNA022 MFTI, which has a UUU codon following the AUG initiation codon, 
led to an apparent rate constant for fMetPhe-tRNAPhe formation, 4.5 s-1, similar to the 
values reported earlier using unlabeled TC and unlabeled 70SIC (Figure 3.4) 
(Gromadski and Rodnina, 2004a; Pan et al., 2008). This result demonstrates the 
functionality of E348C-labeled EF-Tu in catalyzing dipeptide formation during PRE 
complex formation.  
We developed two new stopped-flow FRET assays for monitoring TC interaction 
with 70SIC in real time. The FRET-1 assay involves rapid mixing of 70SIC 
containing Cy3-labeled L11, denoted 70SICCy3, with TCQSY9 (Figure 3.5). Such 
mixing results in a biphasic change in Cy3 fluorescence, with an initial decrease 
corresponding to TC binding to the ribosome that places EF-Tu position 348 in 
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proximity to L11 position 87, followed by a restoration of fluorescence intensity as 
these two positions move apart (Figure 3.5B). These changes are completely 
dependent on the presence of mRNA, with barely any change observed when mRNA 
is omitted.  
The FRET-2 assay involves rapid mixing of unlabeled 70SIC with the TCs 
formed from Phe-tRNAPhe(Cy3), GTP and E348C-EF-TuQSY9, denoted TCQSY9/Cy3, 
which resulted an increase in Cy3 fluorescence (Figure 3.6B), ultimately leading to a 
complete loss of FRET interaction between labeled tRNA and labeled EF-Tu (Figure 
3.6C). This corresponds most probably to EF-Tu·GDP release from the ribosome. 
Although the curves obtained could be adequately fit with single exponentials, in both 
cases superior fits were obtained using double exponentials, giving the kapp1 and kapp2 
values provided in Table 3.3.  
 
3.3.4 Kirromycin and GTP hydrolysis effects on TC interaction with 70SIC 
Perturbing the interaction of TC with 70SIC by adding kirromycin or replacing 
GTP with a non-hydrolyzable analogue in both cases has the effect of holding EF-Tu 
in proximity to L11, in each case resulting in a stalled ribosome. High resolution 
structures of both stalled complexes show similar placements of EF-Tu, although 
some differences are seen in the switch 1 and G-domain regions (Schmeing et al., 
2009a; Voorhees et al., 2010). Not unexpectedly, these perturbations display similar 
effects in eliminating the second phase of the FRET-1 assay that corresponds to 
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moving EF-Tu away from L11 and in forming stalled ribosome complexes having 
virtually identical EF-Tu:L11 FRET efficiencies (Figure 3.5B). Other studies 
measuring aa-tRNA(A/T site):L11 and tRNA(A/T site):tRNAfMet(P site) FRET 
efficiencies have also provided evidence for the structural similarity of stalled 
ribosomes formed in the presence of kirromycin- or of a non-hydrolyzable GTP 
analogue (Geggier et al., 2010; Lee et al., 2007). 
However, the results presented in Figures 3.5 and 3.6 also show some interesting 
differences in the two types of stalled complexes: 1) the first phase of the FRET-1 
assay proceeds more rapidly when kirromycin is added than when GDPNP replaces 
GTP (Figure 3.5B; Table 3.3); 2) more strikingly, while substitution of GDPNP for 
GTP completely blocked the increase in Cy3 fluorescence in the FRET-2 assay, a 
partial increase of this fluorescence is seen in the presence of added kirromycin, 
indicative of a partial separation of EF-Tu from tRNA, monitored at the D-loop of 
tRNA, in the absence of EF-Tu separation from L11.  
 
3.3.5 tRNA misreading 
The FRET-1 and FRET-2 assays provide convenient measures of the selectivity of 
TC binding to 70SIC programmed at the decoding center with cognate (UUU), 
near-cognate (CUC), and non-cognate (CGU) codons, and of the ability of 
aminoglycoside antibiotics to modulate such selectivity.  
  As measured in the FRET-1 assay, reaction of TCQSY9 with 70SICCy3 programmed 
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with near-cognate CUC leads to a monophasic decrease in Cy3 fluorescence intensity, 
which proceeds with a rate constant similar to that found for the first phase of TCQSY9 
binding to 70SICCy3 programmed with cognate UUU (Figure 3.7A; Table 3.3). The 
magnitude of the intensity drop is somewhat lower than in the cognate case, but it can 
be increased by raising the TCQSY9 concentration. However, the second phase of 
reaction is strongly inhibited, mimicking the results obtained in the binding of a 
cognate TC either in the presence of kirromycin or on substitution of GDPNP for GTP 
(Figure 3.5B). These results indicate that near-cognate TC binding closely mirrors that 
of cognate TC binding to the A/T site, albeit with somewhat lower affinity, but that 
subsequent movement away from the A/T site must be at best very slow, consistent 
with conclusions reached in earlier studies (Gromadski et al., 2006). Almost no 
change in Cy3 fluorescence is observed with either non-cognate mRNA or when 
mRNA is omitted.  
TCQSY9/Cy3 reacts more slowly with near-cognate mRNA than with cognate 
mRNA programmed 70SICs (FRET-2 assay, Figure 3.7B; Table 3.3), with substantial 
decreases in the apparent rate constants for both phases of Cy3 fluorescence increase 
(~ 3- and 8-fold, respectively). In addition, although the overall fluorescence change 
is similar in both reactions, for the near-cognate programmed 70SIC the amplitudes of 
the first and second phases show a large decrease and a large increase, respectively, 
with respect to the cognate-programmed 70SIC. The magnitude of the decrease in the 
overall rate of fluorescence increase is similar to that seen for the rate of GTPase 
hydrolysis measured under comparable conditions (Gromadski et al., 2006). For 
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ribosomes programmed with near-cognate mRNA, there is a relatively rapid rise in 
Cy3 fluorescence intensity in the FRET-2 assay (Figure 3.7B) in a time period, 0.2 – 3 
s, over which there is no change in Cy3 fluorescence in the FRET-1 assay (Figure 
3.7A). This indicates that partial movement of aa-tRNA away from EF-Tu can take 
place in the absence of any movement of EF-Tu away from L11, paralleling what was 
found for cognate-programmed ribosomes in the presence of kirromycin (Figures 3.5 
and 3.6). 
Addition of the antibiotics streptomycin (Str) or paromomycin (Par), each of 
which is known to induce misreading, albeit by different mechanisms (Gromadski and 
Rodnina, 2004b), decreases the differences in TC interactions with cognate or 
near-cognate programmed 70SIC, as measured in both FRET assays. In the FRET-1 
assay, the presence of either antibiotic gives rise to similar biphasic changes in Cy3 
fluorescence for ribosomes programmed with either mRNA (Figure 3.7C). Relative to 
what is observed for cognate mRNA and near-cognate mRNA in the absence of 
antibiotic, the decrease of fluorescence in the first phase is much less pronounced, an 
indication that the binding of either antibiotic has the effect of increasing the L11 to 
EF-Tu distance within the initial complex formed on TC binding. kapp1 is little affected 
by either antibiotic. For cognate-programmed 70SICs, both antibiotics slow kapp2 by 
~2-fold (Table 3.3). For near-cognate-programmed 70SICs, both antibiotics restore 
the second phase reaction by which EF-Tu moves away from L11, with kapp2 values 
~5-fold lower than for cognate-programmed 70SICs in the absence of antibiotic. In 
the FRET-2 assay (Figure 3.7D), added Str leads to almost identical Cy3 fluorescence 
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increases for near-cognate and cognate programmed 70SICs, reflecting, relative to 
cognate programmed 70SICs in the absence of Str, ~2-fold decreases in both apparent 
rate constants and a large shift in the relative amplitudes of phases 1 and 2 in favor of 
phase 2 (Table 3.3). Added Par has a less effect on the results obtained with cognate 
programmed 70SICs, decreasing both kapp1 and kapp2 by ~ 35% without altering the 
relative amplitudes of phases 1 and 2, but gives results with near-cognate 
programmed 70SICs similar to those obtained with added Str. 
 
3.3.6 Altering EF-Tu:aa-tRNA interaction 
Schrader et al. have recently presented results leading to the conclusion that the 
affinities of aa-tRNAs for EF-Tu are constrained to be uniform by their need to bind 
tightly enough to form the ternary complex but weakly enough to release from EF-Tu 
during decoding (Schrader et al., 2011). In this work the affinity of variant tRNAVal2Bs 
for EF-Tu was varied by manipulating a portion of the aa-tRNA stem that binds directly 
to EF-Tu. Their principal finding was that overall activity, as measured by the rate of 
dipeptide formation with a 70SIC, was conserved for variants binding to EF-Tu.GTP up 
to 100 times more weakly than wt, but that such activity fell off very quickly for 
variants binding to EF-Tu more tightly than wt. Here we re-examine this question at 
higher kinetic resolution by examining the influence of aa-tRNA affinity for EF-Tu on 
the L11-tRNA interactions measured by the FRET-1 assay, and on movement of 
aa-tRNA from the A/T site into the A/A site, as measured by a third assay. In this work 
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we compare measurements on TCs formed by wt Val-tRNAVal2B and two variants, 
denoted T1 and Ψ, which bind to EF-Tu.GTP with much higher or slightly lower 
affinities compared to wt, respectively (Table 3.4). 
We first examined TC formation. The fluorescence intensity of 
E348C-EF-TuCy3.GTP increases on forming a TC with each of the Val-tRNAVal2B 
transcripts examined. The second-order association rate constant for the wt-transcript, 
determined by measuring the apparent association rate constant as a function of 
E348C-EF-TuCy3 concentration, is 0.74 ± 0.06 µM-1s-1 (Figure 3.8A). A measure of 
the dissociation rate constant, equal to 0.039 ± 0.001 s-1, is provided by the rate of 
decrease in Cy3 fluorescence when the labeled complex is mixed with a large excess 
of unlabeled EF-Tu, under conditions where dissociation of the labeled complex is 
rate limiting for formation of unlabeled TC (Figure 3.8B). Similar measurements were 
made for the Ψ and T1 variants, giving relative values comparable to those measured 
by Schrader et al (Schrader et al., 2009) using a different approach (Table 3.4). 
Carrying out the FRET-1 assay with the TC formed by combining 
E348C-EF-TuQSY9·GTP with wt-Val-tRNAVal2B transcript with a 70SICCy3 
programmed with mRNA MVYF gave biphasic changes in Cy3 fluorescence (Figure 
3.8C) similar to those displayed in Fig. 3.5B for the TC containing native 
Phe-tRNAPhe, with somewhat lower values of kapp1 (14.7 s-1 vs. 26 s-1, respectively) 
and kapp2 (4.3 s-1 vs. 6.2 s-1, respectively). The corresponding results for the Ψ variant, 
with respect to both fluorescence changes and rates are comparable to those for wt, 
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although both rate constants have slightly larger values (Table 3.4). For the T1 variant, 
however, both reaction phases are considerably slower, with a significant reduction in 
kapp1 (2.7-fold) and a very large reduction in kapp2 (22-fold). The much more 
pronounced decrease in Cy3 fluorescence in phase 1 for the T1 variant as compared 
with the wt and Ψ variant is due, at least in part, to more complete formation of the 
intermediate formed in phase 1 as a result of kapp2 being so much less than kapp1. For 
this variant, measurement of kapp1 and kapp2 as a function of TC concentration provides 
clear evidence that they approximate actual rate constants for a 2nd order binding step 
and a first-order conformational change step, respectively (Figure 3.9). Thus, 
tightening aa-tRNA binding to EF-Tu markedly decreases the rate of EF-Tu 
movement away from L11 that follows initial TC binding (Table 3.4, kapp2).  
Proflavin-labeled fMet-tRNAfMet [denoted fMet-tRNAfMet(prf)] bound in the 
P-site of a 70SIC displays a decrease in fluorescence when aa-tRNA bound in the 
A/T-site is accommodated into the A-site, providing a convenient tool for measuring 
the rate of the accommodation process (Pan et al., 2008). Applying this assay to the 
reaction of the TCs formed by the three Val-tRNAVal2B variants with a 70SIC 
programmed with mRNA MVYF gave the results shown in Figure 3.8D. Interestingly, 
allowing for some differences in experimental conditions, there is fairly close 
agreement for the wt and Ψ variants with respect to both the absolute and relative 
values of the rate constants for accommodation measured in this work (kaccom) and 
those for dipeptide formation (kdipep) measured by Schrader et al. (Schrader et al., 
2011) (Table 3.4), consistent with the prevailing view that peptide bond formation 
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proceeds rapidly after accommodation.  
However, it is worth noting that whereas the values of kapp2, kaccom and kdipep are 
all fairly similar to one another for both the wt and Ψ variants, indicating that for 
these variants movement of EF-Tu away from L11, aa-tRNA accommodation and 
peptide bond formation occur roughly simultaneously, for the T1 variant 
accommodation clearly proceeds significantly faster (3-fold) than the movement of 
EF-Tu away from L11. Thus, for this variant, some movement of aa-tRNA toward the 
P-site, as measured by the change in fMet-tRNAfMet(prf) fluorescence, precedes the 
full accommodation that allows rapid peptide formation, in accord with previous 
results demonstrating that movements of the elbow and 3′-end regions of tRNA 
during both forward (Whitford, 2010) and reverse (Liu et al., 2010) translocation can 
be decoupled from one another. 
 
3.4 Discussion 
EF-Tu.GTP acts as a chaperone in accelerating the binding of a cognate aa-tRNA 
to the ribosomal A-site during PRE complex formation, and, following GTP 
hydrolysis, is released from the ribosome as EF-Tu.GDP. Such release requires the 
breaking of strong contacts that EF-Tu makes both with aa-tRNA and with the 
ribosomal GAC. Here we demonstrate that EF-Tu variants labeled at position 348 
with a fluorescent quencher form functional labeled TCs with wild-type or 
fluorescent-labeled wild-type Phe-tRNAPhe and with several unlabeled Val-tRNAVal2B 
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variants. We use such labeled TCs to develop two new FRET assays that provide tools 
for determining the dynamics, during PRE complex formation, of distance changes 
between EF-Tu and both ribosomal protein L11, located within the GAC (FRET-1 
assay), and aa-tRNA (FRET-2 assay). Application of these assays, in conjunction with 
related measurements, has led to several new mechanistic insights concerning the 
details of PRE complex formation, as well as demonstrating the potential that such 
assays have for high throughput screens of protein synthesis inhibitors. 
The first insight concerns the order in which EF-Tu breaks its contacts to the 
GAC and to aa-tRNA. Our results, as summarized in Table 3.3, indicate that, 
following cognate TC binding to the 70SIC leading to PRE complex formation, 
movement of EF-Tu away from L11, and presumably therefore from the GAC, as 
measured by kapp2 in FRET-1 assay, consistently proceeds somewhat faster (1.5 – 
3-fold) than movement of EF-Tu away from aa-tRNA, as measured by kapp1 in 
FRET-2 assay. This inequality is found in the absence or presence of the antibiotics 
Str or Par. It is also seen for near-cognate TC in the presence of Par, although for 
near-cognate TC in the presence of Str, the two apparent rate constants are equal. 
These results indicate that movement of EF-Tu away from the GAC generally 
precedes movement of EF-Tu away from aa-tRNA, and that, given the relatively 
small differences in the values of the two rate constants, the second step follows 
rapidly after the first. However, it is also possible for EF-Tu to move away from 
aa-tRNA when EF-Tu is constrained to remain in close proximity to L11, as when 
70SIC is combined with either cognate TC in the presence of kirromycin (Figsures 3.5 
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and 3.6) or with near-cognate TC in the absence of antibiotic (Figures 3.7A–B). Such 
movement may require GTP hydrolysis, since it is not observed when EF-Tu is 
constrained to remain in close proximity to L11 by replacing GTP with GDPNP 
(Figures 3.5 and 3.6). Thus, under certain circumstances, GTPase-dependent 
movement of EF-Tu away from aa-tRNA could precede movement of EF-Tu away 
from the GAC during PRE complex formation. 
The second insight concerns the effects of strengthening the binding of aa-tRNA 
to EF-Tu via mutation of the T-stem (Table 3.4). Comparing the wt and Ψ variants of 
Val-tRNAVal2B, which have comparable binding affinities for EF-Tu, the values of 
each of the rate constants kapp2 (FRET-1 assay), kaccorm and kdipep are quite similar to 
one another. Furthermore, for each of these variants, all three of these rate constants 
have similar values, indicating that for both variants, the movements of EF-Tu away 
from L11 and of aa-tRNA from the A/T site to the A/A site, and peptide bond 
formation occur roughly simultaneously. The situation is quite different for the T1 
variant of Val-tRNAVal2B, which binds to EF-Tu considerably more tightly than the 
other two variants. This variant was previously shown to also have a markedly 
decreased rate of dipeptide formation (Table 3.4, kdipep). Here we show that this 
decreased rate is likely a consequence of decreases in the rates of two distinct 
processes that precede dipeptide formation, the movement of aa-tRNA from the A/T 
site to the A/A site (kaccorm), and the movement of EF-Tu away from L11 (kapp2). Based 
on the similarities in the values of kapp2 and kdipep (Table 3.4), this latter movement 
may be rate limiting for dipeptide formation. The >20-fold reduction of kapp2 for the 
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T1 variant (Table 3.4) likely reflects an allosteric effect transmitted through the EF-Tu 
structure, since the region of EF-Tu that interacts with the GAC is far removed from 
the region of EF-Tu that interacts with the tRNA T-stem (Schmeing et al., 2009a; 
Voorhees et al., 2010). The T1 variant also differs from wt and Ψ variants in having a 
kaccorm that is substantially (3-fold) greater than kapp2, indicating that movement of 
aa-tRNA toward the P-site precedes the full accommodation of aa-tRNA into the A/A 
site that allows rapid peptide bond formation. This is in accord with previous results 
demonstrating that movement of the flexible 3’-end region of ribosome-bound tRNA 
can be kinetically decoupled from movement of the rest of the tRNA molecule (Liu et 
al., 2010; Liu et al., 2011). 
The third insight concerns the function of ribosomal protein L11. L11 is 
encompassed by L7/L12 stalk consisting of L7/L12 protein and 23S rRNA, and 
together with a 58-nucleotide stretch of 23S rRNA, forms GAC for the GTPase 
activation of all translational GTPase, including EF-Tu. The 70S ribosome lacking 
L11 maintains considerable activity in protein synthesis (Rosenblum et al., 2012), but 
the specific function of L11 remains elusive. Previous studies indicated that TC 
initially binds to the ribosome at L7/L12 stalk and then at A/T site with EF-Tu 
contacting both aa-tRNA and GAC on the 50S subunit (Sheiming et al., 2009a). Very 
recently, Wang et al. showed that TC binding to the ribosome brings EF-Tu in close 
proximity to L11 N-terminal region, and some residues from domain I and domain III 
of EF-Tu (Arg117, Lys121, Tyr310 and Lys312), functioning together as a 
peptdyl-prolyl cis-trans isomerase, catalyze the configuration change at Pro22 of L11, 
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which then bring the L11 N-terminal region into a conformation contacting L12 
C-terminal region (Wang et al., 2013). Our results confirm the EF-Tu:L11 proximity 
upon TC binding and implicate that EF-Tu movement away from L11 has close 
correlation with tRNA selection and accommodation, possibly through proper L11 
configuration and L11:L12 contacts. During cognate tRNA binding, EF-Tu:L11 
separation may occur in a time scale prior to EF-Tu:tRNA separation, whereas, 
near-cognate tRNA binding leads to EF-Tu:tRNA separation before observable EF-Tu 
movement away from L11. Binding of antibiotics that promote near-cognate tRNA 
accommodation alters the patterns of EF-Tu:L11 proximity upon both cognate and 
near-cognate tRNA binding and blurs their differences in the absence of antibiotic. 
Moreover, a tighter EF-Tu:tRNA binding slows down tRNA accommodation, as well 
as EF-Tu:L11 separation. A possible explanation for all these observations is that 
cognate mRNA:tRNA base paring in the DC of the 30S subunit put EF-Tu in a proper 
position that triggers L11 configuration change and L11:L12 interaction, which 
subsequently induces relatively fast GTPase activation and GTP hydrolysis on EF-Tu, 
and tRNA accommodation and EF-Tu release from the ribosome reverse the L11 
configuration change and break L11:L12 contacts. In contrast, near-cognate tRNA 
binding places EF-Tu only in proximity to L11 but not in a position required for L11 
configuration change and GTPase hydrolysis, therefore EF-Tu mediated GTP 
hydrolysis is significantly slowed down.  
The fourth insight concerns step-wise tRNA accommodation. The tertiary 
structure of tRNA in L shape consists of four regions: acceptor stem-arm, D stem-loop, 
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T stem-loop and anticodon stem-loop. On binding at the A/T site of the ribosome in 
the form of TC, tRNA interacts with EF-Tu though its 3’-end and T-stem and mRNA 
with its anticodon; thus D stem-loop is the only region that has no contacts with the 
surroundings at all. During accommodation, tRNA relieves its distortion in the A/T 
state with the anticodon maintaining its base pairing with mRNA codon and the 
acceptor end, together with D and T stem-loop, fully entering the A-site on the 50S 
subunit. Whitford et al. suggested that tRNA accommodation is a step-wise process, 
with D stem-loop accommodated prior to 3’-end by using theoretical calculations 
(Whitford et al., 2010). Previous results from our lab also indicated that, during EF4 
catalyzed back-translocation, the movement of different tRNA regions was decoupled. 
The results reported here provide further clues for the step-wise tRNA movement on 
the ribosome. The presence of antibiotic kirromycin allows GTPase activation and 
GTP hydrolysis but freezes EF-Tu in a GTP-bound form on the ribosome. Our results 
show that, although full tRNA release from EF-Tu is inhibited, tRNA D-stem, where a 
fluorophore was placed in our experimental setup, can still step into its 
accommodation site, which is reflected by the Cy3 fluorescence release in the 
EF-Tu:tRNA FRET experiment (Figure 3.6B). Additional evidence comes from the 
fact that D-stem movement to the A-site could be probed with fMet-tRNAfMet (prf) 
programmed at the ribosomal P-site faster than EF-Tu:L11 separation and dipeptide 
formation (Table 3.4), which were all slowed down by the nucleotide mutation at 
tRNA T-stem. It is unclear whether this decoupled movement of tRNA has any 
functional implications. 
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The FRET-1 and FRET-2 assays provide convenient measures of the selectivity of 
TC binding to 70SIC programmed at the decoding center with cognate (UUU), 
near-cognate (CUC), and non-cognate (CGU) codons, and of the ability of 
aminoglycoside antibiotics to modulate such selectivity. The effects of substituting 
near-cognate- for cognate-programmed 70SIC on reaction with TC, and the Str and 
Par modulation of these effects, as measured using the FRET-1 and FRET-2 assays, 
are, with one caveat, in generally good agreement with those derived from earlier 
studies using different assays (binding of fluorescent-labeled tRNA, 
ribosome-dependent EF-Tu GTPase, dipeptide formation) in showing similar but 
weaker binding of the near-cognate vs. cognate TC to the 70SIC, and in the lower 
overall rate of aa-tRNA separation from EF-Tu that parallels the lower rate of 
ribosome-dependent EF-Tu GTPase (Gromadski and Rodnina, 2004a; Gromadski et 
al., 2006). Str and Par have previously been characterized as misreading-inducing 
antibiotics that act either by slowing cognate 70SIC reaction and speeding up 
near-cognate 70SIC reaction, such that the kinetic behavior of both complexes 
becomes quite similar (Str) (Gromadski and Rodnina, 2004b; Cochella et al., 2007), 
or by selectively speeding near-cognate reaction while having only a minor effect on 
cognate reaction (Par) (Pape et al., 2000; Cochella et al., 2007). The Str effects 
measured in the FRET-1 and FRET-2 assays and the Par effects measured in the 
FRET-2 assay support such characterization. The caveat concerns the Par effect in the 
FRET-1 assay in significantly slowing cognate reaction (phase 2). Based on the lower 
FRET efficiency of cognate complexes formed in the presence of either antibiotic 
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(Figure 3.7A), we speculate that this result may be due to propagation of Str- and 
Par-induced structural changes at the decoding center in the 30S subunit (Demirci et 
al., 2013) through the ribosome structure that results in a distancing of the labeled 
positions in EF-Tu and L11 when TC binds to the ribosome. Such structural changes 
need not necessarily affect either GTPase or dipeptide formation activities. 
Notwithstanding this caveat, it is clear that the fluorescence changes seen in the 
FRET-1 and FRET-2 assays make them desirable candidates as high throughput 
assays for screening new misreading-inducing antibiotics. The FRET-2 assay is likely 
to be superior for this purpose for two reasons. First, fluorescence increases 
monotonically as a function of time, eliminating the need for millisecond time 
resolution, and second, it is less subject to potential complications arising from 
antibiotic-induced changes in ribosome conformation. 
   
3.5 Conclusions 
Functional EF-Tu variants labeled with a fluorescent quencher were prepared and 
found capable of forming TCs with wild-type or labeled Phe-tRNAPhe with stabilities 
equivalent to that of the wild-type ternary complex. Subsequently, the labeled EF-Tu 
variant was utilized for studying the EF-Tu dynamics relative to ribosomal protein 
L11 and aa-tRNA during PRE complex formation. In addition, the effects on PRE 
complex formation of antibiotics, of substituting near-cognate for cognate tRNA, and 
of manipulating the EF-Tu:tRNA interface were investigated.  
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Kirromycin and GDPNP fix EF-Tu relative to L11, as expected. In contrast, a 
partial rearrangement of aa-tRNA relative to EF-Tu is observed in the presence of 
kirromycin. The binding of a near-cognate TC to the A/T site resembles that of 
cognate TC binding, while the subsequent movement away from the A/T site is very 
slow for the near-cognate TC. The antibiotics streptomycin and paromomycin blur the 
distinction between cognate and near-cognate codon:anticodon interactions. This 
appears to be the case during both initial binding and proofreading. Altering of the 
EF-Tu·tRNA interface via mutation within the tRNA T-stem shows that an increase in 
the strength of this interaction decreases the rate of EF-Tu movement away from L11. 
This movement occurs after at least partial aa-tRNA accommodation, and may be 
rate-limiting for subsequent dipeptide formation. 
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Table 3.1. Labeled protein synthesis components. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Labeled Component Description 
E348C-EF-TuQSY9  E348C variant of wt-EF-Tu labeled with QSY9  
E348C-EF-TuCy3 E348C variant of wt-EF-Tu labeled with Cy3 
K324C-EF-TuQSY9 K324C variant of wt-EF-Tu labeled with QSY9 
G325C-EF-TuQSY9 G325C variant of wt-EF-Tu labeled with QSY9 
  
Phe-tRNAPhe(Cy3) Yeast Phe-tRNAPhe labeled at positions 16/17 with Cy3 
fMet-tRNAfMet(prf) E. coli fMet-tRNAfMet labeled at position 20 with proflavin 
  
TCQSY9 TC containing E348C-EF-TuQSY9.GTP and Phe-tRNAPhe 
TC QSY9/Cy3 TC containing E348C-EF-TuQSY9.GTP and Phe-tRNAPhe(Cy3) 
TCCy3 TC containing EF-Tu.GTP and Phe-tRNAPhe(Cy3) 
70SICCy3 70S initiation complex made with ribosomes containing 
C38S/S87C-L11 labeled with Cy3 
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Table 3.2. Labeling stoichiometries of EF-Tu variantsa. 
 
EF-Tu variant Label/EF-Tu 
wt 0.5 QSY9 
0.4 Cy5 
K324C 1.6 QSY9 
G325C 1.8 QSY9 
E348C 1.5 QSY9 
1.4 Cy3 
 
a Labeling conditions as described in Chapter II. 
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Table 3.3. Kinetic parameters for EF-Tu:L11 or EF-Tu:tRNA FRET 
experiments. 
 
Figure  and  
Samplesa  
conditions kapp1, s-1 kapp2, s-1 Relative 
A1 
Relative 
A2 
70SICCy3(0.1) 
+TCQSY9(0.4)        
Standard 
+kirrob 
GDPNPc 
26 ± 4 
35 ± 1 
5.1 ± 0.2 
6.2 ± 0.3 
3.0 ± 0.7 
– 
(-1.0 ± 0.2)d 
-0.8 ± 0.1 
-0.7 ± 0.1 
1.0 ± 0.2 
-0.8 ± 0.2 
– 
70SIC (0.4)  
+ TC QSY9/Cy3(0.1)     
Standard 
+kirro 
2.1 ± 0.3 
5.1 ± 0.8 
0.31 ± 0.05
1.1 ± 0.2 
(1.0 ± 0.2) 
0.3 ± 0.1 
0.7± 0.1 
0.5± 0.1 
70SICCy3 (0.1) + 
TCQSY9(0.4)  
Coge 
NCog  
NCog (1.0)f 
Cog + Str     
Cog + Par     
NCog + Str    
NCog + Par 
26 ± 4 
24 ± 6 
22 ± 6 
22 ± 2 
17 ± 3 
32 ± 1 
23 ± 2 
6.2 ± 0.3 
– 
– 
3.0 ± 0.2 
2.5 ± 0.1 
1.0 ± 0.3 
1.6 ± 0.4 
(-1.0 ± 0.2) 
-0.4± 0.1 
-1.0± 0.3 
-0.3± 0.1 
-0.4± 0.1 
-0.2± 0.1 
-0.3± 0.1 
1.0 ± 0.2 
– 
– 
0.2 ± 0.1 
0.3 ± 0.1 
0.2 ± 0.1 
0.2 ± 0.1 
70SIC (0.4)  
+ TCQSY9/Cy3(0.1)  
Cog 
NCog  
Cog + Str     
Cog + Par     
NCog + Str    
NCog + Par 
2.1 ± 0.3 
0.74 ± 0.02 
0.94 ± 0.04
1.4 ± 0.1 
1.1 ± 0.3 
0.89 ± 0.10
0.31 ± 0.05
0.04 ± 0.01
0.13 ± 0.02
0.22 ± 0.01
0.15 ± 0.04
0.15 ± 0.06
(1.0 ± 0.2) 
0.3± 0.1 
0.4± 0.2 
1.0± 0.1 
0.4± 0.2 
0.4± 0.2 
0.7 ± 0.1 
1.6 ± 0.1 
1.0 ± 0.3 
0.8 ± 0.1 
1.0 ± 0.2 
0.8 ± 0.2 
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a Numbers in parentheses are final concentrations in µM. All antibiotics had final 
concentrations of 100 µM. Average ± average deviation, 2–4 independent 
determinations, except as otherwise indicated 
b Antibiotic abbreviations: kirro, kirromycin; Str, streptomycin; Par, paromomycin 
c GDPNP substituted for GTP in TC 
d Normalized value. All amplitudes are normalized to A1 of standard (cognate) 
experiment 
e mRNA abbreviations: Cog, cognate; NCog, near cognate 
f 1 µM TC was used in this experiment. The lack of dependence of kapp1 on TC 
concentration suggests that phase 1 includes a reversible step following binding, in 
agreement with Pape et al. (1998). 
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Table 3.4. Thermodynamic and kinetic parameters for tRNAVal2B variants. 
 
tRNAVal2B
varianta
 
constantb  
 
wt     
UAA 
GUU 
 
T1   
UGC    
GCG 
 
Ψ 
UUC   
GGG 
TC, rel Kdc 1.0 ± 0.8 0.16 ± 0.12 1.8 ± 0.7
TC, rel. kdc 1.00 ± 
0.31 
0.15 ± 0.04 1.7 ± 0.4
TC, rel. kdd  1.00 ± 
0.05 
0.085 ± 
0.003 
1.4 ± 0.1
70SICCy3e + 
TCQSY9, kapp1, s-1 
14.7 ± 0.7 5.8 ± 0.4 19.0 ± 0.7
70SICCy3 + 
TCQSY9, kapp2, s-1 
4.3 ± 0.5 0.20 ± 0.01 5.1 ± 1.1
kaccom, s-1 7.2 ± 0.1 0.6 ± 0.2 5.5 ± 1.1
 
 
kdipepf, s-1  4.5 ± 0.7 0.32 ± 0.02 4.5 ± 0.8
a Sequences show portion of T-loop stem: top line: nts 65–63; bottom line: nts 49-51 
b Values are from this work, measured at 25 oC, unless otherwise specified. 
Measurements were generally performed in duplicate, with average deviations 
indicated. 
c Kd and kd, equilibrium and dissociation rate constants, 4 oC. Values for wt are 1.2 × 
10-8 M and 0.0013 s-1, respectively (Schrader et al., 2011). 
d This work. Value for wt is 0.039 s-1. The increase of ~30-fold from the value 
measured at 4 oC is consistent with the high ΔH† for this reaction reported in Schrader 
et al. 2011 (Schrader et al., 2011). 
e This 70SIC has the cognate codon for tRNAVal2B, GUC, in the A-site. 
f 20 oC, Schrader et al. 2011. 
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Figure 3.1. Distances within EF-Tu:L11:aa-tRNA triangle. These distances are 
between residue numbers 348 (Cα, EF-Tu), 87 (Cα, L11) and 16 (N-1, 
aminoacyl-tRNA) in a kirromycin- and paromomycin- stabilized ribosome complex 
with Thr-tRNAThr bound in the A/T site. In this chapter, EF-Tu at position 348, L11 at 
position 87 and aa-tRNA at positions 16/17 are labeled with QSY9, Cy3 and Cy3, 
respectively. Protein Data Bank accession codes 2WRN, 2WRO, 2WRQ, and 2WRR. 
This figure is adapted from (Cooperman et al., 2011). 
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Figure 3.2. Characterization of ternary complexes (TCs) formed by labeled EF-Tus. A. 
Quenching of the fluorescence of Phe-tRNAPhe (Cy3), 0.17 µM, by QSY9 derivatives 
of K324C-EF-Tu, G325C-EF-Tu, or E348C-EF-Tu or by free QSY9. No quenching is 
seen with wt-EF-Tu labeled at a background level with QSY9. B. Protection of 
[3H]-Phe-tRNAPhe or [3H]-Phe-tRNAPhe (Cy3) (0.10 – 0.15 µM) from RNase A 
hydrolysis by variant EF-Tus and as well as QSY9 derivatives of K324C-EF-Tu and 
E348C-EF-Tu. EF-Tu variants containing cysteines at possible positions K324, G325 
and E348 were prepared by 1) single mutation of wt-EF-Tu; 2) two further mutations 
at position C81 and C137 (denoted K324C-EF-TuSA, G325C-EF-TuSA and 
E348C-EF-TuSA); 3) three further mutations at position C81, C137 and C255 (denoted 
K324C-EF-TuSAV, G325C-EF-TuSAV and E348C-EF-TuSAV, respectively). C.Relative 
poly(U)-dependent polyPhe activity using different EF-Tus.  
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Figure 3.3. FRET in TCs formed from E348C-EF-TuQSY9 variants and 
Phe-tRNAPhe(Cy3). A. Quenching of the fluorescence of [3H]-Phe-tRNAPhe (Cy3) by 
E348C-EF-TuQSY9 in a purified TC (0.05 µM). B. Kinetics of quenching of 
Phe-tRNAPhe(Cy3) (0.1 µM)  fluorescence following rapid mixing with various 
concentrations of E348C-EF-TuQSY9. A plot of kapp vs. EF-Tu gives a kon value of 1.3 ± 
0.1 µM-1s-1 and koff value of 0.17 ± 0.07 s-1. 
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Figure 3.4. Dipeptide formation of E348C-EF-TuQSY9. Dipeptide is formed by mixing 
TC formed from E348C-EF-TuQSY9.GTP and Phe-tRNAPhe, denoted TCQSY9 (0.3 µM 
final concentration), with a 70SIC (1.2 µM final concentration). Solid lines are single 
exponential results. 
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Figure 3.5. Labeled TC interaction with 70SICCy3. A. Cartoon showing placement of 
labels. Cy3 fluorescence intensity decreases on TCQSY9 binding to the A/T-site and 
increases on accommodation of tRNA into the A-site. B. Changes of 70SICCy3 
fluorescence on rapid mixing with TCQSY9 (black); in the presence of kirromycin 
(precombined with 70SICCy3, red); with GDPNP in place of GTP (green). Very little 
change in fluorescence is seen with wt-EF-Tu labeled at a background level with 
QSY9 (light blue) or when mRNA is omitted (dark blue). Final concentrations were: 
70SICCy3, 0.1 µM; TCs, 0.4 µM; kirromycin, 100 µM; GDPNP, 250 µM.  
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Figure 3.6. Interaction of double-labeled TC with 70SIC. A. Cartoon showing 
placement of labels. A Cy3 fluorescence intensity increase occurs on EF-Tu 
dissociation from the ribosome. B. TCQSY9/Cy3 (0.1 µM) was rapidly mixed with 70SIC 
(0.4 µM) and Cy3 fluorescence was monitored (black); in the presence of kirromycin 
(precombined with 70SIC, red); with GDPNP in place of GTP (green). When GDPNP 
replaced GTP, adding kirromycin had no effect (data not shown). C. Complete loss of 
fluorescence quenching due to FRET on rapid mixing of TCQSY9/Cy3 (0.1 µM) and 
70SIC (0.4 µM) in a stopped-flow spectrofluorometer, as shown by an increase in 
Cy3 fluorescence (black) on EF-Tu release from the ribosome. The red trace is a 
control showing that rapid mixing of TCCy3 (0.1 µM) and 70SIC (0.4 µM), for which 
there is no FRET, gives a nearly constant fluorescence equal to the final fluorescence 
seen in the black trace.  
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Figure 3.7. Transfer RNA selection and antibiotic effects. tRNA selectivity 
demonstrated by A. TCQSY9 effects on the fluorescence of 70SICCy3 or B. by 70SIC 
effects on the fluorescence of TCQSY9/Cy3. Cognate mRNA (UUU, black); near-cognate 
mRNA (CUC, red); near-cognate mRNA, high TC concentration (CUC, cyan); 
non-cognate mRNA (CGU, green); -mRNA (blue). Parts C and D repeat the assays 
shown in A and B, respectively in the presence of aminoglycoside antibiotics. Cognate 
mRNA, no antibiotic (black); cognate mRNA, Str  (green); cognate mRNA, Par 
(blue); near-cognate mRNA, no antibiotic (red); near-cognate mRNA, Str (cyan); 
near-cognate mRNA, Par (lavender). Final concentrations: 70SICCy3 in A, 0.1 µM; 
70SIC in B, 0.4 µM; TCQSY9 in A, 0.4 µM, high concentration, 1.0 µM; TCQSY9/Cy3 in 
B, 0.1 µM; Str, 100 µM; Par, 100 µM. 
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Figure 3.8. Effects of tRNAVal2B mutation. A. TC formation. Increase in 
E348C-EF-TuCy3·GTP (0.4 µM) fluorescence intensity on rapid mixing with 
wt-Val-tRNAVal2B (0.1 µM) (Black line). Inset shows kapp dependence on 
E348C-EF-TuCy3.GTP concentration. Wt-EF-Tu labeled to background levels showed 
no fluorescence change (red line). B. TC dissociation. The dissociation of 
E348C-EF-TuCy3.GTP.Val-tRNAVal2B (formed by premixing of 0.4 µM of labeled 
EF-Tu and 0.1 µM of Val-tRNAVal2B), observed as a decrease in Cy3 fluorescence 
intensity on rapid mixing with excess (8 µM) unlabeled EF-Tu. C. FRET with L11. 
Changes of 70SICCy3 (0.1 µM) fluorescence on rapid mixing with TCs formed by 
combination E348C-EF-TuQSY9.GTP (1.6 µM) with various Val-tRNAVal2B variants 
(0.4 µM). D. Movement of Val-tRNAVal2B from the A/T position. Monitored as a 
change in proflavin fluorescence intensity on rapid mixing of unlabeled Val TCs (0.4 
µM) with 70SIC (0.1 µM) containing fMet-tRNAfMet(prf). All concentrations are final 
after rapid mixing.  
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Figure 3.9. Concentration dependent EF-Tu:L11 FRET of tightly coupled ternary 
complex. Dependence of the apparent rate constants, kapp1 and kapp2, measuring 
changes in 70SICCy3 (0.1 µM) fluorescence, on rapid mixing with varying 
concentrations of the TC formed from E348C-EF-TuQSY9.GTP and the Val-tRNAVal2B 
T1 variant. Values are normalized to those found at 0.4 µM TC.  
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CHAPTER 4  
EF-TU DYNAMICS DURING PRE-TRANSLOCATION 
COMPLEX FORMATION: EF-TU.GDP DISSOCIATES VIA TWO 
DIFFERENT PATHWAYS 
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4.1 Abstract 
 During the first elongation cycle of protein synthesis, aa-tRNA having an 
anticodon cognate to the codon programmed at the ribosomal A-site binds to the 
70SIC via a TC, resulting in PRE complex formation. Fluorophore or fluorescence 
quencher labels placed on L11, EF-Tu and aa-tRNA form an approximately 
equilateral triangle within the ribosomal complex prior to accommodation, with their 
distances appropriate for FRET studies. Here we combine time-dependent ensemble 
and single-molecule FRET (smFRET) measurements of this triangle during PRE 
complex formation with parallel ensemble assays measuring the rates of Pi release and 
of accommodation. Our results suggest that Pi release, EF-Tu separation from L11 and 
aa-tRNA accommodation occur in concert and all proceed prior to EF-Tu release from 
aa-tRNA and the ribosome. Moreover, EF-Tu release can occur prior to the EF-Tu 
conformational change, possibly from GTP to GDP bound form after GTP hydrolysis, 
or either concomitant with or following such conformational change. Our results 
provide direct real-time insights into the dynamics of EF-Tu during tRNA selection 
and accommodation and the timing and possible pathways of EF-Tu release from 
aa-tRNA and the ribosome. 
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4.2 Introduction 
Protein biosynthesis on the ribosome, also called translation, requires the 
participation of various translational factors during each of its three stages: IF1–3 for 
initiation, EF-Tu and EF-G for elongation, and RF1–3 and RRF for termination and 
ribosome recycling. After the formation of 70SIC with fMet-tRNAfMet programmed at 
the P-site and an empty A-site, aa-tRNA is delivered to the ribosome in the form of 
TC formed with EF-Tu.GTP (Pape et al., 1998). The signal of cognate mRNA:tRNA 
base pairing at the DC of the 30S subunit is transduced to the GAC of the 50S subunit 
and activates EF-Tu GTPase activity (Voorhees et al., 2010). GTP hydrolysis on 
EF-Tu is followed by Pi release, aa-tRNA accommodation into the A-site, EF-Tu 
conformational change as a result of GTP hydrolysis to form GDP, peptide bond 
formation, and, finally, EF-Tu.GDP dissociation from the ribosome, resulting in PRE 
complex formation (Rodnina and Wintermyer, 1995b; Pape et al., 1998). 
Translocation of fMet-aa-tRNA from the A-site to the P-site, along with the mRNA 
codon to which it is bound, a reaction catalyzed by EF-G.GTP, completes the first 
elongation cycle (Valle et al., 2003b; Frank and Gonzalez, 2010; Chen et al., 2011a). 
This opens up the A-site for the binding of the next cognate TC, which initiates the 
next elongation cycle.  
Although the movement of tRNA through the ribosome during PRE complex 
formation has been extensively studied by kinetic, structural and modeling studies 
(Pape et al., 1998; Pan et al., 2007; Schmeing and Ramakrishnan, 2009b), very little is 
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known about the dynamics of EF-Tu interaction with either the ribosome or aa-tRNA 
during this process, including the timing of the major conformational change in EF-Tu 
that accompanies conversion of EF-Tu.GTP to EF-Tu.GDP (Kjeldgaard and Nyborg, 
1992; Polekhina et al., 1996), and the interplay between EF-Tu and EF-G during their 
repetitive recruitments to the ribosome in the elongation stage. In Chapter III, two 
assays, based on functional derivatives of EF-Tu, were developed to investigate 
relative movements in the EF-Tu:L11:tRNA triangle during tRNA selection at the 
ribosomal A-site. Here we use these assays, in both ensemble and single molecule 
format, together with other assays measuring TC interaction with 70SIC, to formulate 
a quantitative kinetic scheme describing EF-Tu dynamics during PRE complex 
formation. Our results indicate that EF-Tu moves away from L11 in concert with Pi 
release and tRNA accommodation, but prior to releasing its hold on aa-tRNA, and that 
EF-Tu.GDP can dissociate from the ribosome by two different pathways, one more 
rapid but readily reversible, while the slower pathway proceeds essentially 
irreversibly. They also lead to the suggestion that the rapid and slower pathways 
correspond to EF-Tu.GDP dissociation from the ribosome occurring prior to or 
accompanying the major conformational change in EF-Tu, respectively. 
 
4.3 Results 
4.3.1 Labeled component nomenclature 
Labeled initiation complexes, denoted 70SICCy3 or 70SICCy5, contained protein 
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L11 labeled at position 87 with Cy3 or Cy5, respectively. EF-Tu derivatives, denoted 
E348C-EF-TuQSY9 and E348C-EF-TuCy3, were labeled at a Cys residue introduced by 
site-directed mutagenesis at position 348 by reaction of E348C-EF-Tu with the 
maleimide derivatives of the quencher QSY9 and the fluorophore Cy3, respectively. 
tRNAs labeled at dihydrouridine positions are denoted Phe-tRNAPhe(Cy3) and 
fMet-tRNAfMet (prf), where prf is an abbreviation for proflavin. Labeled TCs were 
prepared from labeled EF-Tu derivatives and either unlabeled Phe-tRNAPhe or 
Phe-tRNAPhe(Cy3), and named as indicated in Table 4.1. 
 
4.3.2 Ensemble experiments 
Rapid mixing in a stopped-flow spectrofluorometer of TCQSY9 with a 70SICCy3 
programmed with mRNA022 MFTI, which has a UUU codon following the AUG 
initiation codon, leads to a biphasic change in Cy3 fluorescence, with an initial 
decrease corresponding to TC binding to the ribosome that places EF-Tu position 348 
in proximity to L11 position 87, followed by a restoration of fluorescence intensity as 
these two positions move apart. In Figure 4.1, we compare, all as a function of TCQSY9 
concentration, rates of fluorescence change on rapid mixing of TCQSY9 and 70SICCy3 
as measured by: biphasic changes in Cy3 fluorescence (Figure 4.1A), increases in 
MDCC-labeled phosphate binding protein (MDCC-PBP) fluorescence on binding of 
released Pi (Figure 4.1B) (Pan et al., 2006), and decreases in P-site bound 
fMet-tRNAfMet(prf) fluorescence (Figure 4.1C), which measures accommodation of 
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aa-tRNA into the A-site (Pan et al., 2007). Fitting of the Cy3 fluorescence change to 
Equation 2.2 demonstrates that kapp1 increases linearly with TCQSY9 concentration 
whereas kapp2 is largely independent of TCQSY9 concentration (Figure 4.1D), 
corresponding to a binding step and a following conformational rearrangement step, 
respectively. The results in Figure 4.1A were obtained using 70SICCy3 containing 
fMet-tRNAfMet(prf) in the absence of MDCC-PBP. Quantitatively similar results were 
obtained using unlabeled fMet-tRNAfMet or in the presence of MDCC-PBP (Figure 
4.2).  
Both of the signal traces of fluorescent PBP and fMet-tRNAfMet(prf) show 
essentially monophasic changes, giving kapp values at various TCQSY9 concentrations, 
when fitted with Equation 2.1, that are in close agreement with each other and are 
approximately equal to the values of the overall rates of EF-Tu separation from L11 
[given by kapp1kapp2 /(kapp1 + kapp2)] measured in the reaction of TCQSY9 with 70SICCy3 
(Figure 4.1D). These results indicate that EF-Tu separation from L11, Pi release and 
aa-tRNA accommodation occur approximately in concert under the conditions 
employed in our experiments. 
In parallel experiments, the rate of increase in Cy3 fluorescence as a function of 
70SIC concentration on rapid mixing of TCQSY9/Cy3 with 70SIC made with 
fMet-tRNAfMet(prf) (Figure 4.3A), measuring EF-Tu release from aa-tRNA, was 
compared directly with the rate of aa-tRNA accommodation (Figure 4.3B) measured 
as above by fitting each set of results to Equation 2.1 (Figure 4.3C). The values of kapp 
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for accommodation measured in this experiment are quite similar to those measured in 
Figures 4.1C–D but are ~1.7-fold greater than the values of kapp measured for EF-Tu 
release from aa-tRNA (Figure 4.3C). Since accommodation occurs in concert with 
EF-Tu separation from L11 (Figure 4.1D), the difference in the rate constants 
presented in Figure 4.3C provides strong evidence that, as measured by ensemble 
reactions, ribosome-bound EF-Tu separates from L11 prior to its release from 
aa-tRNA. Importantly, simultaneous rapid mixing of both EF-G.GTP and TCQSY9/Cy3 
with 70SIC, while having no effect on kapp for accommodation, increases the value of 
kapp for EF-Tu:tRNA separation (Figure 4.3D), nearly abolishing the gap between the 
two kapp values. Direct comparison in the presence and absence of a saturating 
concentration of EF-G.GTP (4 µM) of the rates of EF-Tu:tRNA separation and tRNA 
accommodation as a function of 70SIC shows that added EF-G consistently increased 
the rate of EF-Tu:tRNA separation while having only a negligible effect on the rate of 
tRNA accomodation (Fig. 4.3E; Table 4.2).  
 
4.3.3 Single molecule FRET studies of PRE complex formation 
PRE complex formation using labeled TCs was further examined by smFRET, 
using a total internal reflection fluorescence (TIRF) microscope as described earlier 
(Chen et al., 2011a, b). PRE complex formation was monitored by addition of either 
TCCy3 or TCCy3/Cy5 to immobilized 70SICCy5 (Figure 4.4A) or unlabeled 70SIC (Figure 
4.4B), respectively. The results in both cases are very similar to one another, both 
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showing single FRET states over the entire duration of the FRET signal, as 
demonstrated by analysis of both FRET probability density plots (Figures 4.4C–D) 
and synchronized FRET traces (Figures 4.5A–B, and D–E) (Chen et al., 2012), with 
efficiencies equal to 0.90 ± 0.01 and 0.69 ± 0.01, respectively. Further, for both 
experiments essentially identical values were obtained for the 2nd order rate constant, 
kassoc, for TC binding to the ribosome (Figures 4.6A–B) and kdissoc of EF-Tu from the 
ribosome (Figures 4.6D–E). For the reaction of TCCy3 and immobilized 70SICCy5, 
neither of these rate constants changed significantly (Figures 4.6C and F) in the 
presence of a near-saturating value of EF-G.GTP (4 µM, Figure 4.3D) which catalyzes 
PRE complex conversion to POST complex. Here again, only a single FRET state for 
ribosome-bound EF-Tu is observed (Figures 4.5C and F). 
 
4.3.4 A simplified quantitative model for TC interaction with 70SIC leading to 
PRE complex formation 
The ensemble and smFRET measurements presented in Figs. 4.1–4.6 allow 
formulation of a quantitative kinetic model for PRE complex formation (Scheme 4.1; 
Figure 4.7)  
 
(Scheme 4.1)A + B
k1
k2 (=a*k1)
C D
k3
E
k4
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that, while building on the more complete model formulated by Pape et al (Pape et al., 
1998), stresses changes in the interactions of EF-Tu with both the ribosome and 
aa-tRNA that occur during the process. The main features of this model are: 
1. The identification of two distinct complexes, C1 and C2, prior to PRE complex 
formation.  
2. C1 corresponds to what Rodnina et al. (Rodnina et al., 1994) identify as the codon 
recognition complex that forms prior to GTP hydrolysis, and thus is stabilized when 
GDPNP is substituted for GTP, as shown in Chapter III. In this complex, position 87 
in L11 and the D-loop in aminoacyl-tRNA are each close enough to position 348 in 
EF-Tu to give rise to strong FRET signals (Figure 3.1), as measured by quenching of 
either Cy3 fluorescence (Figures 4.1A and 4.3A) or increase in Cy5 fluorescence 
(Figures 4.4A–B; see also Chapter III).  
3. C2 is formed from C1 by a multistep process, grouped as Step 2, that is initiated by 
GTP hydrolysis and is followed by four processes occurring approximately 
concurrently: Pi release, aa-tRNA accommodation into the A-site, dipeptide formation 
and EF-Tu separation from L11 (Figure 4.1A). Two of these processes, tRNA 
accommodation and EF-Tu separation from L11, are likely to be reversible 
(Agirrezabala et al., 2012; Fischer et al., 2010). As a consequence, the overall rate 
constant for step 2 could reflect sums of forward and reverse rate constants. This, 
along with differences in experimental conditions and dye labeling [TCQSY9 + 
70SICCy3 (Fig. 4.1) vs. TCCy3 + 70SICCy5 (Figure 4.4)], might account for a somewhat 
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higher apparent rate constant for step 2 (k2 = 18 ± 3 s-1, Table 4.3) as compared with 
kdissoc (6.3 ± 0.4 s-1, Figure 4.6D) determined from ensemble and single molecule 
studies, respectively. 
4. EF-Tu.GDP separation from L11 in Step 2 occurs prior to EF-Tu.GDP separation 
from Phe-tRNAPhe and dissociation from the ribosome by either Step 3 or Step 3A. 
Here it should be noted that, conversely, EF-Tu can separate from aa-tRNA without 
separating from L11 either in the presence of kirromycin, an antibiotic that stabilizes 
EF-Tu.GDP binding to the ribosome (Rodnina et al., 1994), or when EF-Tu GTPase 
activity is strongly inhibited by replacement of cognate TC, as used in this paper, with 
near-cognate TC (Gromadski et al., 2006; also see Chapter III). 
5. Step 3A proceeds more rapidly than Step 3 (i.e., k3A > k3). Under ensemble 
conditions, in which relatively high concentrations of ribosomes and TC are employed, 
Step 3A is rapidly reversible and, in the absence of EF-G, C2 accumulates transiently. 
Under single molecule conditions, performed at very low concentrations of ribosomes 
and TC, Step 3A is essentially irreversible, C2 does not accumulate, and virtually all 
EF-Tu dissociation proceeds via step 3A. The failure to detect C2 in the smFRET 
experiment indicates that its lifetime must be ≤ 20 ms, given the 11 ms integration 
time per frame used in the experiment. Step 3 is an essentially irreversible step under 
both ensemble and single molecule conditions. 
6. Addition of EF-G.GTP has no effect on the residence time of EF-Tu on the 
ribosome, as determined by smFRET (Figures 4.6D, F). However, it does accelerate 
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EF-Tu separation from tRNA in the ensemble experiment, such that its rate constant 
approaches that seen for accommodation (Figure 4.3D). This acceleration results from 
EF-G.GTP sequestration of the PRE complex that is the product of step 3A, which 
converts step 3A into an essentially irreversible step, even under ensemble conditions.  
7. Dye incorporation into Phe-tRNAPhe can significantly alter rate constants for C1 
formation and dissociation, but has little effect on the rate of C1 conversion to C2. 
Rate constants for two dye combinations, derived from results presented in Figures 
4.1 and 4.3, are compared in Table 4.3. Replacement of TCQSY9 with TCQSY9/Cy3 leads 
to a ~10-fold increase in the equilibrium dissociation constant for TC binding, largely 
due to an increase in k-1, indicating that Cy3 labeling of Phe-tRNAPhe reduces TC 
affinity for the ribosome. This is consistent with other studies of ours showing 
reduced activity in protein synthesis of Cy3-labeled vs. unlabeled Phe-tRNAPhe under 
conditions of limiting Phe-tRNAPhe concentration (Rosenblum et al., 2012).  
 
4.3.5 The timing of EF-Tu conformational change 
While it is clear from the differences between the structures of the GTP- and 
GDP-bound forms of EF-Tu (Kjeldgaard and Nyborg, 1992; Polekhina et al., 1996) 
that dissociation from EF-Tu of the Pi produced on GTP hydrolysis must ultimately 
lead to a major conformational change within EF-Tu, the timing of such change, and 
whether it occurs on or off the ribosome, is unclear. Our scheme posits two pathways 
for EF-Tu.GDP dissociation from the ribosome. Our results are consistent with the 
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assumption that the rapid, reversible dissociation step, 3A, corresponds to dissociation 
of EF-Tu.GDP*, which retains the “EF-Tu.GTP” conformation, while the slower, 
essentially irreversible step corresponds to dissociation of EF-Tu.GDP, having the 
altered “EF-Tu.GDP” conformation. Experiments testing this assumption more 
directly, and reaching the same conclusion, are described elsewhere (unpublished data 
from Dr. Darius Kavaliauskas and Prof. Charlotte R. Knudsen). The suggestion that 
EF-Tu.GDP* has an at least transient existence both on and off the ribosome is 
supported by considerable evidence, summarized recently (Hauryliuk et al., 2008), 
that GTPases like EF-Tu fluctuate in a dynamic equilibrium between different 
conformational states, independently of which nucleotide, GTP or GDP, is bound. A 
particularly striking example of this phenomenon is provided by the X-ray crystal 
structure of a Rab6A' mutant containing bound GDP, which shows the protein to be in 
a GTP-like conformation (Shin et al., 2012). As we have demonstrated (Figure 4.3D), 
addition of EF-G.GTP accelerates overall EF-Tu.GDP dissociation, which we attribute 
to its binding to the PRE complex produced via reaction 3A. Given the high cellular 
concentration of EF-G (~20 µM, stoichiometrically equivalent to ribosomes), it seems 
probable that reaction 3A is the major route for EF-Tu dissociation in vivo. 
 
4.4 Discussion 
 A quantitative kinetic model has been proposed more than a decade ago to 
describe the elementary steps during PRE complex formation (Pape et al., 1998). 
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Herein, we add more details to this model by ensemble multi-color experiments 
combining FRET assays based on a labeled EF-Tu derivative (see Chapter III) and 
assays measuring fluorescence changes of Pi release and aa-tRNA accommodation, as 
well as smFRET experiments utilizing fluorophore labeled EF-Tu. Our results 
indicate that EF-Tu gets into proximity to L11 upon TC binding to the 70SIC, and 
moves away from L11 in concert with Pi release after GTP hydrolysis and tRNA 
accommodation. After tRNA release, EF-Tu can dissociate from the ribosome via two 
different pathways depending on the timing of EF-Tu conformational change. 
 Previous studies using labeled tRNA showed that TC binding to the ribosome 
proceeded through an initial mRNA-independent binding, presumably to the L7/L12 
stalk (Schmeing et al., 2009a), followed by a mRNA-dependent binding to the 
ribosome body, with roughly equal forward rates for these two steps (Rodnina et al., 
1994). Our EF-Tu:L11 FRET experiments show that the step by which EF-Tu 
achieves proximity to L11 is second order, with an apparent rate constant that 
increases linearly as a function of TC concentration, but is much slower than what has 
previously been measured for initial TC binding (Pape et al., 1998). This result 
suggests the possibility that initial TC binding to the L7/L12 stalk is immediately 
followed by repositioning of EF-Tu to bring it to the proximity to L11, consistent with 
recent results showing that part of EF-Tu interacts with L11 to induce L11 
conformational change and construct L11:L12 contacts (Wang et al., 2012). However, 
we can not exclude the possibility that TC initial biding to L7/L12 stalk directly put 
EF-Tu at a position interacting with L11 or binding to L7/L12 stalk is not a 
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pre-requisite for TC to reside at the A/T site of the ribosome.  
After GTP hydrolysis, EF-Tu moves away from L11 approximately at the same 
time as Pi release and tRNA accommodation, which is evidenced by their similar 
apparent rate constants in concentration dependence experiments and successfully 
fitting to a global kinetic scheme with all of these three processes occurring in one 
step. Concurrent EF-Tu:L11 separation and tRNA accommodation confirms their 
correlation as revealed in experiments using tight tRNAVal2B mutant, in which delayed 
tRNA release from EF-Tu slowed down EF-Tu:L11 separation and tRNA 
accommodation to the same level (see Chapter III).  
 In multi-color experiments simultaneously measuring tRNA accommodation by 
fMet-tRNAfMet(prf) programmed at ribosomal P-site and EF-Tu:tRNA separation by 
TCQSY9/Cy3, the rates of EF-Tu:tRNA separation were apparently slower than those of 
tRNA accommodation (Figure 4.3C), presumably also slower than those of Pi release 
and EF-Tu:L11 separation, indicating a delayed EF-Tu dissociation from the ribosome. 
Global fitting results suggest that EF-Tu:tRNA separation can be treated as a separate 
step after EF-Tu:L11 separation, Pi release and tRNA accommodation, with the latter 
three steps proceeding with the same rate constant. In our scheme (Figure 4.7), it is 
proposed that, EF-Tu undergoes a conformational change after GTP hydrolysis, which 
occurs after EF-Tu:L11 separation, Pi release, and tRNA accommodation. This 
proposal is consistent with what was previously reported that Pi release after GTP 
hydrolysis is much slower than GTP hydrolysis, leading to slow EF-Tu 
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conformational rearrangement from GTP to GDP bound form after GTP hydrolysis 
(Kothe and Rodnina, 2006), in which the rate of conformational change was indirectly 
obtained from the difference between the lag phase of Pi release and tRNA 
accommodation experiments.  
This dissociation occurs via two possible pathways: 1) rapid but reversible 
dissociation from the ribosome in the high-affinity state followed by the 
conformational change off the ribosome (Step 3A in Figure 4.7); or 2) conformational 
change on the ribosome followed by slow but irreversible dissociation from the 
ribosome in the low affinity state (Step 3 in Figure 4.7). Under ensemble condition, 
because of the relatively high concentration components used, backward 
re-association in Step 3A becomes significant and intermediate C2 is accumulated, 
making Step 3 dominantly observable. Thus, presence of EF-G has no effect on the 
rates of tRNA accommodation but increase the rates of EF-Tu:tRNA separation to a 
level similar to tRNA accommodation by trapping the ribosome complex after 
EF-Tu.GDP* dissociation, pushing the reaction mostly though Step 3A. In contrast, 
under single molecule conditions, highly diluted components make the rapid TC 
dissociation in the high affinity state essentially irreversible and C2 mostly proceeds 
through Step 3A. EF-Tu and EF-G share the same binding site on the ribosome both 
as translational GTPase and are recruited to the ribosome regulated by the ribosome 
states. Our observations raise the question of, if EF-Tu conformational rearrangement 
changes its affinity with the ribosome and facilitates its dissociation from the 
ribosome, why a second pathway exists with this rearrangement occurring off the 
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ribosome, and whether the EF-Tu:EF-G interplay has any functional significance 
during translation elongation. 
  
4.5 Conclusions 
Here we describe the dynamics of EF-Tu interaction with tRNA and with the 
ribosome during PRE complex formation by combining the results of multi-color 
ensemble stopped-flow and single-molecule FRET measurements. We demonstrate 
that EF-Tu separation from L11 within the GTPase associated center of the ribosome 
occurs prior to EF-Tu separation from Phe-tRNAPhe and that EF-Tu.GDP dissociates 
from the ribosome via two different pathways, one more rapid and reversible and one 
slower and essentially irreversible, that are likely to correspond to two different 
EF-Tu.GDP conformations on the ribosome. 
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Table 4.1. Labeled ternary complexes (TCs). 
 
TC name Labeled EF-Tu variant Phe-tRNAPhe  
TCQSY9 E348C-EF-TuQSY9 Phe-tRNAPhe 
TCQSY9/Cy3 E348C-EF-TuQSY9 Phe-tRNAPhe(Cy3) 
TCCy3 E348C-EF-TuCy3 Phe-tRNAPhe 
TCCy3/Cy5 E348C-EF-TuCy3 Phe-tRNAPhe(Cy5) 
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Table 4.2. Comparison of apparent rate constants between TCQSY9/Cy3 and 
fMet-tRNAfMet(prf)a.  
 
No EF-Gb EF-G (4 µM)c 
70SIC  
(µM) 
kapp(Cy3) 
(s-1) 
kapp(prf)  
(s-1) 
kapp(Cy3) 
(s-1) 
kapp(prf)  
(s-1) 
0.4 3.2 ± 0.8 4.9 ± 0.5 4.9 4.9 
0.8 3.9 ± 0.5 6.1 ± 0.4 6.9 8.0 
1.2 5.2 ± 0.8 8.7 ± 0.9 8.0 10.2 
2.4 6.5 ± 1.1 8.8 ± 0.8 11.0 13.5 
 
aTCQSY9/Cy3 (0.1 µM) was rapidly titrated with 70SIC programmed with 
fMet-tRNAfMet(prf) at indicated concentrations, in absence or presence of EF-G (4 
µM).  
bAverage ± error of two determinations. 
cSingle determination. 
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Table 4.3. Fitted rate constants for schemea. 
 
 
a Rate constants in parentheses are fixed during fitting using Scientist. 
 
 
 
 
 
 
 
 
 
 
Reaction 
Components 
 
k1, s-1 µM-1 k-1/k1, µM k2, s-1 k3, s-1 
TCQSY9 + 70SICCy3 
Fig. 4.1 
39.3 ± 1.3 0.12 ± 0.03 17.7 ± 2.5 (19.6) 
TuQSY9/Cy3 + 70SIC 
Fig. 4.3 
100 ± 39 1.2 ± 0.1 19.9 ± 0.5 19.6 ± 1.1 
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Figure 4.1. Ensemble studies of TCQSY9 reaction with 70SICCy3. A – C. Changes of 
fluorescence on rapid mixing of 70SICCy3 (0.1 µM) with TCQSY9 as a function of 
TCQSY9 concentration. Lines through the traces are fit to Scheme 4.1 (Table 4.3).  A. 
Cy3 fluorescence. B. MDCC-PBP fluorescence. C. fMet-tRNAfMet(prf) fluorescence. 
In parts A and C, 70SIC contained fMet-tRNAfMet(prf). Unlabeled fMet-tRNAfMet was 
used in part B. D. kapp values derived from measurements of changes in the 
fluorescence: Cy3, kapp1 (black); Cy3, kapp2 (red); Cy3, kov (green); prf (blue); 
MDCC-PBP (cyan). Rate constants for Cy3 are averaged values obtained in the 
presence of MDCC-PBP or fMet-tRNAfMet(prf). 
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Figure 4.2. Concentration dependence of EF-Tu:L11 FRET. kapp1 and kapp2 are as a 
function of TCQSY9 concentration for the reaction with 70SICCy3 (0.1 µM). These 
experiments were carried out with 70SICCy3 containing either fMet-tRNAfMet(prf) or 
fMet-tRNAfMet (indicated as +prf and –prf, respectively) and in the presence or 
absence of MDCC-PBP (indicated as +MDCC-PBP and –MDCC-PBP, respectively). 
The values at 0.4 µM are mean ± standard deviation of four determinations. 
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Figure 4.3. Ensemble studies of TCQSY9/Cy3 reaction with 70SIC. Changes of 
fluorescence on rapid mixing of 70SIC with TCQSY9/Cy3 (0.1 µM) as a function of 
70SIC concentration. 70SIC was made up with fMet-tRNAfMet(prf).  A. Cy3 
fluorescence. B. fMet-tRNAfMet(prf) fluorescence. In A and B lines through the traces 
are fit to Scheme 4.1 (Table 4.3). C. kapp values for parts A and B. Data shown are 
average ± error of two determinations. D. kapp(Cy3)/ kapp(prf) as a function of 
EF-G.GTP concentration. Data shown in the absence or in the presence of EF-G (4 
μM) are average ± error of two determinations. 70SIC, 0.4 µM. E. Relative rates of 
EF-Tu:tRNA separation and tRNA accommodation in the presence of EF-G (4 μM) at 
different 70SIC concentrations. Data in the absence of EF-G come from part C. 
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Figure 4.4. Real-time courses of single molecule fluorescence intensities and FRET. 
EF-Tu.GTP assisted tRNA delivery was measured between A. TCCy3 and 70SICCy5 
and B. TCCy3/Cy5 and 70SIC.  TC (10 nM) was injected at time zero into the imaging 
chamber with immobilized 70SIC. Cy3 (green) and Cy5 (red) fluorescence intensity 
traces were under excitation of 532 nm TIRF illumination at 11 ms integration time 
per frame. The FRET ratio was calculated as ICy5/(ICy5 + ICy3) C. and D. FRET 
probability density plots for the reactions described in A and B, respectively. Upper 
and lower traces are aligned to the first or last time points, respectively, of the FRET 
events as t = 0. Besides the 0 FRET state, which corresponds to no fluorescence signal, 
only one FRET state is observed in each reaction. The same conclusion is reached 
from consideration of the synchronized FRET traces shown in Fig. 4.5. 
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Figure 4.5. Synchronized smFRET values. A. and D. Synchronized to FRET 
appearance and disappearance, respectively, for TCCy3 added to 70SICCy5. B. and E. 
Synchronized to FRET appearance and disappearance, respectively, for TCCy3/Cy5 
added to 70SIC. C. and F. Synchronized to FRET appearance and disappearance, 
respectively, for TCCy3 added to 70SICCy5 in the presence of 4 µM EF-G.GTP.  
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Figure 4.6. Association (A, B, and C) and dissociation (D, E, and F) times and rate 
constants for TC interaction with immobilized 70SIC. A. and D. TCCy3 (5 nM) and 
70SICCy5; B. and E. TCCy3/Cy5 (10 nM) and 70SIC; C. and F. TCCy3 (10 nM) and 
70SICCy5 in the presence of EF-G (4 µM) and 400 µM GTP. Lines are best fits to 
single exponentials, giving the indicated association (tassoc) and dissociation (tdissoc) 
times and corresponding values of kassoc and kdissoc. 
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Figure 4.7. A simplified quantitative model for TC interaction with 70SIC. The rate 
constants shown are for reaction of TCQSY9 with 70SICCy3. Rate constants for this and 
other TC/70SIC combinations are summarized in Table 4.3. The metastable species 
EF-Tu.GDP* has a conformation characteristic of EF-Tu.GTP, even though the GTP 
has hydrolyzed. Only upper and lower limits, respectively, can be given for Kd and k3A. 
These limits require a rapid association rate constant (≥ 1.5 x 108 M-1s-1) for 
EF-Tu.GDP* binding to the PRE complex. Rate constants of this order have 
previously been found for TC binding to 70SIC (Gromadski, 2004; Pape, 1998). 
Because of uncertainty regarding the position of equilibrium in Step 3A under 
ensemble conditions, the simplifying assumption was made in carrying out the fitting 
that C2 was dominant. Thus, the fitted value for k3 is a lower limit.  
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CHAPTER 5  
MONITORING TRANSLATION WITH MODIFIED  
mRNAS STRATEGICALLY LABELED WITH ISOMORPIC 
FLUORESCENT NUCLEOSIDE MIMETICS 
 
[Part of the data in this chapter is adapted with permission from (Liu, W., Shin D., 
Tor, Y., and Cooperman, B. S. (2013). Monitoring translation with modified mRNAs 
strategically labeled with isomorphic fluorescent guanosine mimetic. ACS Chem Biol 
8, 2017–2023). Copyright (2013) American Chemical Society.] 
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5.1 Abstract 
Here we examine seven mRNAs with new emissive and responsive isosteric 
nucleoside mimetics (thG and thA), with the goal of developing real time assays for 
monitoring translation-related events at nucleotide resolution. In these mRNAs the 
emissive nucleosides are placed site-specifically at codon positions 1, 4, 5, and 6, 
counting the AUG start codon as positions 1–3. All emissive mRNAs tested form 
initiation (70SIC), pretranslocation (PRE) and posttranslocation (POST) complexes. 
In most cases spectral differences are seen on binding of the mRNA to the ribosome 
during 70SIC formation, and on conversion of 70SIC to PRE complexes and PRE 
complexes to POST complexes. These differences allow measurement of the kinetics 
of such conversions by changes in the fluorescence of labeled mRNAs. Such 
measurements directly identify a specific step during PRE complex formation, 
provisionally assigned to codon:anticodon-loop base pair formation, that follows 
EF-Tu.GTP.aa-tRNA ternary complex binding to the ribosome and precedes 
aa-tRNA accommodation into the A-site of the ribosome. These observations not 
only demonstrate the functionality of mRNAs modified with the emissive nucleoside 
mimetic, but also the potential this mimetic offers for observing the formation and 
disappearance of discrete intermediates during the polypeptide elongation cycle. 
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5.2 Introduction 
The past dozen years or so have witnessed huge progress in our understanding of 
ribosome function, fueled by high resolution structures (Schmeing et al., 2009a; 
Wilson and Doudna Cate, 2012) and by increasingly sophisticated biochemical, 
biophysical, and computational studies that probe the detailed workings of this 
complex machine (Dever and Green, 2012; Frank and Gonzalez, 2010; Wohlgemuth 
et al., 2011; Rodnina and Wintermeyer, 2011; Sanbonmatsu, 2012). Many of the 
studies directed toward understanding of the dynamics of ribosome function rely 
heavily on both ensemble and single molecule time-resolved observations made with 
functional, fluorescent-labeled derivatives of components of the protein synthesis 
machinery, for the most part including tRNAs, ribosomal proteins, and protein 
auxiliary factors such as EF-Tu and EF-G (Frank and Gonzalez, 2010; Pan et al., 2009; 
Chen et al., 2011a; Cooperman et al., 2011). For example, changes in the fluorescence 
of labeled tRNAs and labeled ribosomal proteins, combined with several other assays 
measuring GTP hydrolysis, dipeptide formation, Pi release, and peptidyl-tRNA 
reactivity toward puromycin have resulted in the formulation of quantitative kinetic 
schemes for the two major steps within the elongation cycle: i) ternary complex (TC, 
consisting of EF-Tu.GTP.aminoacyl (aa)-tRNA) binding to a posttranslocation (POST) 
or 70S initiation complex (70SIC) followed by accommodation of aa-tRNA within the 
A-site of the ribosome and peptide bond formation, leading to pretranslocation (PRE) 
complex formation (Pape et al., 1998; Geggier et al., 2010; Wohlgemuth et al., 2011), 
and ii) EF-G.GTP-catalyzed translocation of tRNAs bound in the A- and P-sites to the 
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P-and E-sites, respectively, along with mRNA to which they are bound, leading to 
conversion of PRE complex to POST complex (Savelsbergh et al., 2003; Pan et al., 
2007; Munro et al., 2010; Chen et al., 2011a; Cunha et al., 2013), thus completing the 
cycle. 
Despite the central role of mRNA in protein synthesis, the use of fluorescent 
mRNAs has, by contrast, been quite limited, confined almost exclusively to mRNAs 
derivatized at the 3’-end with fluorophores that monitor the movement of this 
terminus to a position at the entrance of the mRNA channel during translocation 
(Savelsbergh et al., 2003; Studer et al., 2003; Liu et al., 2010; Cunha et al., 2013). 
Although it would be of obvious interest to monitor mRNA codons that interact 
directly with the anticodon loops of tRNAs bound within the A, P, and E sites of the 
ribosome, progress in this direction has been held back by the expectation that bulky 
fluorophores attached to codon nucleotides within the narrow confines of the mRNA 
channel would either abolish or distort mRNA activity, making such derivatives 
unreliable probes of normal mechanism. Recently, however, new emissive and 
responsive nucleoside mimetics based on thieno[3,4-d]pyrimidine, which maintain 
normal Watson-Crick base pairing, have been described for all four RNA nucleosides 
(Shin, 2011 et al.; Samanta et al., 2012; Gedik and Brown, 2013), that either are 
isosteric with the nucleoside being mimicked [thGuanosine (thG) or thAdenosine (thA), 
Figure 1.5] or have the effect of converting pyrimidines into isosteres of purines 
(thUridine and thCytosine).  
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Here we describe the preparation of seven functional mRNAs containing emissive 
nucleoside mimetics within the initiation or the second codon that display easily 
measurable fluorescence changes at different stages of protein synthesis. Such 
changes permit monitoring of the conversion of a 70SIC first to a pretranslocation 
(PRE) complex and then to posttranslocation (POST) complex, at nucleotide 
resolution. We use such monitoring, in conjunction with other fluorescence assays, to 
directly identify a specific step during PRE complex formation, that follows 
EF-Tu.GTP.aa-tRNA ternary complex binding to the ribosome and precedes aa-tRNA 
accommodation into the A-site of the ribosome, and that we provisionally assign to 
codon:anticodon-loop base pair formation. 
 
5.3 Results 
5.3.1 Modified mRNAs 
Seven short mRNAs containing a single thG or thA within the AUG initiation 
codon or the following second codon were prepared, and named as thG4, thG5, thG6, 
thA1, thA4, thA5, and thA6, respectively, according to the positions of the modification 
at the 5’ position of initiation codon, or 5’, middle, and 3’-positions of the second 
codon (Figure 5.1). The amino acids that these mRNAs encode at the second codon 
position are: Val for thG4 and thG6, Arg for thG5, and Lys for thA1, thA4, thA5 and thA6. 
Three additional mRNAs containing no modified nucleotides were also prepared and 
named as MVF, corresponding to thG4 or thG6, MRF, corresponding to thG5, and MKF, 
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corresponding to thA1, thA4, thA5 or thA6. 
 
5.3.2 Formation of functional initiation and elongation complexes 
Modified mRNAs were tested for their activities in different stages of translation: 
70S initiation complex (70SIC) formation (Figures 5.2A–B and 5.3A), as measured 
by fMet-tRNAfMet co-sedimentation with a 70S ribosome; pretranslocation (PRE) 
complex formation (Figures 5.2C–D and 5.3B), as measured by Val-tRNAVal (thG4, 
thG6), Arg-tRNAArg (thG5), or Lys-tRNALys (thA1, thA4, thA5, thA6) co-sedimentation 
with a 70SIC; and EF-G.GTP dependent translocation (Figures 5.2E–F and 5.3C), as 
measured by fMet-Val-puromycin (thG4, thG6), fMet-Arg-puromycin (thG5) or 
fMet-Lys-puromycin (thA1, thA4, thA5, thA6) formation.  
The results in Figures 5.2 and 5.3 demonstrate that substantial functionality is 
retained on nucleoside mimetic substitution at positions 1, 4, 5, or 6. Noteworthy are 
the lower relative activities of thG4- and thG6-programmed ribosomes in stable PRE 
complex formation (Figure 5.2C), and of thA5-programmed ribosomes in stable POST 
complex formation (Figure 5.3C), respectively (see Section 5.4). 
 
5.3.3 Fluorescence changes on functional complex formation 
thG and thA are both ideally emissive (Φ = 0.46 and 0.21, respectively) and 
responsive fluorescent nucleoside mimetics (Shin et al., 2011). Although 
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incorporation into oligonucleotides generally lowers the quantum yield of emissive 
nucleosides (Sinkeldam et al., 2010), we anticipated that modified oligonucleotides 
shown in Figure 5.1 would retain a high level of responsiveness that would allow one 
to monitor mRNA binding, movement and subtle environmental changes within the 
ribosome during the elongation cycle. thG4, thG5, thG6, thA1, thA4, thA5 and thA6 
mRNAs each have a broad excitation maximum at 340–360 nm (Figure 5.4A and C). 
To minimize the background fluorescence from the ribosome, 360 nm was chosen as 
the excitation wavelength for fluorescence experiments.  
 
5.3.3.1 Fluorescence changes of mRNA binding to the ribosome 
Each of the three mRNAs with an thG substitution within the second codon shows 
a negligible bathochromic shift on binding to the ribosome as part of a 70SIC but 
clear emission intensity changes (Figure 5.4B), presumably arising from the altered 
environment of emissive nucleoside mimetics on the ribosome compared to solution. 
The four mRNAs with an thA substitution within the initiation or the second codon 
also display emission intensity changes on binding to the ribosome as part of a 70SIC 
(Figure 5.4D). However, the data of thA-containing mRNAs are preliminary and need 
to be further confirmed. 
 
5.3.3.2 Fluorescence changes of 70SIC conversion to PRE complex 
Conversion of 70SIC programmed with six of the seven emissive mRNAs (all but 
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thA1) to the corresponding PRE complex via addition of cognate 
EF-Tu.GTP.aminoacyl-tRNA ternary complex (EF-Tu.GTP.aa-tRNA, denoted TC) 
results in Watson-Crick base pairing of the thG or thA present in the first elongator 
tRNA codon, so that observed changes (Figures 5.5 and 5.6; Table 5.1) reflect both 
generalized environmental effects of converting a 70SIC into the first PRE complex 
and the specific effects of codon:anticodon H-bonding at the A-site. No such changes 
are seen on addition of non-cognate TCs in place of cognate TCs (Figures 5.7 and 5.8). 
All 70SICs programmed with mRNAs with an thG or thA present in the first elongator 
tRNA codon, show measurable changes in fluorescence intensity on conversion to 
PRE complexes. In addition, the thG4- and thA4-programmed 70SIC show small 
hypsochromic shifts. No clear fluorescence intensity change is observed when 70SIC 
programmed with thA1 was mixed with cognate TC. However, an ~10% uncertainty in 
intensity is expected due to the background fluorescence subtraction performed (see 
legend of Figure 5.6). Therefore, the lack of fluorescence intensity change observed 
for thA1 in the static experiment is not inconsistent with the small intensity decrease 
seen in the kinetic experiment (Figure 5.10A). 
 
5.3.3.3 Fluorescence changes of PRE conversion to POST complex 
Conversion of a PRE complex to a POST complex via EF-G.GTP addition 
proceeds with maintenance of the anticodon-loop:codon Watson-Crick base pairs. For 
the thG4-, thG6- and thA4-programmed PRE complexes, such conversions result in 
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fluorescence changes that either completely (thG4 and thA4) or partially (thG6) reverse 
the changes seen on conversion of 70SIC to PRE complex (Figures 5.5A, C–D and 
5.6B, E). thA1-programmed PRE complex to POST complex conversion shows a 
significant fluorescence decrease (Figures 5.6A, E). Only a small fluorescence 
increase was observed for both thA5- and thA6-programmed PRE complex to POST 
complex conversion (Figures 5.6C–E). In contrast, conversion of the thG5- 
programmed PRE complex to POST complex proceeds with virtually no fluorescence 
change (Figures 5.5B, D). These changes (summarized in Table 5.1) provide sensitive 
spectroscopic handles allowing us to monitor the changes in the microenvironments 
of specific codon nucleotides at the decoding center during the first cycle of 
polypeptide elongation. 
 
5.3.4 Kinetics of PRE complex formation 
We used the changes seen in Figures 5.5 and 5.6 to determine rates of PRE 
complex formation. Earlier work showed that 1) proflavin(prf)-labeled aa-tRNA can 
be used to monitor a two phase reaction of ternary complex (EF-Tu.GTP.aa-tRNA, TC) 
with 70SIC, initial TC binding followed by aa-tRNA accommodation into the A-site  
(Pape et al., 1998), that results in PRE complex formation; and 2) fMet-tRNAfMet(prf) 
bound in the P-site monitors accommodation of aa-tRNA within the ribosome in an 
essentially single-phase reaction (Pan et al., 2008). Rates of thG and thA fluorescence 
change were determined in three parallel experiments, using either i) unlabeled 
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fMet-tRNAfMet and unlabeled aa-tRNAaa, ii) unlabeled fMet-tRNAfMet and 
aa-tRNAaa(prf), or iii) fMet-tRNAfMet(prf) and unlabeled aa-tRNA (Figures 5.9 and 
5.10. In ii) and iii), parallel measurements were made for the rates of proflavin 
fluorescence change. Rates of proflavin fluorescence change were also determined 
when unlabeled MVF, MRF and MKF were substituted for the corresponding 
emissive mRNAs (thG4 or thG6; thG5; and thA1, thA4, thA5 or thA6, respectively). All 
of the emissive mRNA changes proceeded as essentially single-phase reactions, with 
the exception of thA5, which proceeded via a two-phase reaction. 
 
5.3.4.1 thG4- and thG6-programmed ribosomes 
Below we distinguish apparent rate constants, which are determined by fitting the 
kinetic data in Figures 5.9A, and 5.9C to either a double exponential [aa-tRNA(prf) 
fluorescence intensity changes] or to a single exponential [both fMet-tRNAfMet(prf) 
and thG fluorescence changes], from microscopic rate constants, which are determined 
by globally fitting all of the kinetic data obtained with a given mRNA to a posited 
kinetic mechanism. For both mRNAs, the measured apparent rate constants fall in the 
order aa-tRNA(prf)-Phase 1 (denoted kapp1) >> thG (denoted kapp2) > 
aa-tRNA(prf)-Phase 2 ~ fMet-tRNAfMet(prf) (both denoted kapp3) (Table 5.2). That 
kapp2 values, derived from thG fluorescence changes, differ from both kapp1 and kapp3 
values, derived from prf-labeled tRNA fluorescence changes, demonstrates that 
thG-labeled mRNA provides evidence for a step in PRE complex formation not 
 138
previously seen with prf-labeled tRNAs. kapp2 values for thG4 and thG6 fluorescence 
change were very similar to each other and in both cases were little affected by prf 
labeling of either fMet-tRNAfMet or Val-tRNAVal. Similarly, kapp1 values were 
unaffected by thG substitution for unmodified G, although kapp3 values were reduced by 
about one-third.  
Microscopic rate constants for the two mRNAs were determined by globally 
fitting each set of rate measurements in Figures 5.9A and 5.9C to a simplified 
three-step kinetic scheme for the mixing of 70SIC and TC that results in PRE 
complex formation (Scheme 5.1, Table 5.4). Such fittings were carried out ignoring 
the quite minor changes resulting from carrying out experiments with unlabeled vs. 
prf-labeled forms of fMet-tRNAfMet or Val-tRNAVal. Interpreted in the light of earlier 
results (Gromadski and Rodnina, 2004a; Pan et al., 2008), steps 1 and 3 should 
correspond, respectively, to an initial binding of TC to 70SIC that doesn’t involve 
codon:anticodon base pairing, and to accommodation of aa-tRNA into the A-site that 
is followed by peptide bond formation and EF-Tu.GDP release from the ribosome. 
The thG fluorescence change provides a new probe for the intervening step 2, that we 
presume corresponds to the base pairing step between the codon and the aa-tRNA 
anticodon loop. Importantly, the rate constant values k1–k3 obtained with thG4- and 
thG6-programmed ribosomes are virtually identical to one another.   
Scheme 5.1 
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5.3.4.2 thG5-programmed ribosomes 
Results with thG5-programmed ribosomes (Figure 5.9B) differed from those 
discussed above in showing an apparent interaction between Arg-tRNAArg(prf) and 
thG5 that slowed PRE complex formation, as manifested by ~2-fold increased values 
of kapp1 when MRF replaces thG5 and of kapp2 and kapp3 when Arg-tRNAArg replaces 
Arg-tRNAArg(prf) (Table 5.2). As a result, we separately fit results obtained with 
thG5-programmed ribosomes to Scheme 5.1 according to whether they were obtained 
with Arg-tRNAArg(prf) or unlabeled Arg-tRNAArg (Table 5.4).  
The values obtained lead to two observations concerning thG5-programmed 
ribosomes. First, using unlabeled Arg-tRNAArg, k2 and k3 are quite similar to the 
values found for thG4- and thG6-programmed ribosomes, using either prf-labeled or 
unlabeled Val-tRNAVal. Second, labeling Arg-tRNAArg with proflavin has major 
(~3–4-fold) and minor (1.6-fold) inhibitory effects on k2 and k3, respectively.  
 
5.3.4.3 thA4- and thA6-programmed ribosomes 
Unlike Val-tRNAVal(prf) and Arg-tRNAArg(prf) (Figure 5.9), Lys-tRNALys(prf) can 
only be used as a good probe for the initial TC binding to the ribosomes programmed 
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with thA4- and thA6- containing mRNA. Thus, apparent rate constants of thA4- and 
thA6-programmed ribosomes are determined by fitting all of the kinetic data in 
Figures 5.10B and 5.10D to a single exponential. Similar to thG-programmed 
ribosomes, the measured apparent rate constants also fall in the order aa-tRNA(prf) 
(denoted kapp1) >> thA (denoted kapp2) > fMet-tRNAfMet(prf) (denoted kapp3) (Table 5.3). 
The kapp1 value for thA4 and thA6, corresponding to rate of initial TC binding to the 
ribosome, were a little faster (~ 1.6 fold) than the kapp1 values for thG4 and thG6. Both 
kapp2 and kapp3 values for thA4 and thA6 were very similar to the values for thG4 and 
thG6 fluorescence changes. In addition, kapp2 values for thA4 and thA6 were little 
affected by prf labeling of either fMet-tRNAfMet of Lys-tRNAVal. kapp1 values were 
unaffected by thA substitution for unmodified adenosine, although kapp3 values were 
reduced by about one-fourth.  
Microscopic rate constants for thA4 and thA6, determined by globally fitting 
measurements in Figures 5.10B and 5.10D to Scheme 5.1, are listed in Table 5.4. The 
rate constant values k1–k3 obtained with thA4- and thA6-programmed ribosomes are 
similar to one another. Compared with microscopic rate constants for thG4 and thG6, 
k1 and k2 for thA4 and thA6 are a little faster, while k3 values are essentially identical.  
 
5.3.4.4 thA1 -programmed ribosomes 
Although base pairing at the ribosomal P-site between AUG codon and 
fMet-tRNAfMet anticodon is maintained during 70SIC to PRE complex formation, a 
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consistent small decrease of thA1 fluorescence intensity was observed when 70SIC 
programmed with thA1 was rapidly mixed with corresponding cognate TC, whether 
fMet-tRNAfMet or Lys-tRNALys is unlabeled or labeled (Figure 5.10A). kapp2 with 
unlabeled fMet-tRNAfMet and Lys-tRNALys was similar to those for thA4 and thA6, but 
a little slower (1.5 – 2-fold ) when labeled tRNAs were used. More importantly, when 
70SIC programmed with both thA1 and fMet-tRNAfMet(prf) was mixed with 
EF-Tu.GTP.Lys-tRNALys, kapp2 was very similar to kapp3 (Table 5.3). These results 
indicate that the thA1 response during 70SIC to PRE complex conversion monitors the 
tRNA accommodation. kapp1 and kapp3 values for thA1 were essentially identical to 
those for thA4 and thA6. 
 
5.3.4.5 thA5-programmed ribosomes 
Different from all other modified mRNAs, thA5 displayed a two-phase 
fluorescence intensity change using either labeled or unlabeled Lys-tRNALys and 
fMet-tRNAfMet (Figure 5.10C and Table 5.3). The apparent rate constants of the first 
phase of thA5 fluorescence change using either unlabeled fMet-tRNAfMet and 
unlabeled Lys-tRNALys, or unlabeled fMet-tRNAfMet and Lys-tRNALys(prf) are similar 
to each other, but a little faster than when fMet-tRNAfMet(prf) and unlabeled 
Lys-tRNALys are used. The major thA5 fluorescence change occurs in the second phase, 
for which the apparent rate constants were 20 – 30 times lower than the fluorescence 
changes of thA4 and thA6. Because the same amino acid sequence is encoded in all 
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thA-containing mRNAs, this large rate decrease likely arises from perturbations in 
codon:anticodon base pairing at the middle position. Moreover, the slow second phase 
rate constants, which varied from 0.28 – 0.66 sec-1 (Table 5.3), were in all cases 
comparable to kapp3 measured by fMet-tRNAfMet(prf), suggesting that base pairing at 
the middle codon position is rate-limiting for tRNA accommodation. Interestingly, 
compared with thA4 and thA6, the kapp1 value measured by Lys-tRNALys(prf) was also 
subject to a significant decrease (~ 3 fold). 
Microscopic rate constants for thA5 were determined by globally fitting the 
measurements in Figures 5.10C to a different three-step kinetic scheme (Scheme 5.2, 
Table 5.4), ignoring the small changes resulting from carrying out experiments with 
unlabeled vs. prf-labeled forms of fMet-tRNAfMet or Lys-tRNALys. Steps 1 correspond 
to an initial binding of TC to 70SIC, the same as step 1 in Scheme 5.1. Different from 
Scheme 5.1, codon:anticodon base pairing is accomplished in two steps. Step 2 
presumably corresponds to the fast base pairing at the 5’ or 3’ positions of the A-site 
codon, as measured by the fast phase of thA5 fluorescence changes; while step 3 
presumably corresponds to the slow base pairing at middle codon position, as 
measured by the slow phase of thA5 fluorescence changes. Because tRNA 
accommodation is rate-limited by the full base pairing, the fMet-tRNAfMet(prf) 
fluorescence signal change provides no information about tRNA accommodation, but 
is presumed to be rapid compared with the rate of step 3. The rate constant value of k1 
is modestly decreased (3 – 4 fold) compared with thA4 and thA6. Compared with the 
rate of full base pairing measured for thA4 and thA6, initial base pairing is ~ 2 – 6-fold 
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faster at the 5’ or 3’ positions and ~ 20-fold slower at the middle codon position. 
 
Scheme 5.2 
70SIC + TC 70SIC.TC1 70SIC.TC2 70SIC.TC3
k1 k2a k2b
 
 
 
5.3.5 Kinetics of POST complex formation 
5.3.5.1 thG-programmed ribosomes 
Previous work demonstrated that fluorescence changes resulting from rapid 
mixing of PRE complexes containing fMet-aa-tRNA(prf) with EF-G.GTP measures 
the rate of translocation of fMet-aa-tRNA(prf) from the A- to the P-site of the 
ribosome (Savelsbergh et al., 2003; Pan et al., 2007). When PRE complexes 
containing thG4-labeled mRNA and fMet-Val-tRNAVal(prf) are rapidly mixed with 
EF-G.GTP, the changes in both thG and fMet-Val-tRNAVal(prf) fluorescence intensity 
are well fit by a single kapp value (4.7 ± 0.3 s-1; Figure 5.11A; Table 5.5), indicating 
that both fluorophores are monitoring the same process. Similar results are obtained 
for the PRE complex containing thG6-labeled mRNA, with a slightly lower kapp value 
(3.4 ± 0.2 s-1; Figure 5.11B; Table 5.5). The PRE complex programmed with thG5 had 
a rate constant of 6.2 ± 1.6 s-1 for fMet-Arg-tRNAArg(prf) fluorescence change (Table 
5.5), but showed, as expected from the results presented in Figure 5.5B, almost no 
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change in thG fluorescence. These results demonstrate that thG-programmed ribosomes 
are fully functional in the translocation step that converts PRE complex to POST 
complex, and that in some cases this step can be monitored by changes in thG 
fluorescence.   
 
5.3.5.2 thA-programmed ribosomes 
 According to the results in Figure 5.6, all of the four thA-containing mRNAs have 
a response to EF-G catalyzed translocation; however, different patterns of real-time 
fluorescence changes were obtained when PRE complexes containing 
fMet-aa-tRNA(prf) and thA were mixed with EF-G.GTP. 
 Change of thA1 fluorescence intensity was significantly slower that that of 
fMet-Lys-tRNALys(prf) fluorescence intensity (1.3 ± 0.1 vs 4.2 ± 0.2 s-1; Figure 5.12A; 
Table 5.5), suggesting, not unexpectedly, that thA1 fluorescence may respond to a step 
after PRE to POST complex conversion, possibly tRNAfMet dissociation from the 
ribosomal E-site. Similar to thG4 and thG6, thA4 and fMet-Lys-tRNALys(prf) 
fluorescent signals can be well fit to a single kapp value (4.4 ± 0.3 s-1; Figure 5.12B; 
Table 5.5), indicating that thA4 monitors the same translocation process as 
fMet-Lys-tRNALys(prf). In contrast, when PRE complexes containing thA5 and 
fMet-Lys-tRNALys(prf) are rapidly mixed with EF-G.GTP, the observed thA5 intensity 
change proceeds with a apparent rate constant (2.3 ± 0.2 s-1; Figure 5.12C; Table 5.5) 
that is much smaller than that for the major fluorescence change of 
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fMet-Lys-tRNALys(prf), 13 ± 1 s-1 ( a minor slower phase, with a rate constant of  
0.94 ± 0.16 s-1 is observed, possibly corresponding to tRNAfMet dissociation), so that, 
in this case, tRNA translocation measured at the D-loop proceeds more rapidly than 
mRNA translocation. thA6 has no fluorescence intensity change during PRE to POST 
complex conversion ( the apparent small fluorescence intensity change of thA6 show 
in Figure 5.6D is likely a result of intrinsic experimental error) though 
fMet-Lys-tRNALys(prf) displays a signal change with an apparent rate constant of 2.6 
± 0.2 s-1 (Table 5.5). These results suggest that all of the thA-programmed ribosomes 
are functional in translocation, and that thA substitution at different positions can be 
used to monitor different substeps during or after translocation. 
 
5.4 Discussion 
5.4.1 Functional activities 
Modified mRNAs, site-specifically labeled with thG or thA nucleoside mimetics at 
the 5’ position of initiation codon, or 5’, middle, and 3’-positions of the second codon, 
were all shown to be functional in the formation of 70SIC, PRE and POST complexes 
(Figures 5.2 and 5.3). In general, measured activities were similar to those found with 
unmodified mRNAs. However, significantly lower activities were found in PRE 
complex formation for thG4- and thG6-programmed ribosomes and in POST complex 
formation for thA5-programmed ribosomes. The reasons for these lower activities are 
not well understood. PRE complex formation was measured at a single TC 
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concentration, and lower activities are most likely due to lower affinity and/or more 
labile binding of TC to 70SIC, as compared with MRF-programmed ribosomes. 
Lower activity in POST complex formation for thA5-programmed ribosome is also 
likely due to more labile binding of peptidyl-tRNA to the ribosome arising from the 
perturbation of nucleoside modification in base pairing (see Section 5.3.4.5), since 
thA5-programmed PRE complex is active in translocation as indicated by a rate 
constant of translocation similar to those of PRE complex programmed with thG- or 
other thA- containing mRNAs (see below, Table 5.5). The decoding center forms a 
tight ‘‘mould’’ that strongly constrains the mRNA (Ogle et al., 2001; Demeshkina et 
al., 2012; Demeshkina et al., 2013), so that such weakening of TC binding could 
result from small structural perturbations arising from both the substitution of the 
larger sulfur for carbon (atomic radii 1.0 Å and 0.7 Å, respectively) at purine position 
8, and the loss of polar interactions resulting from carbon for nitrogen substitution at 
purine positions 7 and 9.  
 
5.4.2 Fluorescence changes 
Correct codon recognition in the decoding center induces local conformational 
changes, with base pairing at different codon positions stabilized by different rRNA 
and ribosomal protein residues (Ogle et al., 2001; Demeshkina et al., 2012; 
Demeshkina et al., 2013). In most cases, conversions between 70SIC and PRE 
complex or between PRE and POST complexes were accompanied by fluorescence 
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intensity changes (summarized in Table 5.1), with varied patterns seen for different 
modified mRNAs. We are unable to attribute the fluorescence intensity changes, 
shown in Figures 5.5 and 5.6 and summarized in Table 5.1, to specific changes in the 
immediate surroundings of the modified base, since they may include contributions 
from multiple effects, including changes in polarity, viscosity and H bonding, as well 
as ground and excited state processes brought about by neighboring nucleobases. 
Nevertheless, they provide sensitive spectroscopic handles (as summarized in Table 
5.1), allowing us to monitor changes in the microenvironments of specific codon 
nucleotides at the decoding center during the first cycle of polypeptide elongation. 
 
5.4.3 Kinetics 
For 70SICs programmed with six of the seven mRNAs tested (thA1 excepted), 
fluorescence signal changes measured with thG- or thA-containing mRNAs during 
PRE complex formation are slower than those of initial TC binding to the ribosome 
and faster than tRNA accommodation, consistent with the notion that these changes 
monitor a common event, the formation of anticodon-codon base pairs. The 
similarities in the value of k2 (obtained from global fits) for all three thG-labeled 
mRNAs and for thA4 and thA6 as well (Table 5.4) support this notion. It was 
previously indicated that EF-Tu interacts with L11 after binding to the ribosome and 
induces its conformational change (Wang et al., 2012). Our results suggest that this 
conformational change may occur as a result of cognate codon:anticodon interaction, 
 148
as part of a series of conformational changes during aa-tRNA accommodation. 
During translocation, the base pairing between mRNA codon and tRNA 
anticodon loop is maintained, and both mRNA and tRNA move relative to the 
ribosome. It is well documented that tRNA movements during translocation occur in 
essentially two stages: first from classical states (tRNAs in A/A and P/P states, 
respectively) in PRE complex to hybrid states (tRNAs in A/P and P/E states, 
respectively), and then from hybrid states to POST complex (tRNAs in P/P and E 
states, respectively) (Pan et al., 2007; Zhang et al., 2009). Recently, experiments using 
mRNA labeled at the 3’-end showed that mRNA movements occur dominantly in 
coupling with ribosomal subunit rotation and tRNA movement from the hybrid state 
to the state in POST complex (Ermolenko and Noller, 2011), but a small signal 
change could be observed upon EF-G.GTP binding (Studer et al., 2003; Ermolenko 
and Noller, 2011). Here, utilization of emissive nucleoside mimetics programmed 
within the decoding codon provides the potential for directly studying mRNA 
movement during translocation and tRNA release from the ribosomal E-site after 
translocation. EF-G.GTP dependent translocation was monitored using PRE complex 
programmed with fMetLys-tRNALys(prf) and thA-containing mRNAs with substitution 
at different positions of the first or the second codon. All PRE complexes used were 
functional in translocation as indicated by POST complex formation (Figure 5.3C). 
The fluorescence intensity change of thA4 and the simultaneous change of 
fMetLys-tRNALys(prf) respond to the same translocation step, and their apparent rate 
constants are similar to those of PRE complexes programmed with thG4 or thG6, and 
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those previously reported using unmodified mRNAs (Pan et al., 2007; Ermolenko and 
Noller, 2011), the latter of which corresponds to the transition from hybrid state to 
POST complex. However, the measurements using thA1 or thA5 resulted in different 
results. The fluorescence intensity change of thA1 was clearly slower than that of 
fMetLys-tRNALys(prf) and thA4, presumably reporting the tRNA release from the 
ribosomal E-site after translocation. Although the rate of thA5 fluorescence intensity 
change is similar to thA4, the rate of the dominant phase of fluorescence intensity 
change of fMetLys-tRNALys(prf) is faster. These results can be fit in a simple model 
for translocation with four steps: i) EF-G.GTP binding to the ribosome; ii) 
translocation of tRNA on the 50S subunit seen by D-loop fluorescence change; iii) 
translocation of mRNA; and iv) tRNA release from the ribosomal E-site. For thG4, 
thG6 and thA4, steps ii) and iii) appear to proceed close to simultaneously, whereas for 
thA5, ii) clearly precedes iii). 
 
5.4.4 Substitution at the middle codon position – Effects on PRE complex 
formation 
Substitution at the middle position of the second codon (thG5 and thA5) has an 
inhibitory effect in all three steps that are measured here: initial TC binding to the 
ribosome, codon:anticodon base pairing and tRNA accommodation, with the effect 
more prominent for thA5. Previous results showed that aa-tRNA(prf) fluorescence 
change monitors initial TC binding to the ribosome in the absence of mRNA: i.e.,  
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without codon:anticodon interaction (Pape et al., 1998). However, the k1 values we 
obtain from global fits indicate that this binding step is clearly affected by the identity 
of the nucleoside at the middle codon position. The mechanism of TC binding to the 
ribosome is still not completely understood, but our results suggest that 
mRNA-independent TC binding is not a pre-requisite for codon:anticodon base 
pairing, which is contrary to the model put forward by Pape et al. (1998). 
According to the crystallographic studies of cognate TC bound to the ribosome 
(Demeshkina et al., 2012), codon:anticodon base pairing is monitored by highly 
conserved rRNA residues A1492, A1493 and/or G530. Full codon recognition 
requires at least three steps in principle, corresponding to the base pair formation at all 
three codon positions, but it is unclear whether the formation of these three base pairs 
is simultaneous or sequential. The interaction between the middle position of an 
mRNA codon and the tRNA anticodon loop was strongly inhibited by thA substitution 
(Table 5.3), and in a more nuanced way by thG substitution. In the latter case, a small 
(2-fold) decrease in the rate of base pairing with thG5 was only seen in the presence of 
Arg-tRNAArg(prf) (Table 5.2). We speculate that this rate effect might result from 
small perturbations in tRNA binding to the ribosome resulting from proflavin 
substitution in the D-loop of aa-tRNA that are propagated to the anticodon loop. 
Different from thG5, the rate of base pairing with thA5 is very slow using either 
labeled or unlabeled forms of Lys-tRNALys and fMet-tRNAfMet (Table 5.3), 
presumably due to a slowdown of base pairing at the middle codon position. A global 
fit for the biphasic thA5 fluorescence changes gives two values for codon:anticodon 
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base pairing: 40 ± 16 (minor change) and 0.44 ± 0.07 s-1 (major change) for k2a and 
k2b, respectively. The k2a value is very close to the previously reported rate constant 
from tRNA fluorescence changes that was assigned to codon recognition (Pape et al., 
1998). It’s likely that the k2a value is a reflection of environmental changes upon fast 
base pair formation at the 5’ and/or 3’ codon position. We propose that the k2a value 
obtained for thA5 represents the normal rate for initial codon:anticodon base pair 
formation with unmodified codon. This is followed by a very slow base pairing step 
(rate constant k2b) with the middle codon position, which then becomes the 
rate-determining step for full base pairing and subsequent tRNA accommodation. We 
further propose that during normal base pairing, as exemplified by the results with 
thA4 and thA6, the three base pairing steps occur in a series of rapid steps that we are 
not able to resolve, giving the appearance of a single first-order process with a rate 
constant of k2. This accounts for why k2a is 2–6-fold higher than k2 (Table 5.4). 
These results are consistent with the observation that misreading by the ribosome 
occurs least frequently at the middle codon nucleotide (Szaflarski et al., 2008), and 
the tight structural constraints to which codon:anticodon base pairing at the middle 
position is subject within the ribosomal decoding center (Ogle et al., 2001; 
Demeshkina et al., 2012; Demeshkina et al., 2013). Our results indicate that a 
nucleoside mimetic can be utilized not only as a fluorescent probe for kinetic studies, 
but also as an activity probe for the functional studies of the effects of base 
modifications, using the sensitivity of reaction rate to base modifications. 
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5.5 Conclusions 
Herein we report the preparation of functional modified mRNAs containing 
emissive nucleoside mimetics (thG or thA), and their application in elucidating the 
dynamics of mRNA:tRNA pair during the decoding and translocation steps of the 
elongation cycle of active ribosomes. Our results indicate that an thG or thA present at 
the 5’, middle, or 3’-positions of an mRNA codon is an effective probe of 
codon:anticodon interaction at the ribosomal decoding center as well as for mRNA 
translocation within the ribosome. Such nucleoside analogues could also serve as 
direct reporters of various changes during translation, including mRNA:tRNA 
interaction during frame shifting events, or of the melting (e. g., of a downstream 
pseudo-knot) or transient formation (e. g., of an internal Shine-Dalgarno sequence 
with the 3’-end of 16S rRNA) of secondary structure. 
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Table 5.1. Static fluorescence spectral changes during conversions between 
different ribosome complexes. 
 
 70SIC to PRE PRE to POST 
 Δ Intensity Δ λmax Δ Intensity Δ λmax 
thG4 Increase Blue shift Decrease Red Shift 
thG5 Decrease No change No change No change 
thG6 Decrease No change Increase No change 
thA1 No changea No change Decrease No change 
thA4 Decrease Blue shift Increase No change 
thA5 Decrease No change Increase No change 
thA6 Decrease No change Increase No change 
 
aDue to the necessary background subtraction in the experiments, a ~10% uncertainty 
in fluorescence intensity change is expected. Therefore, a slight intensity change may 
occur even if no apparent change is observed in static fluorescence experiments. 
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Table 5.2. Apparent rate constants for reactions between 70SIC programmed 
with thG-containing mRNAs and TCa. 
 
mRNA fMet-tRNAfMet aa-tRNA kapp1b kapp2c kapp3d 
thG4 unlabeled 
prf 
unlabeled 
Val-prf 
Val 
Val 
37 ± 2 
– 
– 
8.3 ± 0.6 
7.0 ± 0.3 
10.9 ± 0.1
4.9 ± 0.3 
4.1 ± 0.4 
– 
thG6 
 
unlabeled 
prf 
unlabeled 
Val-prf 
Val 
Val 
37 ± 7 
– 
– 
8.3 ± 0.5 
8.9 ± 1.2 
10.5 ± 3.1
5.5 ± 0.4 
3.9 ± 0.1 
– 
MVF unlabeled 
prf 
Val-prf 
Val 
34 ± 1 
– 
– 
– 
7.2 ± 1.2 
6.2 ± 0.5 
thG5 unlabeled 
prf 
unlabeled 
Arg-prf 
Arg 
Arg 
11± 2 
– 
– 
2.3 ± 0.2 
5.3 ± 0.1 
4.0 ± 0.2 
1.7± 0.1 
3.1 ± 0.3 
– 
MRF unlabeled 
prf 
Arg-prf 
Arg 
22 ± 2 
– 
– 
– 
3.9 ± 0.1 
4.8 ± 0.2 
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aValues presented are average ± average deviation from 2 independent determinations 
and are fits of stopped-flow data to single exponentials [kapp2  (thG fluorescence 
changes) and kapp3 (second entry tRNAfMet(prf) fluorescence changes)] or double 
exponentials [kapp1 and kapp3, first entry (tRNAVal(prf) fluorescence changes)]. For thG4, 
thG5 and thG6, rates in the first, second and third rows were determined, respectively, 
in the presence of: aa-tRNA(prf) and fMet-tRNAfMet; aa-tRNA and 
fMet-tRNAfMet(prf); and aa-tRNA and fMet-tRNAfMet. For MVF and MRF, rates in 
the first and second rows were determined, respectively, in the presence of: 
aa-tRNA(prf) and fMet-tRNAfMet; and aa-tRNA and fMet-tRNAfMet(prf).  
bRapid phase of aa-tRNA (prf) fluorescence change. 
c thG fluorescence change: upper, in presence of aa-tRNA(prf); middle, in presence of 
fMet-tRNAfMet(prf); lower, in presence of unlabeled tRNAs. 
dUpper, slow phase of aa-tRNA (prf) fluorescence change; lower, fMet-tRNAfMet (prf) 
fluorescence change. 
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Table 5.3. Apparent rate constants for reactions between 70SIC programmed 
with thA-containing mRNAs and TCa. 
 
mRNA fMet-tRNAfMet aa-tRNA kapp1b kapp2c kapp3d 
thA1 unlabeled 
prf 
unlabeled 
Lys-prf 
Lys 
Lys 
55 ± 10 
– 
– 
7.3 ±1.0 
5.5 ± 0.3 
11 ± 4 
– 
6.4 ± 0.1 
– 
thA4 
 
unlabeled 
prf 
unlabeled 
Lys-prf 
Lys 
Lys 
53 ± 1 
– 
– 
8.9 ± 0.5 
9.1 ± 1.7 
9.8 ± 0.7 
– 
5.2 ± 0.6 
– 
thA5 
 
unlabeled 
 
prf 
 
unlabeled 
Lys-prf 
 
Lys 
 
Lys 
18 ± 5 
– 
– 
– 
– 
– 
13.2 ± 3.2 
0.28 ± 0.09 
8.9 ± 1.2 
0.45 ± 0.08 
15.0 ± 1.2 
0.66 ± 0.01 
– 
– 
– 
0.43 ± 0.05 
– 
– 
thA6 unlabeled 
prf 
unlabeled 
Lys-prf 
Lys 
Lys 
62 ± 11 
– 
– 
9.8 ± 1.6 
12.0 ± 1.3 
11.6 ± 1.3 
– 
6.6 ± 0.8 
– 
MKF unlabeled 
prf 
Lys-prf 
Lys 
44 ± 3 – 
– 
– 
8.1±0.3 
 
 
 157
aValues presented are average ± average deviation from 2 independent determinations 
and are fits of stopped-flow data to single exponentials [kapp1 (first entry tRNALys(prf) 
fluorescence changes), kapp2  (thA fluorescence changes) and kapp3 (second entry 
tRNAfMet(prf) fluorescence changes)].  For thA1, thA4, thA5 and thA6, rates in the first, 
second and third rows were determined, respectively, in the presence of: aa-tRNA(prf) 
and fMet-tRNAfMet; aa-tRNA and fMet-tRNAfMet(prf); and aa-tRNA and 
fMet-tRNAfMet. For MKF, rates in the first and second rows were determined, 
respectively, in the presence of: aa-tRNA(prf) and fMet-tRNAfMet; and aa-tRNA and 
fMet-tRNAfMet(prf).  
b Aa-tRNA (prf) fluorescence change. 
c thA fluorescence change for thA1, thA4 and thA6: upper, in presence of aa-tRNA (prf); 
middle, in presence of fMet-tRNAfMet (prf); lower, in presence of unlabeled tRNAs. 
thA fluorescence change for thA5: upper two, in presence of aa-tRNA (prf), 
-0.026±0.005 and -0.059±0.009 in amplitude changes for fast and slow phase, 
respectively; middle two, in presence of fMet-tRNAfMet (prf), -0.016±0.003 and 
-0.044±0.007 in amplitude changes for fast and slow phase, respectively; lower two, 
in presence of unlabeled tRNAs, -0.030±0.007 and -0.037±0.010 in amplitude 
changes for fast and slow phase, respectively. 
dfMet-tRNAfMet (prf) fluorescence change 
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Table 5.4. Microscopic rate constants (s–1) for 70SIC reaction with TCa. 
 
 
 
 
 
 
 
 
aValues presented are for results in Figures 5.9, 5.10B–D that are fit to Scheme 5.1 or 
Scheme 5.2 (see text). 
bUpper values: Fit using fluorescence changes of Arg-tRNAArg(prf) and thG5 mRNA; 
lower values: Fit using fluorescence changes of fMet-tRNAfMet(prf) and thG5 mRNA. 
cFor thA5. 
dThe values are mean ± standard deviation of two fits, with and without thA5 data 
measured with unlabeled fMet-tRNAfMet and unlabeled Lys-tRNALys. 
 
 
 
 
 
 
 
 
mRNA k1 k2 or k2ac k3 or k2bc 
thG4 82 ± 9 7.2 ± 0.2 15.2 ± 0.7 
thG5b 
 
45 ± 10 
(45–85)c 
1.8 ± 0.2 
7.5 – 6.0 
6.1 ± 1.1 
9.9 ± 0.4 
thG6 80 ± 11 8.4 ± 0.4 13.7 ± 1.3 
thA4 123 ± 13 10.6 ± 0.3 12.0± 0.4 
thA5d 42 ± 1 40 ± 16 0.44 ± 0.07 
thA6 170 ± 9 11.3 ± 0.1 15.0 ± 0.5 
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Table 5.5. Apparent rate constants for POST complex formation on reaction of 
PRE complexes programmed with thG- and thA-containing mRNAs and 
EF-G.GTPa. 
mRNA 
kapp 
(thG or thA) 
kapp 
[fMet-aa-tRNA(prf)] 
kapp 
(Global fit) 
thG4 3.7 ± 1.5 4.6 ± 0.1 4.7 ± 0.3 
thG5 N/Ab 6.2 ± 1.6 N/Ac 
thG6 4.1 ± 0.6 3.1 ± 0.1 3.4 ± 0.2 
thA1 1.3 ± 0.1 4.2 ± 0.2 N/Ac 
thA4 3.5 ± 0.2 5.2 ± 0.3 4.4 ± 0.3 
thA5 2.3 ± 0.2 
13 ± 1 (0.074±0.022)c 
0.94 ± 0.16 (0.044±0.007)c
N/Ad 
thA6 N/Ab 2.6 ± 0.2 N/Ad 
 
 
aValues presented are average ± average deviation from 2 independent determinations 
and are, in most cases, fits of stopped-flow data to single exponentials [second 
column, fits of thG or thA fluorescence changes alone; third column, fits 
fMet-aa-tRNA(prf) fluorescence changes alone; and fourth column, global fits of both 
thG or thA and fMet-aa-tRNA(prf) fluorescence changes]. The only exception is 
fMet-aa-tRNA(prf) fluorescence change of PRE complex programmed with thA5, 
which is fit to double exponential.  
b No thA fluorescence change. 
c Values in the parentheses are amplitude changes. 
d thG or thA fluorescence change can not be globally fitted together with 
fMet-aa-tRNA(prf) fluorescence change. 
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Figure 5.1. mRNAs labeled with isomorphic fluorescent nucleoside mimetics. 
Modification positions are shown in red. 
 
 
 
 
 
 
 
 
 161
0.0
0.1
0.2
0.3
0.4
  No mRNA      MVF        thG4           thG6 
fM
et
-tR
N
A
fM
et
 / 
m
R
N
A
0.0
0.2
0.4
0.6
No mRNA           MRF               thG5 
fM
et
-tR
N
A
fM
et
 / 
m
R
N
A
A                                B 
 
 
 
 
C                                D 
 
 
 
 
E                                  F 
 
 
 
 
 
 
 
 
 
0.0
0.4
0.8
1.2
R
el
at
iv
e 
PR
E 
fo
rm
at
io
n
  MVF               thG4                 thG6           
0.0
0.4
0.8
1.2
R
el
at
iv
e 
PR
E 
fo
rm
at
io
n
      MRF                           thG5 
 
0.0
0.4
0.8
1.2
R
el
at
iv
e 
PO
ST
 fo
rm
at
io
n
      MRF                           thG5 
0.0
0.4
0.8
1.2
R
el
at
iv
e 
PO
ST
 fo
rm
at
io
n
      MVF               thG4                thG6
 162
Figure 5.2. Activities of mRNAs containing thG. Formation of various complexes with 
ribosomes programmed with thG4 or thG6 (A, C, E) or thG5 (B, D, F). A and B. 70SIC 
formation, measured as fMet-tRNAfMet co-sedimented per mRNA added: ribosomes, 
1.0 μM, mRNA 0.5 μM. C and D. Normalized PRE complex formation, with 
background in the absence of mRNA subtracted: ribosomes, 0.8 μM. E and F. 
Normalized POST complex formation. thG4, thG6: ribosomes, 2 μM. thG5: ribosomes 
4.8 ± 0.2 μM. Control experiments were performed, as indicated, with either no added 
mRNA, or with added unmodified mRNA, or with no added EF-G. Values reported in 
C and D were relative to the corresponding unmodified mRNAs (MVF for thG4 and 
thG6; MRF for thG5) after subtraction of background obtained with no mRNA and 
normalized to the value obtained for unmodified mRNA. Values reported in E and F 
were obtained from Equations 2.1A and 2.1B and normalized to the value obtained for 
unmodified mRNA.   
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Figure 5.3. Activities of mRNAs containing thA. A. 70SIC formation, measured as 
fMet-tRNAfMet co-sedimented per mRNA added: ribosomes, 1.0 μM, mRNA 0.5 μM. 
B. Normalized PRE complex formation, with background in the absence of mRNA 
subtracted: ribosomes, 0.8 μM. C. Normalized POST complex formation (ribosomes, 
4.8 ± 0.2 μM). Control experiments were performed, as indicated, with either no 
added mRNA, or with added unmodified mRNA, or with no added EF-G. Values 
reported in B were relative to the corresponding unmodified MKF mRNA after 
subtraction of background obtained with no mRNA and normalized to the value 
obtained for unmodified mRNA. Values reported in C were obtained from Equations 
2.1B and normalized to the value obtained for unmodified mRNA. 
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Figure 5.4. Excitation and emission spectra of thG- and thA-containing mRNAs. A. 
Excitation spectra of free thG-containing mRNAs (0.8 μM). B. Slight bathochromic 
shift of fluorescence maximum of thG4 and thG5 but not of thG6 upon binding to the 
ribosome as part of a 70SIC. 70SICs programmed with thG containing-mRNAs were 
prepared in situ by using 70S (1.2 μM) and thG-containing mRNA (0.6 μM), and 
incubating at 37 oC for 5 min. Buffer background fluorescence was subtracted from 
the signals of free thG-containing mRNAs (0.6 μM). Background fluorescence from 
the mixture of 70S, translation factors and fMet-tRNAfMet with no incubation was 
subtracted from the 70SIC programmed with thG-containing mRNAs. The traces 
shown in B are average of two independent determinations. C. Excitation spectra of 
free thA-containing mRNAs (0.8 μM). D. 70SICs programmed with thA 
containing-mRNAs were prepared in situ by using 70S (1.2 μM) and thA-containing 
mRNA (0.6 μM), and incubating at 37 oC for 5 min. Buffer background fluorescence 
was subtracted from the signals of free thA-containing mRNAs (0.6 μM). Background 
fluorescence from the mixture of 70S, translation factors and fMet-tRNAfMet with no 
incubation was subtracted from the 70SIC programmed with thA-containing mRNAs. 
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Figure 5.5. Fluorescence changes of thG-containing mRNAs. A–C. Traces are shown 
for 70SIC (black); PRE complex (red); POST complex (green). 70SIC traces are for 
purified samples. PRE complex traces shown are the average of two independently 
determined traces: i) PRE complex prepared in situ by addition of TC to 70SIC; ii) 
purified PRE complex used in the preparation of POST complex. To account for small 
concentration differences arising from the two preparation methods, the traces for 
purified PRE complexes were normalized to those for in situ generated PRE 
complexes, using an 8 nm window covering the fluorescence maximum to generate a 
normalization factor. The resulting two very similar traces were then averaged. POST 
complexes were prepared in situ from purified PRE complexes by incubation with 
EF-G.GTP (2.5 µM for 20 s), and traces were normalized using the same 
normalization factors as above. For all traces and prior to any normalization, 
background fluorescence of the corresponding complex made with unlabeled mRNA 
was subtracted from the observed fluorescence of each of the labeled ribosome 
complexes. Intensities are normalized to the peak intensity value of 70SIC for each 
mRNA. D. Fluorescence intensity changes were obtained by subtracting the spectrum 
of a purified complex (70SIC or PRE) from the spectrum of a complex prepared in 
situ (PRE or POST, respectively) and then normalizing the intensity differences to the 
peak intensity value of purified complex (70SIC or PRE, respectively). 
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Figure 5.6. Fluorescence changes of thA-containing mRNAs. A–D. Traces are shown 
for 70SIC (black); PRE complex (red); POST complex (green). 70S IC traces are for 
purified samples. PRE complex traces shown are the average of two independently 
determined traces: i) PRE complex prepared in situ by addition of TC to 70SIC; ii) 
purified PRE complex used in the preparation of POST complex. To account for small 
concentration differences arising from the two preparation methods, the traces for 
purified PRE complexes were normalized to those for in situ generated PRE 
complexes, using an 8 nm window covering the fluorescence maximum to generate a 
normalization factor. The resulting two very similar traces were then averaged. POST 
complexes were prepared in situ from purified PRE complexes by incubation with 
EF-G.GTP (2.5 µM for 20 s), and traces were normalized using the same 
normalization factors as above. For all traces and prior to any normalization, 
background fluorescence of the corresponding complex made with unlabeled mRNA 
was subtracted from the observed fluorescence of each of the labeled ribosome 
complexes. Intensities are normalized to the peak intensity value of 70SIC for each 
mRNA. E. Fluorescence intensity changes were obtained by subtracting the spectrum 
of a purified complex (70SIC or PRE) from the spectrum of a complex prepared in 
situ (PRE or POST, respectively) and then normalizing the intensity differences to the 
peak intensity value of purified complex (70SIC or PRE, respectively). 
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Figure 5.7. Lack of fluorescence change on adding non-cognate TCs to 70SICs 
programmed with thG-containing mRNAs. A–C. Traces are shown for 70SIC alone 
(black) and 70SIC with added non-cognate TC (red; EF-Tu.GTP.Arg-tRNAArg for 
thG4 and thG6, and EF-Tu.GTP.Val-tRNAVal for thG5). 70S IC traces are for purified 
samples. For all traces, background fluorescence of the corresponding complex made 
with unlabeled mRNA was subtracted from the observed fluorescence of each of the 
labeled ribosome complexes. D. Time-resolved fluorescence changes on rapid mixing 
of 70SIC programmed with thG-containing mRNAs (0.1 µM) with non-cognate TC 
(0.4 µM). 
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Figure 5.8. Lack of fluorescence change on adding non-cognate TCs to 70SICs 
programmed with thA-containing mRNAs. A–D. Traces are shown for 70SIC alone 
(black) and 70SIC with added non-cognate TC (red; EF-Tu.GTP.Arg-tRNAArg). 70S 
IC traces are for purified samples. For all traces, background fluorescence of the 
corresponding complex made with unlabeled mRNA was subtracted from the 
observed fluorescence of each of the labeled ribosome complexes.  
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Figure 5.9. Kinetics of PRE complex formation of thG-containing mRNAs. 
Fluorescence changes on rapid mixing of 70SICs (0.1 μM) programmed with 
thG-containing mRNAs and cognate TCs (0.4 μM) compared with fluorescence 
changes of aa-tRNA(prf) (dark blue), present as part of the TC, or of 
fMet-tRNAfMet(prf) (cyan), present as part of the 70SIC. Rates of thG fluorescence 
change were determined using either unlabeled fMet-tRNAfMet and unlabeled 
aa-tRNAaa (green), unlabeled fMet-tRNAfMet and aa-tRNAaa(prf) (red), or 
fMet-tRNAfMet(prf) and unlabeled aa-tRNAaa (magenta). A. thG4; B. thG5; C. thG6. 
Traces shown are the average of two independently determined traces, which, in each 
case were quite similar to one another. Solid black lines are global fittings to Scheme 
5.1 values, using rate constant values summarized in Table 5.4. The green, magenta 
and cyan curves in part B was fit with the following values (in s–1): k1 65 ± 4, k2 6.6 ± 
0.2, k3 9.9 ± 0.4. 
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Figure 5.10. Kinetics of PRE complex formation of thA-containing mRNAs. 
Fluorescence changes on rapid mixing of 70SICs (0.1 μM) programmed with 
thA-containing mRNAs and cognate TCs (0.4 μM) compared with fluorescence 
changes of aa-tRNA(prf) (dark blue), present as part of the TC, or of 
fMet-tRNAfMet(prf) (cyan), present as part of the 70SIC. Rates of thA fluorescence 
change were determined using either unlabeled fMet-tRNAfMet and unlabeled 
aa-tRNA (green), unlabeled fMet-tRNAfMet and aa-tRNA(prf) (red), or 
fMet-tRNAfMet(prf) and unlabeled aa-tRNA (magenta). A. thA1; B. thA4; C. thA5; D. 
thA6. Traces shown are the average of two independently determined traces, which, in 
each case were quite similar to one another. Solid black lines in B and D are global 
fittings to Scheme 5.1 (thA4 and thA6), using rate constant values summarized in Table 
5.4. Solid black lines in C are global fittings to Scheme 5.2 with thA5 data measured 
with unlabeled fMet-tRNAfMet and unlabeled Lys-tRNALys included, using rate 
constant values(in s–1): k1 42, k2 40, k3 0.44. . 
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Figure 5.11. Kinetics of POST complex formation of thG-containing mRNAs. 
Fluorescence changes on rapid mixing of PRE complexes (0.1 μM) programmed with 
thG-containing mRNAs (black) and EF-G.GTP (2 μM) compared with fluorescence 
changes of fMetVal-tRNAVal(prf) (red), present as part of the PRE complex. A. thG4; B. 
thG6. Solid black lines are single exponential fits of both the thG and 
fMetVal-tRNAVal(prf) fluorescence intensity changes, with kapp of 4.7 ± 0.3 and 3.4 ± 
0.2 sec-1 for thG4 and thG6, respectively. Average deviations are given for the two 
independent experiments. 
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Figure 5.12. Kinetics of POST complex formation. Fluorescence changes on rapid 
mixing of PRE complexes (0.1 μM) programmed with thA-containing mRNAs (black) 
and EF-G.GTP (2 μM) compared with fluorescence changes of fMetLys-tRNALys(prf) 
(red), present as part of the PRE complex. A. thA1; B. thA4; C. thA5. Solid black lines 
in B are single exponential fits of both the thA4 and fMetLys-tRNALys(prf) 
fluorescence intensity changes, with kapp of 4.1 ± 0.3 sec-1. Average deviations are 
given for the two independent experiments. 
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APPENDIX I 
MONITORING TRANSLATION WITH MODIFIED mRNAS 
STRATEGICALLY LABELED WITH ISOMORPHIC 
FLUORESCENT URIDINE AND CYTIDINE MIMETICS 
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I.1 Abstract 
Here we examine three mRNAs, site-specifically modified at codon positions 2, 5, 
and 6 with new emissive and responsive isosteric nucleoside mimetics (thU and thC), 
with the goal of developing real time assays for monitoring translation-related events 
at nucleotide resolution. thU5 and thC6, but not thU2, form functional initiation 
(70SIC), pretranslocation (PRE) and posttranslocation (POST) complexes. Spectral 
differences are seen on conversion of 70SIC to PRE complexes and these differences 
allow measurement of the kinetics of such conversions by changes in the fluorescence 
of labeled mRNAs.  
 
II.2 Introduction 
Many of the studies directed toward understanding of the dynamics of ribosome 
function rely heavily on both ensemble and single molecule time-resolved 
observations made with functional, fluorescent-labeled derivatives of components of 
the protein synthesis machinery, for the most part including tRNAs, ribosomal 
proteins, and protein auxiliary factors such as EF-Tu and EF-G (Frank and Gonzalez, 
2010; Pan et al., 2009; Chen et al., 2011a; Cooperman et al., 2011). Despite the central 
role of mRNA in protein synthesis, the use of fluorescent mRNAs has, by contrast, 
been quite limited, confined almost exclusively to mRNAs derivatized at the 3’-end 
with fluorophores that monitor the movement of this terminus to a position at the 
entrance of the mRNA channel during translocation (Savelsbergh et al., 2003; Studer 
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et al., 2003; Liu et al., 2010; Cunha et al., 2013).  
In Chapter V, we describe the preparation of functional mRNAs containing 
emissive and responsive thGuanosine (thG) or thAdenosine (thA) mimetic based on 
thieno[3,4-d]pyrimidine, within the initiation or the first elongation codon. The 
fluorescence changes of these mRNAs permit monitoring of the conversion of a 
70SIC first to a pretranslocation (PRE) complex, and a specific step corresponding to 
codon:anticodon-loop base pair formation was identified (Liu et al., 2013). thG and thA 
are isosteric with the nucleoside being mimicked; however, thUridine (thU) and 
thCytosine (thC) have the effect of converting pyrimidines into isosteres of purines 
(Shin et al., 2011). Here, we describe the preliminary characterization of three 
mRNAs containing emissive and responsive thU or thC within the initiation or the first 
elongation codon. Our results show that mRNAs carrying an thU or thC substitution 
within the second codon are functional in 70SIC, PRE or POST complex formation. 
The fluorescence changes of these two mRNAs during conversion of 70SIC to PRE 
complexes can be used to monitor codon:anticodon base pairing. 
 
I.3 Results 
I.3.1 Modified mRNAs 
Three short mRNAs containing a single thU or thC within the AUG initiation codon 
or the following codon were prepared, and named as thU2, thU5 and thC6, respectively, 
according to the positions of the modification at the middle position of initiation 
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codon, or middle, and 3’-positions of the second codon (Figure I.1). All these mRNAs 
encode Phe at the second codon position. An additional mRNA MFTI containing no 
modified nucleotides was also prepared. 
 
I.3.2 Formation of functional initiation and elongation complexes 
Modified mRNAs were tested for their activities in different stages of translation: 
70S initiation complex (70SIC) formation (Figure I.2A), as measured by 
fMet-tRNAfMet co-sedimentation with a 70S ribosome; pretranslocation (PRE) 
complex formation (Figure I.2B), as measured by Phe-tRNAPhe co-sedimentation with 
a 70SIC; and EF-G.GTP dependent translocation (Figure I.2C), as measured by 
fMet-Phe-puro formation. The results in Figure I.2 demonstrate that substantial 
functionality is retained on nucleoside mimetic substitution at positions 5 or 6 (thU5 
and thC6). The thU substitution at the middle position of AUG codon (thU2) abolishes 
fMet-tRNAfMet binding to the ribosome. Therefore, thU2 was not used in following 
studies. 
 
I.3.3 Fluorescence changes on functional complex formation 
thU and thC are both ideally emissive and responsive fluorescent nucleoside 
mimetics with the same quantum yields of 0.41 (Shin et al., 2011). Although 
incorporation into oligonucleotides generally lowers the quantum yield of emissive 
nucleosides (Sinkeldam et al., 2010), we anticipated that modified oligonucleotides 
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shown in Figure I.1 would retain a high level of responsiveness that would allow one 
to monitor mRNA binding and movement and subtle environmental changes within 
the ribosome during the elongation cycle. Excitation wavelength was chosen for thU5 
(320 nm) and thC6 (340 nm) by comparing their maximum emission intensity at 
different excitation wavelength, to obtain the high emission intensity and minimize 
the background fluorescence from the ribosome (Figure I.3). 
Conversion of 70SIC to PRE complex via addition of cognate 
EF-Tu.GTP.aminoacyl-tRNA ternary complex (EF-Tu.GTP.aa-tRNA, denoted TC) 
results in Watson-Crick base pairing of the thU or thC present in the first elongator 
tRNA codon, so that observed changes reflect both generalized environmental effects 
of converting a 70SIC into the first PRE complex and the specific effects of 
codon:anticodon H-bonding at the A-site. Conversion of thU5- or thC6-programmed 
70SIC to PRE complex proceeds with a small decrease and a large increase in 
fluorescence intensity, respectively. Such fluorescence changes allow us to monitor 
changes in the microenvironments of specific codon nucleotides at the decoding 
center during the first cycle of polypeptide elongation.  
 
I.3.4 Kinetics of PRE complex formation 
Earlier work showed that fMet-tRNAfMet(prf) bound in the P-site monitors 
accommodation of aa-tRNAaa within the ribosome in an essentially single-phase 
reaction (Pan et al., 2008). Rates of fluorescence change of thU5- and 
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thC6-programmed ribosomes on PRE complex formation were determined using 
unlabeled fMet-tRNAfMet and unlabeled aa-tRNA, or fMet-tRNAfMet(prf) and 
unlabeled aa-tRNA (Table I.1; Figure I.5). In the latter experiments, parallel 
measurements were made for the rates of fMet-tRNAfMet(prf) fluorescence change. 
Rates of fMet-tRNAfMet(prf) fluorescence change were also determined when MFTI  
were substituted. Change of thC6 fluorescence was somewhat slower than that of thG6 
and thA6 (see Chapter V), and tRNA accommodation measured by fMet-tRNAfMet(prf) 
was slowed down by ~2 fold compared with unmodified MFTI mRNA. Similar to 
thG5 and thA5, thU substitution at the middle position of first elongation codon led to a 
decrease for both kapp2 and kapp3 compared with thC6. 
 
I.4 Experimental 
Modified mRNAs are kind gifts from Prof. Yitzhak Tor (University of California, 
San Diego). Functionality of mRNAs in 70SIC, PRE or POST complexes formation 
was tested using the same procedures as thG4 or thG6 (Section 2.2.5.2). Fluorescence 
experiments were performed using similar procedures to thG4 or thG6 (Section 2.2.6) 
with some modifications. thU5 was excited at 320 nm and fluorescence signal was 
collected using a 410 ± 10 nm filter. thC6 was excited at 320 nm and fluorescence 
signal was collected using a 410 ± 10 nm filter. Static fluorescence intensity 
measurements were performed using purified 70SIC and purified PRE complexes at 
the same concentration for both thU5 and thC6. 
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I.5 Conclusions 
Herein we report the preliminary data showing that mRNAs containing emissive 
nucleoside mimetics (thU or thC) can form functional ribosomal complexes and are 
effective probes of codon:anticodon interaction at the ribosomal decoding center. 
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Table I.1. Apparent rate constants for reactions between 70SIC programmed 
with thU- and thC-containing mRNAs and TCa. 
 
mRNA fMet-tRNAfMet aa-tRNA kapp2b kapp3c 
thU5 prf 
unlabeled 
Phe 
Phe 
3.2 
2.6 
1.0 
– 
thC6 
 
prf 
unlabeled 
Phe 
Phe 
6.7 
6.1 
0.67 
– 
MFT prf Phe – 2.7 ± 0.1 
 
aValues presented are mostly results from one independent determinations, except for 
MFT with fMet-tRNAfMet(prf) and Phe-tRNAPhe, which is average ± average 
deviation from two independent determinations; Values are fits of stopped-flow data 
to single exponentials [kapp2  (thU or thC fluorescence changes) and kapp3 (tRNAfMet(prf) 
fluorescence changes)]. For thU5 and thC6, rates in the first and second rows were 
determined, respectively, in the presence of aa-tRNA and fMet-tRNAfMet(prf) or 
aa-tRNA and fMet-tRNAfMet. For MFT, rate was determined in the presence of: 
aa-tRNA and fMet-tRNAfMet(prf).  
b thU and thC fluorescence change: upper, in presence of fMet-tRNAfMet (prf); lower, in 
presence of unlabeled tRNAs. 
cfMet-tRNAfMet (prf) fluorescence change. 
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Figure I.1. mRNAs labeled with isomorphic fluorescent nucleoside mimetics. 
Modification positions are shown in red. 
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Figure I.2. Activities of mRNAs containing thU or thC. A. 70SIC formation, measured 
as fMet-tRNAfMet co-sedimented per mRNA added: ribosomes, 1.0 μM, mRNA 0.5 
μM. B. Normalized PRE complex formation, with background in the absence of 
mRNA subtracted: ribosomes, 0.8 μM. C. Normalized POST complex formation. 
Ribosomes, 2 μM. Control experiments were performed, as indicated, with either no 
added mRNA, or with added unmodified mRNA, or with no added EF-G. Values 
reported in C were after subtraction of background obtained with no mRNA and 
normalized to the value obtained for unmodified mRNA. Values reported in C were 
obtained from Equations 2.2A and normalized to the value obtained for unmodified 
mRNA.  
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A                               B 
 
 
 
 
 
 
Figure I.3. Determination of excitation wavelength for thU- or thC-containing mRNAs. 
Emission spectra of free thU5 (A) or thC6 (B) mRNAs (0.8 μM) were recorded at 
different excitation wavelength. Background fluorescence from the buffer used was 
subtracted at each excitation wavelength. 
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A                                 B 
 
 
 
 
 
 
Figure I.4. Fluorescence changes of thU- and thC-containing mRNAs. A–B. Traces are 
shown for 70SIC (black) and PRE complex (red). Both 70SIC and PRE complex 
traces are for purified samples. Background fluorescence of the corresponding 
purified complex made with unlabeled mRNA was subtracted from the observed 
fluorescence of each of the labeled ribosome complexes.  
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A                                    B 
 
 
 
 
 
 
Figure I.5. Kinetics of PRE complex formation of thU- and thC-containing mRNAs. 
Fluorescence changes on rapid mixing of 70SICs (0.1 μM) programmed with thU- or 
thC-containing mRNAs and cognate TCs (0.4 μM) compared with fluorescence 
changes of fMet-tRNAfMet(prf) (cyan), present as part of the 70SIC. Rates of thU or thC 
fluorescence change were determined using either unlabeled fMet-tRNAfMet and 
unlabeled aa-tRNA (green), or fMet-tRNAfMet(prf) and unlabeled aa-tRNA (magenta). 
A. thU5; B. thC6.  
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APPENDIX II 
RIBOSOME LABELING WITH GOLD PARTICLE FOR 
TRANSLATION IMAGING 
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II.1 Abstract 
 Nanoparticles have great potentials in translation imaging. Here we present 
preliminary results to show that ribosomal protein L1 can be specifically labeled with 
an Au particle. The reconstituted 70S ribosome containing Au labeled L1 is partially 
functional in peptide synthesis. 
  
II.2. Introduction 
Protein synthesis takes place on the ribosome. Currently, most of our 
understandings of the kinetics of ribosomal translation heavily relies on labeling of 
the ribosome, translation factors and/or tRNAs with organic fluorophores, using them 
for both ensemble and single molecule studies (Frank and Gonzalez, 2010; Pan et al., 
2009; Chen et al., 2011a; Cooperman et al., 2011). Compared with ensemble strategy, 
single molecule FRET (Fluorescence Resonance Energy Transfer) method overcomes 
both time- and sample-dependent heterogeneity problems, and promises detection of 
short-lived, but functionally essential intermediates (Marshall et al., 2008; Perez and 
Gonzalez Jr, 2011). However, single molecule fluorescence techniques have suffered 
significantly from numerous requirements imposed on the probes, especially the fast 
photobleaching of organic dyes. Nanoparticles are ideal candidates to overcome such 
a limitation due to their high quantum yield, photostability and tunable absorption and 
emission (Gao et al., 2005; Chang and Rosenthal, 2013). Although nanoparticles have 
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recently been extensively used as fluorescent probes or FRET donor or acceptor in 
single molecule experiments (Grecco et al., 2004; Vale, 2008), only sparse attention 
has been paid to the ribosome translation apparatus [e.g., an Au particle was used to 
label L7/L12 protein on prokaryotic ribosome (Montesano-Roditis et al., 2001)]. Here 
it is shown that i) ribosomal protein L1 can be specifically labeled with an Au particle; 
ii) the L1 derivative is competent in L1 uptake by a mutant 50S ribosome subunit 
lacking L1; and iii) the reconstituted 70S ribosome maintains at least part of its 
translation function in an in vitro peptide synthesis system. 
 
II.3. Results 
II.3.1 L1 labeling with Au particle 
 The Au particle used here has a uniform diameter of 1.4 nm and molecular weight 
of 15 kD, bearing one maleimide group per particle on average. Mutant L1(S40C) 
was incubated with 2-fold excess of Au particle. After quenching of free Au particle 
with glutathione, the reaction mixture was analyzed by SDS-PAGE with two gels 
running in parallel. One gel was silver stained, which detect any protein or Au particle; 
and the second gel was stained by LI Silver Stain Plus kit, which only detects Au 
particles. Besides the band for L1(S40C) (~ 31 kD), which is only observed on the gel 
stained by silver, two bands around ~34–36 kD and one band at ~68 kD were 
observable on the gel stained by both silver and LI silver (Figure II.1). The two bands 
at 34–36 kD were assumed to be the Au:L1(S40C) conjugate in 1:1 ratio, and the two 
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resolved bands and their apparent molecular weight lower than expected (~ 46 kD) 
were probably because of the relative conformation of Au particle and L1(S40C) 
protein within the conjugate. The higher band at ~68 kD was assumed to be the 
Au:L1(S40C) conjugate in 1:2 ratio, resulting from a small amount of Au particle 
carrying two maleimide groups. In a control experiment incubating Au particle with 
wild type L1 [Au:L1(WT)], the resulting mixture showed bands located at 31, 34 and 
64 kD on the gel stained by silver, but these bands disappeared (64 kD) or became 
much weaker (31 and 34 kD) on the gel stained by LI silver (Figure II.1), which may 
result from non-specific binding of Au particle to wild type L1 protein. These results 
demonstrated that ribosomal protein L1 can be specifically and stoichiometrically 
labeled with Au particle [L1(S40C)Au] via cysteine-maleimide chemistry. 
 
II.3.2 Reconstitution of functional 50S ribosome 
 Reconstitution of intact 50S subunit was performed by incubating 50S mutant 
lacking L1 (50S-L1) with either L1(S40C)Au conjugate or Au:L1(WT) mixture. The 
resulting 50S was purified by centrifugation through sucrose cushion, and the 
re-suspended 50S was analyzed on SDS-PAGE gel and stained by LI silver (Figure 
II.2). It was shown that L1(S40C)Au can be specifically uptaken by 50S-L1, even in 
competition with unlabeled L1(S40C). The labeling efficiency of 50S by Au (50SAu) 
was estimated to be roughly 50% by comparing the band intensity with a “standard 
curve” made on the same gel using free Au (Figure II.3).  
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 Labeled 70S ribosome by Au (70SAu) was prepared by incubating reconstituted 
50SAu with stoichiometric 30S subunit, and the functionality of 70SAu was evaluated 
in a poly(U) dependent poly(Phe) synthesis assay (Pan et al., 2009). The results in 
Figure II.4 showed that the activity of reconstituted 70SAu was comparable with 70S 
reconstituted from 30S and unlabeled 50S subunit, and both of them are somewhat 
less active than intact 70S ribosome. 
 
II.4 Experimental 
The following materials were purchased from the indicated suppliers: glutathione 
(Sigma); Silver Stain Plus kit (Bio-Rad); LI Silver Stain kit (Nanoprobes); Nanogold 
monomaleimide (Invitrogen). Yeast tRNAPhe was aminoacylated and AcPhe-tRNAPhe 
was prepared as in Section 2.2.4. 
 
II.4.1 Purification of L1 variants 
Overexpression and purification of L1 variants were based on the published 
procedures (Stevens et al., 2012). BL21(DE3) competent cell, transformed with 
pET16b plasmids carrying wild type or S40C mutant L1, was grown in S.O.C. 
medium at 37 °C for one hour. The cell culture was plated onto LB-Agar plate with 
100 μg/ml of ampicillin and grown overnight at 37 °C. Single colony on the plate was 
inoculated into 6 ml of LB medium with 100 μg/ml of ampicillin for overnight growth 
at 37 °C. Then the cell culture was transferred into 1 L of LB medium with 100 μg/ml 
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of ampicillin for growth until A260 reached ~0.6–0.8. Protein expression was started 
by addition of 1 mM IPTG and lasted overnight at 37 °C. 
Harvested cells were resuspended in 30 ml of L1 equilibration buffer (50 mM 
NaH2PO4 pH 7.0, 300 mM NaCl) and incubated at room temperature for 30 min after 
addition of lysozyme (0.75 mg/ml). Cell was broken by French press twice 
(12,000–14,000 psi) and centrifuged (4 °C, 20k rpm with SS34 rotor, 20 min) to 
remove the cell debris. The supernatant was mixed with 6 ml of Co(II)-Sepharose 
(Talon) resin, pre-washed with 30 ml of L1 equilibration buffer, and shaken at 4 °C 
for 1 hour. Resins bound with L1 were pulled down by centrifugation (4 °C, 700 xg, 5 
min), washed twice with 30 ml of L1 equilibration buffer, and transferred to a small 
gravity small column (18 mm in diameter). The column was washed with 30 ml of L1 
equilibration buffer, and L1 was eluted using L1 equilibration buffer with a imidazole 
gradient (25 mM, 2 ml; 50 mM, 2 ml; 100 mM, 2 ml; 150 mM, 5 ml; 300 mM, 10 ml). 
Fractions containing L1 were confirmed by 12% SDS-PAGE and pooled for dialysis 
at 4 °C, first against buffer A (50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 
mM MgCl2 and 1 mM DTT) without MgCl2 overnight and then against buffer A for 3 
hours with MgCl2. L1 was concentrated using Amicon Ultra ultrafiltration units 
(MWCO: 10,000) and protein concentration was determined by Bradford assay. 
 
II.4.2 Labeling of L1(S40C) and the 50S subunit with Au particle 
 L1(S40C) or wild type L1 (7 μM after exchange) was exchanged into L1 
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labeling buffer (20 mM NaH2PO4 pH 7.0, 150 mM NaCl, 1 mM EDTA) using NAP-5 
column (bed volume 0.5 ml), mixed with equal volume of Au particle (21 μM) freshly 
dissolved in 20% DMSO, and incubated at room temperature for 2 hours in the 
presence of 1 mM of TCEP. Reaction was stopped by adding 1 mM of glutathione to 
quench all free Au particles. The samples were directly loaded onto gel or further used 
without any purification.  
50S mutant lacking L1 (50S-L1) and 30S subunit were prepared as previously 
described (Subramanian and Dabbs, 1980). To make reconstituted Au labeled 50S 
subunit (50SAu), L1(S40C)Au was incubated with 50S-L1 in 100 μl of 50S 
reconstitution buffer (10 mM Tris-HCl pH 7.5, 150 mM NH4Cl, 8 mM MgCl2, 5 mM 
2-mercaptoethanol) (see Figure II.2 for amounts of the 50S subunit and L1 used) at 
room temperature for 1 hour. Reconstituted 50S subunit was purified by 
centrifugation through a sucrose cushion in 50S sucrose cushion buffer (10 mM 
Tris-HCl pH 7.5, 30 mM NH4Cl, 10 mM MgCl2, 5 mM 2-mercaptoethanol, 1.1 M 
sucrose) (SORVALL S120-AT2 rotor, 110K rpm, 40 min, 4 oC), and the pellets were 
resuspended in 50S resuspension buffer (10 mM Tris-HCl pH 7.5, 100 mM NH4Cl, 10 
mM MgCl2, 5 mM 2-mercaptoethanol). 
 
II.4.3 Activity of Au labeled ribosome in poly(Phe) synthesis 
The poly(Phe) assay was carried out in buffer C (20 mM Tris-HCl pH 7.6, 200 
mM NH4Cl, 10 mM MgAc2). All concentrations below are final concentrations after 
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mixing. 70S ribosome was prepared by incubating equal amounts of 50S and 30S 
subunits at 30 °C for 30 min. Initiation mixture was prepared by mixing 70S ribosome 
(0.3 μM, based on 50S or 30S subunits), poly(U) (0.3 g/L) and [3H]-AcPhe-tRNAPhe 
(0.36 μM), and incubated at 30 °C for 30 min. Poly(Phe) synthesis was started by 
adding 2-mercaptoethanol (3 mM), PEP (0.4 mM), PK (4 mg/L), GTP (0.5 mM), 
[3H]-Phe-tRNAPhe (3.6 μM) and EF-G (0.5 μM), and performed by incubating at 30 
°C. Fractions ( 3.5 μl) were aliquoted out at different time points (0, 0.7, 2, 8, 30, 60 
and 120 min), quenched with 0.3 mL of 5% TCA, and heated to 95 °C for 15 min. 
Filter binding was performed using a nitrocellulose filter followed by three washes 
with chilled 5% TCA, and the radioactivity of [3H]-Phe-tRNAPhe was determined. 
 
II.5 Conclusions 
 Here we report the specific and stoichiometic labeling of ribosome protein L1 
with Au nanoparticle. L1(S40C)Au was competent in binding to the 50S subunit, and 
partial activity is retained for reconstituted 70SAu in in vitro peptide synthesis assay. 
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A 
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Figure II.1. Specific and stoichiometric labeling of L1 with Au nanoparticle. Au 
particle was incubated with either mutant L1(S40C) or wild type L1. The resulting 
mixtures [L1(S40C)Au and Au:L1(WT), respectively] were analyzed by SDS-PAGE 
stained by either silver (A) or LI silver (B). 
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Lane 1 2 3 4 5 6 7 8 
L1(S40C)Au 270 pmol 270 pmol 270 pmol 270 pmol 180 pmol 120 pmol – – 
Au:L1(WT) – – – – – – 270 pmol – 
L1(S40C) – – 100 pmol 200 pmol 90 pmol 150 pmol – + 
50S-L1 – 80 pmol 80 pmol 80 pmol 80 pmol 80 pmol 80 pmol – 
50S 80 pmol – – – – – – – 
 
 
Figure II.2. Reconstitution of 50SAu from L1(S40C)Au. L1(S40C)Au or Au:L1(WT) 
was incubated in the presence of 50S-L1 or intact 50S. Unlabeled L1(S40C) was used 
as a reconstitution competitor for L1(S40C)Au as indicated. The samples loaded onto 
each lane were listed in the table. The gel was stained by LI silver, which is specific 
for Au particle. 
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Figure II.3. Semi-quantifying of 50SAu labeling efficiency. Samples loaded onto 
SDS-PAGE gel were: Lane 1, L1(S40C)Au, 80 pmol; Lane 2, L1(S40C)Au, 60 pmol; 
Lane 5, 50SAu, 43 pmol; Lane 4–9, Au particle (60, 50, 40, 30, 20, 10 pmol, 
respectively). The gel was stained by LI silver. 
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Figure II.4. Function of Au labeled ribosome subunit in peptide synthesis. Poly(U) 
dependent poly(Phe) synthesis was measured, as a function of time, for wild type 70S 
(black), reconstituted 70S from wild type 50S and wild type 30S (red), and 
reconstituted 70SAu from 50SAu and wild type 30S. 
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